RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
Term: Reperfusion Injury
Accession: DOID:9004009
browse the term
Definition: Adverse functional, metabolic, or structural changes in ischemic tissues resulting from the restoration of blood flow to the tissue (REPERFUSION), including swelling; HEMORRHAGE; NECROSIS; and damage from FREE RADICALS. The most common instance is MYOCARDIAL REPERFUSION INJURY.
Synonyms: exact_synonym: Ischemia Reperfusion Injury; Ischemia-Reperfusion Injuries; Reperfusion Damage; Reperfusion Damages; Reperfusion Injuries
primary_id: MESH:D015427
xref: EFO:0002687
G
Abcb1a
ATP binding cassette subfamily B member 1A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22749977
NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709
G
Abcc5
ATP binding cassette subfamily C member 5
IEP
mRNA, protein:increased expression:brain, neuron
RGD
PMID:16997484
RGD:2301088
NCBI chr11:80,473,809...80,567,257
Ensembl chr11:80,473,872...80,567,253
G
Abcg2
ATP binding cassette subfamily G member 2
IEP
mRNA, protein:increased expression, altered localization:small intestine
RGD
PMID:18451542
RGD:2315580
NCBI chr 4:87,676,241...87,802,757
Ensembl chr 4:87,745,319...87,802,409
G
Ace
angiotensin I converting enzyme
IMP
RGD
PMID:20436217
RGD:2325213
NCBI chr10:90,910,316...90,930,437
Ensembl chr10:90,910,316...90,931,131
G
Adcyap1
adenylate cyclase activating polypeptide 1
IEP
mRNA:increased expression:hippocampal granule cell
RGD
PMID:19647005
RGD:2315956
NCBI chr 9:113,102,632...113,122,500
Ensembl chr 9:113,103,718...113,109,773
G
Adcyap1r1
ADCYAP receptor type I
IEP
mRNA:decreased expression:dentate gyrus (rat)
RGD
PMID:19647005
RGD:2315956
NCBI chr 4:84,593,558...84,642,700
Ensembl chr 4:84,593,892...84,642,700
G
Adgrl1
adhesion G protein-coupled receptor L1
IEP
RGD
PMID:12225880
RGD:2314400
NCBI chr19:24,202,405...24,244,137
Ensembl chr19:24,204,360...24,244,139
G
Adgrl3
adhesion G protein-coupled receptor L3
IEP
RGD
PMID:12225880
RGD:2314400
NCBI chr14:26,336,320...27,104,060
Ensembl chr14:26,368,277...27,105,860
G
Adipoq
adiponectin, C1Q and collagen domain containing
IMP
associated with Non-alcoholic Fatty Liver Disease;
RGD
PMID:18098300
RGD:5686804
NCBI chr11:77,721,912...77,735,644
Ensembl chr11:77,721,912...77,735,564
G
Adm
adrenomedullin
IEP
protein:increased expression:plasma:
RGD
PMID:17263982
RGD:7364988
NCBI chr 1:164,745,484...164,747,655
Ensembl chr 1:164,745,466...164,747,654
G
Adora2a
adenosine A2a receptor
IDA ISO
CTD Direct Evidence: therapeutic
CTD RGD
PMID:27757725 PMID:17937935
RGD:4890367
NCBI chr20:13,315,848...13,333,386
Ensembl chr20:13,315,853...13,333,386
G
Adora2b
adenosine A2B receptor
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:27757725
NCBI chr10:46,940,394...46,956,772
Ensembl chr10:46,940,384...46,956,772
G
Adrb1
adrenoceptor beta 1
IMP
RGD
PMID:20451506
RGD:5129116
NCBI chr 1:255,771,962...255,774,973
Ensembl chr 1:255,771,597...255,807,259
G
Adrb2
adrenoceptor beta 2
IDA
RGD
PMID:14630341 PMID:18336819
RGD:1598754 , RGD:4145097
NCBI chr18:55,642,459...55,644,501
Ensembl chr18:55,502,903...55,644,512
G
Agt
angiotensinogen
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23875703
NCBI chr19:52,529,139...52,549,618
Ensembl chr19:52,529,185...52,540,977
G
Agtr2
angiotensin II receptor, type 2
IDA
RGD
PMID:22920387
RGD:6903870
NCBI chr X:112,119,876...112,124,060
Ensembl chr X:112,120,228...112,124,057
G
Aif1
allograft inflammatory factor 1
IEP
protein:increased expression:Kupffer cell (rat)
RGD
PMID:16500929
RGD:2313040
NCBI chr20:3,646,784...3,652,670
Ensembl chr20:3,646,777...3,652,668
G
Akt1
AKT serine/threonine kinase 1
ISO
RGD
PMID:21351045
RGD:5509067
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
G
Akt1s1
AKT1 substrate 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16397181
NCBI chr 1:95,333,186...95,339,678
Ensembl chr 1:95,332,898...95,339,677
G
Alb
albumin
IEP
mRNA, protein:increased expression:brain
RGD
PMID:20193666
RGD:2325686
NCBI chr14:17,607,397...17,622,814
Ensembl chr14:17,607,381...17,622,836
G
Aldoa
aldolase, fructose-bisphosphate A
IEP
RGD
PMID:10395295
RGD:1599061
NCBI chr 1:181,402,275...181,407,476
Ensembl chr 1:181,402,275...181,406,182
G
Alox12
arachidonate 12-lipoxygenase, 12S type
IEP
RGD
PMID:15518705
RGD:5509617
NCBI chr10:54,958,263...54,970,542
Ensembl chr10:54,958,271...54,970,542
G
Alox15
arachidonate 15-lipoxygenase
ISO
RGD
PMID:18635843
RGD:5509608
NCBI chr10:55,060,169...55,068,885
Ensembl chr10:55,060,412...55,068,874
G
Alox5
arachidonate 5-lipoxygenase
IEP ISO IMP
protein:increased expression:cerebral hemisphere CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:15266012 PMID:14769366 PMID:19816089
RGD:1626152 , RGD:2317531
NCBI chr 4:149,531,329...149,578,696
Ensembl chr 4:149,531,515...149,578,743
G
Ang
angiogenin
IEP
protein:increased expression:brain
RGD
PMID:19666176
RGD:2325717
NCBI chr15:24,312,711...24,323,361
G
Angpt1
angiopoietin 1
ISO
RGD
PMID:19885826
RGD:2316041
NCBI chr 7:73,528,345...73,783,953
Ensembl chr 7:73,531,486...73,784,067
G
Aoc3
amine oxidase, copper containing 3
IMP
RGD
PMID:16339390
RGD:2313821
NCBI chr10:86,272,757...86,280,702
G
Apaf1
apoptotic peptidase activating factor 1
IEP
RGD
PMID:18205898
RGD:2292105
NCBI chr 7:25,494,143...25,579,540
Ensembl chr 7:25,494,609...25,579,540
G
Apex1
apurinic/apyrimidinic endodeoxyribonuclease 1
IEP
protein:increased expression:placenta
RGD
PMID:18373555
RGD:2315671
NCBI chr15:24,144,595...24,146,785
Ensembl chr15:24,144,362...24,146,785
G
Aqp4
aquaporin 4
IEP ISO
protein:increased expression:cerebral cortex mRNA, protein:increased expression:parietal cortex
RGD
PMID:20979759 PMID:21718723 PMID:19806476 PMID:20924629
RGD:5148016 , RGD:5684013 , RGD:5148037 , RGD:5148022
NCBI chr18:6,507,903...6,524,558
Ensembl chr18:6,507,903...6,524,856
G
Arg1
arginase 1
IEP
protein:increased expression:serum (rat)
RGD
PMID:17023552
RGD:4143185
NCBI chr 1:20,475,878...20,488,422
Ensembl chr 1:20,475,968...20,488,422
G
Asl
argininosuccinate lyase
resistance
IEP
protein:increased expression:brain, neuron (rat)
RGD
PMID:17198704
RGD:1599263
NCBI chr12:26,659,664...26,677,136
Ensembl chr12:26,659,565...26,679,662
G
Ass1
argininosuccinate synthase 1
resistance
IEP
protein:increased expression:brain, neuron (rat)
RGD
PMID:17198704
RGD:1599263
NCBI chr 3:14,747,355...14,796,909
Ensembl chr 3:14,747,368...14,796,903
G
Bad
BCL2-associated agonist of cell death
IEP
protein:altered localization:brain, mitochondria
RGD
PMID:18347331
RGD:2292679
NCBI chr 1:204,133,502...204,142,829
Ensembl chr 1:204,131,501...204,142,823
G
Bag1
BAG cochaperone 1
IMP
RGD
PMID:12215270
RGD:2296021
NCBI chr 5:56,068,494...56,081,075
Ensembl chr 5:56,068,494...56,081,075
G
Bag3
BAG cochaperone 3
IEP
protein:increased expression:hippocampus, astrocyte
RGD
PMID:12061864
RGD:2325848
NCBI chr 1:183,103,038...183,126,862
Ensembl chr 1:183,102,871...183,126,858
G
Bax
BCL2 associated X, apoptosis regulator
IEP
protein:increased expression:brain
RGD
PMID:18083315 PMID:18221257
RGD:2290557 , RGD:2293026
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
G
Bcl2
BCL2, apoptosis regulator
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:15449323
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
Bdnf
brain-derived neurotrophic factor
IEP
mRNA:increased expression:retina
RGD
PMID:20554625
RGD:4891135
NCBI chr 3:96,165,042...96,215,621
Ensembl chr 3:96,165,042...96,215,615
G
Becn1
beclin 1
IEP
protein:increased expression:brain
RGD
PMID:22306244
RGD:6483054
NCBI chr10:86,231,387...86,246,742
Ensembl chr10:86,231,388...86,246,742
G
Bid
BH3 interacting domain death agonist
IDA
RGD
PMID:19888517
RGD:2317562
NCBI chr 4:154,113,198...154,136,353
Ensembl chr 4:154,113,198...154,134,720
G
Birc5
baculoviral IAP repeat-containing 5
IEP IMP
protein:increased expression:brain
RGD
PMID:18159002 PMID:18053646
RGD:2293126 , RGD:2293127
NCBI chr10:103,072,530...103,081,382
Ensembl chr10:103,073,408...103,081,380
G
Bmp6
bone morphogenetic protein 6
IEP
RGD
PMID:11245809
RGD:2289024
NCBI chr17:26,318,121...26,469,691
Ensembl chr17:26,318,569...26,470,365
G
Bmpr2
bone morphogenetic protein receptor type 2
IEP
mRNA:increased expression:dentate gyrus, granule cell
RGD
PMID:10996456
RGD:5129486
NCBI chr 9:61,192,718...61,307,280
Ensembl chr 9:61,190,566...61,301,809
G
Bsg
basigin (Ok blood group)
IEP
protein:increased expression:basal ganglia
RGD
PMID:16029217
RGD:2289063
NCBI chr 7:9,993,170...10,000,387
Ensembl chr 7:9,993,170...10,000,387
G
Btg2
BTG anti-proliferation factor 2
IEP
mRNA:increased expression:kidney
RGD
PMID:9712737
RGD:2289078
NCBI chr13:45,531,881...45,535,642
Ensembl chr13:45,531,925...45,535,628
G
C3
complement C3
IEP
protein:increased expression:intestine
RGD
PMID:17981193
RGD:5129536
NCBI chr 9:2,087,437...2,114,366
Ensembl chr 9:2,087,437...2,114,429
G
C3ar1
complement C3a receptor 1
IMP
RGD
PMID:15159277
RGD:5129702
NCBI chr 4:156,074,747...156,084,680
Ensembl chr 4:156,075,389...156,084,701
G
C5
complement C5
IDA
RGD
PMID:15158333
RGD:1600597
NCBI chr 3:18,270,696...18,361,994
Ensembl chr 3:18,270,696...18,361,994
G
C5ar1
complement C5a receptor 1
IMP
RGD
PMID:15158333 PMID:15159277
RGD:1600597 , RGD:5129702
NCBI chr 1:76,948,622...76,959,826
G
Casp1
caspase 1
IMP
RGD
PMID:17845807
RGD:2315890
NCBI chr 8:2,587,812...2,597,403
Ensembl chr 8:2,587,831...2,597,383
G
Casp12
caspase 12
IEP
RGD
PMID:18273070
RGD:2311461
NCBI chr 8:2,642,296...2,669,549
Ensembl chr 8:2,642,434...2,674,037
G
Casp3
caspase 3
treatment
IMP IDA ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:23875703 PMID:18490106 PMID:29568770
RGD:2293311 , RGD:13792595
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Casp6
caspase 6
IEP
protein:increased expression, increased activity:small intestine mucosa
RGD
PMID:15010362
RGD:2301320
NCBI chr 2:218,466,063...218,478,503
Ensembl chr 2:218,466,076...218,478,502
G
Casp8
caspase 8
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23875703
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
G
Casp9
caspase 9
treatment
IDA
RGD
PMID:29568770
RGD:13792595
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
G
Cast
calpastatin
IEP
RGD
PMID:11035539
RGD:5509823
NCBI chr 2:3,973,112...4,082,658
Ensembl chr 2:3,973,112...4,082,659
G
Cat
catalase
IDA ISO IEP
CTD Direct Evidence: marker/mechanism|therapeutic
CTD RGD
PMID:8215636 PMID:16682413 PMID:23743330 PMID:23875703 PMID:19196076 PMID:20888583 More...
RGD:5130760 , RGD:5130200
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
G
Cav1
caveolin 1
IEP
protein:increased expression:brain
RGD
PMID:17293479
RGD:2289123
NCBI chr 4:45,640,624...45,673,708
Ensembl chr 4:45,634,918...45,673,705
G
Ccl11
C-C motif chemokine ligand 11
IEP
mRNA:increased expression:aorta
RGD
PMID:9665468
RGD:4145482
NCBI chr10:67,028,328...67,032,929
Ensembl chr10:67,028,328...67,032,926
G
Ccl2
C-C motif chemokine ligand 2
treatment
IDA ISO
Gastric Reperfusion Injury CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:12468449 PMID:15829914 PMID:22611311
RGD:8549744
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
G
Ccl3
C-C motif chemokine ligand 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15829914
NCBI chr10:68,451,388...68,452,938
Ensembl chr10:68,451,388...68,452,938
G
Ccl5
C-C motif chemokine ligand 5
ISO IEP
protein:increased secretion:lung, secretion (mouse) protein:increased expression:gut
RGD
PMID:19558673 PMID:15542513
RGD:4891479 , RGD:2307184
NCBI chr10:68,322,826...68,327,380
Ensembl chr10:68,322,829...68,327,377
G
Ccnb1
cyclin B1
IEP
protein;altered expression:cerebral cortex, hippocampus CA1, neuron
RGD
PMID:18278459
RGD:2315990
NCBI chr 2:31,912,190...31,921,163
Ensembl chr 2:31,912,193...31,921,172
G
Ccnd1
cyclin D1
IEP
RGD
PMID:16718823
RGD:2289145
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
G
Ccne1
cyclin E1
IEP
protein:decreased expression:liver
RGD
PMID:17584601
RGD:2289275
NCBI chr 1:90,781,947...90,791,188
Ensembl chr 1:90,781,949...90,791,101
G
Ccng1
cyclin G1
IEP
mRNA, protein:increased expression:brain
RGD
PMID:9698156
RGD:2316027
NCBI chr10:25,176,231...25,182,604
Ensembl chr10:25,176,234...25,181,641
G
Ccr1
C-C motif chemokine receptor 1
ISO
mRNA:increased expression:kidney
RGD
PMID:20410256
RGD:5688141
NCBI chr 8:123,556,286...123,561,841
G
Cd2ap
CD2-associated protein
IEP
RGD
PMID:16088078
RGD:1581187
NCBI chr 9:18,086,744...18,182,744
Ensembl chr 9:18,086,984...18,182,199
G
Cd36
CD36 molecule
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16526316
NCBI chr 4:17,317,343...17,410,084
Ensembl chr 4:17,354,466...17,513,903
G
Cd40
CD40 molecule
IMP
RGD
PMID:12388354
RGD:5508171
NCBI chr 3:153,790,372...153,805,279
Ensembl chr 3:153,790,449...153,805,534
G
Cd40lg
CD40 ligand
ISO IMP
RGD
PMID:20659085 PMID:12388354
RGD:5490531 , RGD:5508171
NCBI chr X:135,127,052...135,138,768
Ensembl chr X:135,126,969...135,138,306
G
Cd44
CD44 molecule
IEP
protein:increased expression:kidney protein:increased expression:testis, macrophage
RGD
PMID:16786159 PMID:16891795
RGD:2289354 , RGD:2289369
NCBI chr 3:89,155,850...89,244,615
Ensembl chr 3:89,157,058...89,244,620
G
Cd55
CD55 molecule (Cromer blood group)
IEP
RGD
PMID:20403613
RGD:2326175
NCBI chr13:41,857,242...41,885,966
Ensembl chr13:41,857,395...41,885,831
G
Cd59b
CD59b molecule
IDA
RGD
PMID:10530491
RGD:1600493
NCBI chr 3:90,459,085...90,477,571
Ensembl chr 3:90,459,162...90,478,847
G
Cdc42
cell division cycle 42
IDA
protein:increased activation:hippocampus CA1
RGD
PMID:17161586
RGD:2298583
NCBI chr 5:149,555,069...149,593,239
Ensembl chr 5:149,553,724...149,593,111
G
Cdkn1a
cyclin-dependent kinase inhibitor 1A
IEP ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:16968891 PMID:10451498
RGD:10043817
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
G
Cdkn1b
cyclin-dependent kinase inhibitor 1B
IEP
protein:increased expression:skeletal muscle
RGD
PMID:15799773
RGD:2293627
NCBI chr 4:167,760,067...167,765,177
Ensembl chr 4:167,760,181...167,764,982
G
Cfh
complement factor H
IEP
protein:increased expression:plasma:
RGD
PMID:17263982
RGD:7364988
NCBI chr13:51,512,376...51,613,829
Ensembl chr13:51,511,828...51,613,838
G
Chat
choline O-acetyltransferase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23075401
NCBI chr16:7,657,362...7,717,093
Ensembl chr16:7,657,362...7,717,093
G
Cldn4
claudin 4
IEP
protein:increased expression, altered localization:small intestine epithelium
RGD
PMID:17375208
RGD:2317600
NCBI chr12:21,751,638...21,753,436
Ensembl chr12:21,751,331...21,753,436
G
Cnr1
cannabinoid receptor 1
IMP
RGD
PMID:19372445
RGD:2314674
NCBI chr 5:48,408,543...48,436,099
Ensembl chr 5:48,408,574...48,435,099
G
Cspg4
chondroitin sulfate proteoglycan 4
IEP
RGD
PMID:17565360
RGD:5686869
NCBI chr 8:57,264,962...57,300,010
Ensembl chr 8:57,264,962...57,300,010
G
Ctsb
cathepsin B
IEP
protein:increased expression:cerebral cortex, mitochondrion (rat)
RGD
PMID:18938146
RGD:2315506
NCBI chr15:37,389,636...37,410,508
Ensembl chr15:37,389,629...37,410,500
G
Ctsg
cathepsin G
ISO
RGD
PMID:17322378
RGD:7242055
NCBI chr15:29,930,988...29,937,353
Ensembl chr15:29,931,003...29,937,353
G
Cx3cl1
C-X3-C motif chemokine ligand 1
IEP
mRNA, protein:increased expression:brain
RGD
PMID:19563789
RGD:4891956
NCBI chr19:10,227,337...10,237,826
Ensembl chr19:10,227,340...10,236,833
G
Cxcl1
C-X-C motif chemokine ligand 1
ISO IEP
mRNA:increased expression:liver CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:16526316 PMID:20160675 PMID:10655268
RGD:5134970 , RGD:5135270
NCBI chr14:17,193,364...17,195,143
Ensembl chr14:17,193,365...17,195,215
G
Cxcl10
C-X-C motif chemokine ligand 10
IEP ISO
mRNA:increased expression:liver protein:increased expression:respiratory system fluid/secretion associated with Anemia, Sickle Cell;protein:increased expression:lung
RGD
PMID:18589091 PMID:16709871 PMID:19433855
RGD:2311376 , RGD:5135441 , RGD:5135307
NCBI chr14:15,704,772...15,706,969
Ensembl chr14:15,704,758...15,706,975
G
Cxcl12
C-X-C motif chemokine ligand 12
IEP
protein:increased expression:retina
RGD
PMID:18709383
RGD:2306570
NCBI chr 4:150,388,326...150,401,173
Ensembl chr 4:150,388,325...150,401,168
G
Cxcl2
C-X-C motif chemokine ligand 2
IEP ISO
mRNA:increased expression:jejunum, lung CTD Direct Evidence: marker/mechanism protein:increased expression:liver mRNA:increased expression:liver
CTD RGD
PMID:12468449 PMID:19691980 PMID:10655268 PMID:11580116 PMID:20160675
RGD:5134974 , RGD:5135270 , RGD:5135251 , RGD:5134970
NCBI chr14:17,181,030...17,183,075
Ensembl chr14:17,181,062...17,183,075
G
Cxcl3
C-X-C motif chemokine ligand 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16526316
NCBI chr14:17,287,727...17,289,451
Ensembl chr14:17,270,146...17,289,511
G
Cxcl6
C-X-C motif chemokine ligand 6
IEP
protein:increased expression:liver
RGD
PMID:11580116 PMID:10655268
RGD:5135251 , RGD:5135270
NCBI chr14:17,310,790...17,312,250
Ensembl chr14:17,310,426...17,313,093
G
Cxcl9
C-X-C motif chemokine ligand 9
ISO
associated with Anemia, Sickle Cell;protein:increased expression:lung
RGD
PMID:19433855
RGD:5135307
NCBI chr14:15,722,868...15,727,779
Ensembl chr14:15,722,908...15,728,435
G
Cxcr3
C-X-C motif chemokine receptor 3
IEP
mRNA:increased expression:liver
RGD
PMID:18589091
RGD:2311376
NCBI chr X:66,844,318...66,846,969
Ensembl chr X:66,844,318...66,846,969
G
Cyba
cytochrome b-245 alpha chain
IEP
RGD
PMID:15148062
RGD:1599683
NCBI chr19:50,487,598...50,495,669
Ensembl chr19:50,487,597...50,495,721
G
Cybb
cytochrome b-245 beta chain
IEP ISO
Protein:increase expression:brain CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:19193722 PMID:16766636
RGD:1599677
NCBI chr X:13,358,101...13,392,570
Ensembl chr X:13,359,430...13,392,586
G
Cyp19a1
cytochrome P450, family 19, subfamily a, polypeptide 1
IEP
protein:increased expression:hippocampus (rat)
RGD
PMID:21114983
RGD:4890041
NCBI chr 8:54,552,978...54,580,375
Ensembl chr 8:54,553,165...54,580,758
G
Cyp2e1
cytochrome P450, family 2, subfamily e, polypeptide 1
IEP
protein:decreased expression:liver
RGD
PMID:21094789
RGD:4892235
NCBI chr 1:195,840,330...195,850,728
Ensembl chr 1:195,840,058...195,864,023
G
Cyp3a62
cytochrome P450, family 3, subfamily a, polypeptide 62
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:22749977
NCBI chr12:16,397,998...16,433,833
Ensembl chr12:16,397,998...16,433,833
G
Cyp3a9
cytochrome P450, family 3, subfamily a, polypeptide 9
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:22749977
NCBI chr12:16,806,222...16,846,428
Ensembl chr12:16,806,207...16,846,422
G
Cysltr1
cysteinyl leukotriene receptor 1
IEP
protein:increased expression:kidney
RGD
PMID:18790177
RGD:4781446
NCBI chr X:71,661,421...71,690,012
Ensembl chr X:71,663,821...71,690,121
G
Cysltr2
cysteinyl leukotriene receptor 2
IEP
protein:increased expression:brain
RGD
PMID:21664436
RGD:5144004
NCBI chr15:48,189,476...48,228,750
Ensembl chr15:48,189,073...48,304,136
G
Dcc
DCC netrin 1 receptor
IEP
protein:increased expression:brain
RGD
PMID:17574219
RGD:2314372
NCBI chr18:64,868,987...65,972,783
Ensembl chr18:64,873,898...65,972,740
G
Dsg1
desmoglein 1
IEP
protein:decreased expression:lung
RGD
PMID:19500802
RGD:2316254
NCBI chr18:11,674,687...11,705,383
Ensembl chr18:11,674,402...11,703,443
G
Edn1
endothelin 1
IEP ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:17470888 PMID:18722366
RGD:4892577
NCBI chr17:22,454,924...22,460,812
Ensembl chr17:22,454,420...22,460,885
G
Edn2
endothelin 2
IEP
RGD
PMID:1479622
RGD:1580920
NCBI chr 5:133,751,316...133,756,814
Ensembl chr 5:133,751,217...133,756,814
G
Ednrb
endothelin receptor type B
IEP
RGD
PMID:18722366
RGD:4892577
NCBI chr15:80,640,839...80,672,115
Ensembl chr15:80,643,043...80,672,115
G
Eef2
eukaryotic translation elongation factor 2
IEP
protein:hypophosphorylation:cortex, hippocampus:
RGD
PMID:15211596
RGD:10401223
NCBI chr 7:8,533,248...8,538,518
Ensembl chr 7:8,533,116...8,559,183
G
Efna5
ephrin A5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16526316
NCBI chr 9:102,316,753...102,595,480
Ensembl chr 9:102,320,295...102,597,413
G
Efnb2
ephrin B2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16526316
NCBI chr16:80,783,389...80,827,420
Ensembl chr16:80,783,417...80,824,391
G
Egf
epidermal growth factor
resistance
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:16526316 PMID:16417467
RGD:6906916
NCBI chr 2:218,219,408...218,302,359
Ensembl chr 2:218,219,415...218,302,064
G
Egr1
early growth response 1
ISO IEP
Lung Reperfusion Injury CTD Direct Evidence: marker/mechanism Lung Reperfusion Injury; protein:increased expression:lung, nucleus (rat) Lung Reperfusion Injury; protein:increased expression:lung, nucleus (mouse)
CTD RGD
PMID:12468449 PMID:16551742 PMID:16488723 PMID:19342415
RGD:5131903 , RGD:5131904 , RGD:5131887
NCBI chr18:26,462,967...26,466,766
Ensembl chr18:26,462,981...26,466,766
G
Eif2a
eukaryotic translation initiation factor 2A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19041636
NCBI chr 2:142,761,303...142,794,767
Ensembl chr 2:142,761,416...142,795,068
G
Eif2ak3
eukaryotic translation initiation factor 2 alpha kinase 3
IDA
protein:increased phosphorylation:kidney
RGD
PMID:15936177
RGD:1581062
NCBI chr 4:102,805,495...102,866,914
Ensembl chr 4:102,805,510...102,866,911
G
Eif2s1
eukaryotic translation initiation factor 2 subunit alpha
IDA
protein:increased phosphorylation:kidney
RGD
PMID:15936177
RGD:1581062
NCBI chr 6:97,672,829...97,697,499
Ensembl chr 6:97,672,766...97,706,225
G
Eno2
enolase 2
IDA
RGD
PMID:17683050
RGD:2293745
NCBI chr 4:157,572,085...157,580,971
Ensembl chr 4:157,572,088...157,580,980
G
Ep300
E1A binding protein p300
treatment
IDA IEP
retina retina; protein:altered localization:Hsp70, promoter (rat)
RGD
PMID:22143029 PMID:22143029
RGD:5686888 , RGD:5686888
NCBI chr 7:113,108,476...113,178,529
Ensembl chr 7:113,106,247...113,136,088 Ensembl chr 7:113,106,247...113,136,088
G
Epha2
Eph receptor A2
IDA
RGD
PMID:16735461
RGD:1580976
NCBI chr 5:153,605,644...153,634,115
Ensembl chr 5:153,605,644...153,634,117
G
Ephx2
epoxide hydrolase 2
ISO
RGD
PMID:19471280
RGD:5688359
NCBI chr15:40,289,901...40,327,632
Ensembl chr15:40,289,902...40,327,615
G
Ercc1
ERCC excision repair 1, endonuclease non-catalytic subunit
IMP
RGD
PMID:19440222
RGD:2313668
NCBI chr 1:78,971,310...79,007,963
Ensembl chr 1:78,996,390...79,007,963
G
Ets1
ETS proto-oncogene 1, transcription factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16526316
NCBI chr 8:31,045,909...31,168,010
Ensembl chr 8:31,045,945...31,168,010
G
F2
coagulation factor II, thrombin
IMP
RGD
PMID:20705928
RGD:5147777
NCBI chr 3:77,596,196...77,609,486
Ensembl chr 3:77,596,198...77,609,486
G
Fas
Fas cell surface death receptor
treatment
IDA
RGD
PMID:29568770
RGD:13792595
NCBI chr 1:231,798,963...231,832,591
Ensembl chr 1:231,798,960...231,832,591
G
Fgf1
fibroblast growth factor 1
IDA ISO
Rat model using human FGF1
RGD
PMID:19497570 PMID:16635575
RGD:5509879 , RGD:5509881
NCBI chr18:30,686,555...30,772,667
Ensembl chr18:30,686,581...30,772,357
G
Fgf2
fibroblast growth factor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16526316
NCBI chr 2:120,236,328...120,290,673
Ensembl chr 2:120,236,328...120,291,221
G
Fgf7
fibroblast growth factor 7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16526316
NCBI chr 3:113,280,448...113,333,279
Ensembl chr 3:113,281,283...113,332,929
G
Fos
Fos proto-oncogene, AP-1 transcription factor subunit
IEP ISO
protein:increased expression:brain CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:7922267 PMID:15121240
RGD:2293779
NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036
G
Fosl1
FOS like 1, AP-1 transcription factor subunit
IEP
mRNA:increased expression:hippocampus
RGD
PMID:15306117
RGD:1642465
NCBI chr 1:202,754,549...202,763,057
Ensembl chr 1:202,754,529...202,764,930
G
Fosl2
FOS like 2, AP-1 transcription factor subunit
IEP
protein:increased expression:brain
RGD
PMID:15121240
RGD:2293779
NCBI chr 6:24,297,898...24,319,219
Ensembl chr 6:24,300,956...24,320,034
G
G6pd
glucose-6-phosphate dehydrogenase
IEP
RGD
PMID:17250641
RGD:2307361
NCBI chr X:152,201,081...152,220,863
Ensembl chr X:152,201,098...152,220,801
G
Gast
gastrin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:10594344
NCBI chr10:85,264,832...85,269,393
Ensembl chr10:85,264,832...85,267,496
G
Gh1
growth hormone 1
treatment
ISO
RGD
PMID:21439711
RGD:10003153
NCBI chr10:91,228,102...91,230,079
Ensembl chr10:91,228,103...91,230,078
G
Ghrl
ghrelin and obestatin prepropeptide
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:16581065
NCBI chr 4:146,865,712...146,869,621
Ensembl chr 4:146,865,712...146,869,621
G
Gjb1
gap junction protein, beta 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25530438
NCBI chr X:66,501,848...66,509,783
Ensembl chr X:66,501,820...66,509,925
G
Glud1
glutamate dehydrogenase 1
IEP
protein:decreased activity:brain
RGD
PMID:7808037
RGD:6484655
NCBI chr16:9,640,312...9,673,961
Ensembl chr16:9,640,312...9,673,957
G
Gnai2
G protein subunit alpha i2
IEP
RGD
PMID:11367746
RGD:13513922
NCBI chr 8:108,288,401...108,309,009
Ensembl chr 8:108,288,401...108,308,979
G
Gnai3
G protein subunit alpha i3
IEP
RGD
PMID:11367746
RGD:13513922
NCBI chr 2:195,742,765...195,780,720
Ensembl chr 2:195,742,642...195,780,742
G
Gpt
glutamic--pyruvic transaminase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:8215636
NCBI chr 7:108,416,646...108,419,495
Ensembl chr 7:108,416,642...108,419,494
G
Gpx1
glutathione peroxidase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23743330
NCBI chr 8:109,026,905...109,028,031
Ensembl chr 8:109,026,905...109,028,024
G
Gria1
glutamate ionotropic receptor AMPA type subunit 1
IEP
mRNA:decreased expression:hippocampus (rat)
RGD
PMID:20408958
RGD:4107069
NCBI chr10:41,210,713...41,527,283
Ensembl chr10:41,210,713...41,527,283
G
Grik2
glutamate ionotropic receptor kainate type subunit 2
IMP
RGD
PMID:17639597
RGD:2316528
NCBI chr20:52,135,325...52,833,061
Ensembl chr20:52,133,851...52,838,375
G
Grik5
glutamate ionotropic receptor kainate type subunit 5
IMP
RGD
PMID:17639597
RGD:2316528
NCBI chr 1:80,605,878...80,667,896
Ensembl chr 1:80,605,892...80,667,125
G
Grin2a
glutamate ionotropic receptor NMDA type subunit 2A
IEP
mRNA, protein:decreased expression:cerebral cortex, hippocampus (rat)
RGD
PMID:20350575
RGD:2325867
NCBI chr10:5,629,683...6,053,262
Ensembl chr10:5,631,369...6,044,637
G
Grin2b
glutamate ionotropic receptor NMDA type subunit 2B
IEP
mRNA, protein:decreased expression:cerebral cortex, hippocampus (rat)
RGD
PMID:20350575
RGD:2325867
NCBI chr 4:168,580,824...169,044,110
Ensembl chr 4:168,599,546...169,042,279
G
Gsr
glutathione-disulfide reductase
treatment
IEP
associated with Diabetes Mellitus, Experimental
RGD
PMID:24904723
RGD:10401882
NCBI chr16:58,482,209...58,525,256
Ensembl chr16:58,482,505...58,525,661
G
Gstp1
glutathione S-transferase pi 1
ISO
RGD
PMID:17142801
RGD:6903953
NCBI chr 1:201,337,762...201,340,230
Ensembl chr 1:201,321,672...201,340,226
G
Hbegf
heparin-binding EGF-like growth factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:7635938
NCBI chr18:28,106,284...28,116,167
Ensembl chr18:28,105,760...28,116,441
G
Hgf
hepatocyte growth factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16526316
NCBI chr 4:18,673,736...18,745,582
Ensembl chr 4:18,677,101...18,745,409
G
Hif1a
hypoxia inducible factor 1 subunit alpha
treatment
IDA
Spinal Cord Reperfusion Injury Limb Reperfusion Injury
RGD
PMID:16465055 PMID:23816242
RGD:9068924 , RGD:9068927
NCBI chr 6:92,624,059...92,669,262
Ensembl chr 6:92,624,390...92,669,261
G
Hmgb1
high mobility group box 1
treatment
IMP
RGD
PMID:22392147
RGD:10402071
NCBI chr12:5,972,950...5,979,658
Ensembl chr12:5,901,586...5,978,565 Ensembl chr16:5,901,586...5,978,565
G
Hmgcr
3-hydroxy-3-methylglutaryl-CoA reductase
IMP ISO
associated with Diabetes Mellitus, Experimental
RGD
PMID:21724106 PMID:16009498 PMID:18398369
RGD:5508445 , RGD:5508473 , RGD:2315888
NCBI chr 2:27,997,523...28,018,983
Ensembl chr 2:27,997,525...28,019,703
G
Hmox1
heme oxygenase 1
IDA ISO IEP IMP
CTD Direct Evidence: marker/mechanism|therapeutic protein:increased expression:serum, Bronchoalveolar Lavage Fluid
CTD RGD
PMID:12352873 PMID:16982915 PMID:17660127 PMID:17906103 PMID:23075401 PMID:25780291 PMID:16699460 PMID:19885035 PMID:12919086 More...
RGD:1582708 , RGD:4145338 , RGD:4145514
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
G
Hrh3
histamine receptor H3
IDA
RGD
PMID:17169356
RGD:1626416
NCBI chr 3:167,191,551...167,196,642
Ensembl chr 3:167,191,558...167,196,642
G
Hspa1a
heat shock protein family A (Hsp70) member 1A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:7922267
NCBI chr20:3,870,765...3,873,221
Ensembl chr20:3,856,006...3,873,227
G
Hspa1b
heat shock protein family A (Hsp70) member 1B
ISO IEP
RGD
PMID:10965299 PMID:10550516
RGD:7242748 , RGD:7242749
NCBI chr20:3,855,104...3,859,148
Ensembl chr20:3,856,006...3,873,240 Ensembl chr20:3,856,006...3,873,240
G
Hspa5
heat shock protein family A (Hsp70) member 5
IMP
associated with Diabetes Mellitus, experimental (D003921): protein:increased expression:brain
RGD
PMID:22075494
RGD:5685650
NCBI chr 3:18,055,507...18,059,969
Ensembl chr 3:18,055,405...18,059,891
G
Hspa8
heat shock protein family A (Hsp70) member 8
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:10216529
NCBI chr 8:41,183,397...41,187,260
Ensembl chr 8:41,183,264...41,187,259
G
Hspb1
heat shock protein family B (small) member 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:19193722
NCBI chr12:20,794,014...20,795,675
Ensembl chr12:20,794,028...20,795,743
G
Icam1
intercellular adhesion molecule 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11557319 PMID:23743330
NCBI chr 8:19,553,063...19,565,438
Ensembl chr 8:19,553,645...19,565,438
G
Id3
inhibitor of DNA binding 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16526316
NCBI chr 5:148,372,784...148,374,353
Ensembl chr 5:148,372,762...148,374,349
G
Ifng
interferon gamma
IEP
protein:increased expression:plasma
RGD
PMID:19514843
RGD:2308950
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
G
Igf1
insulin-like growth factor 1
ISO
RGD
PMID:16306169
RGD:1598442
NCBI chr 7:22,282,895...22,361,972
Ensembl chr 7:22,282,930...22,359,296
G
Il10
interleukin 10
IEP ISO IDA
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:18460982 PMID:19514843 PMID:12388354 PMID:16141682
RGD:2308950 , RGD:5508171 , RGD:1598625
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
G
Il12a
interleukin 12A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16526316
NCBI chr 2:152,965,769...152,973,035
Ensembl chr 2:152,965,769...152,972,734
G
Il13
interleukin 13
IEP ISO
protein:decreased expression:plasma
RGD
PMID:18354382 PMID:18354382
RGD:2301685 , RGD:2301685
NCBI chr10:37,790,130...37,792,687
Ensembl chr10:37,790,130...37,792,737
G
Il18
interleukin 18
ISO
protein:increased expression:serum
RGD
PMID:19394645 PMID:16052682
RGD:4889555 , RGD:4889825
NCBI chr 8:50,904,630...50,932,887
Ensembl chr 8:50,906,960...50,932,887
G
Il1a
interleukin 1 alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23875703
NCBI chr 3:116,526,601...116,537,055
Ensembl chr 3:116,526,604...116,536,822
G
Il1b
interleukin 1 beta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:10594344 PMID:12468449 PMID:15829914 PMID:19058328 PMID:19673871
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
G
Il6
interleukin 6
IEP ISO
CTD Direct Evidence: marker/mechanism protein:increased expression:lung
CTD RGD
PMID:15829914 PMID:17032661 PMID:18258783 PMID:19673871 PMID:21940958 PMID:20680426 PMID:20659747 More...
RGD:4143250 , RGD:4143253
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
G
Il6r
interleukin 6 receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21940958
NCBI chr 2:175,289,157...175,347,719
Ensembl chr 2:175,298,686...175,347,536
G
Il6st
interleukin 6 cytokine family signal transducer
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21940958
NCBI chr 2:44,065,979...44,106,255
Ensembl chr 2:44,066,130...44,109,936
G
Inpp5d
inositol polyphosphate-5-phosphatase D
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:25780291
NCBI chr 9:88,287,680...88,392,748
Ensembl chr 9:88,287,677...88,392,746
G
Irak3
interleukin-1 receptor-associated kinase 3
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:25780291
NCBI chr 7:55,653,949...55,714,371
Ensembl chr 7:55,653,962...55,713,121
G
Irf1
interferon regulatory factor 1
IEP
mRNA:increased expression:cerebral cortex
RGD
PMID:12437578
RGD:632385
NCBI chr10:37,917,155...37,924,166
Ensembl chr10:37,916,670...37,924,166
G
Itga2b
integrin subunit alpha 2b
IMP
RGD
PMID:11705748
RGD:2316361
NCBI chr10:87,408,532...87,426,055
Ensembl chr10:87,408,536...87,426,168
G
Itga5
integrin subunit alpha 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16526316
NCBI chr 7:134,478,963...134,502,837
Ensembl chr 7:134,478,968...134,502,837
G
Itgb3
integrin subunit beta 3
IMP
RGD
PMID:11705748
RGD:2316361
NCBI chr10:89,509,917...89,564,679
Ensembl chr10:89,509,989...89,564,679
G
Jak2
Janus kinase 2
ISO
RGD
PMID:20440769
RGD:6483026
NCBI chr 1:226,995,334...227,054,381
Ensembl chr 1:226,995,334...227,054,189
G
Jun
Jun proto-oncogene, AP-1 transcription factor subunit
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:7922267
NCBI chr 5:109,894,175...109,897,268
Ensembl chr 5:109,893,145...109,897,656
G
Kcnj8
potassium inwardly-rectifying channel, subfamily J, member 8
IDA
RGD
PMID:10708603
RGD:1581697
NCBI chr 4:175,508,908...175,515,829
Ensembl chr 4:175,508,912...175,515,603
G
Kdr
kinase insert domain receptor
IEP ISO
mRNA:increased expression:hippocampus CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:16526316 PMID:17402857
RGD:5684415
NCBI chr14:32,217,871...32,261,018
Ensembl chr14:32,217,871...32,261,018
G
Keap1
Kelch-like ECH-associated protein 1
ISO IEP
protein:decreased expression:brain, neuron, cytoplasm (mouse) protein:decreased expression:left coronary artery (rat)
RGD
PMID:21075092 PMID:18078953
RGD:6893270 , RGD:6902919
NCBI chr 8:19,768,375...19,777,862
Ensembl chr 8:19,768,375...19,777,862
G
Klk1
kallikrein 1
IEP
RGD
PMID:12746231
RGD:1641806
NCBI chr 1:94,642,644...94,646,760
Ensembl chr 1:94,642,687...94,646,754
G
Ldlr
low density lipoprotein receptor
IEP
RGD
PMID:17288738
RGD:2324630
NCBI chr 8:20,270,020...20,292,981
Ensembl chr 8:20,270,041...20,294,580
G
Lep
leptin
IDA
RGD
PMID:21086559
RGD:5128549
NCBI chr 4:57,661,127...57,675,262
Ensembl chr 4:57,661,131...57,675,262
G
Lig3
DNA ligase 3
IEP
protein:increased expression:brain
RGD
PMID:17412650
RGD:2302580
NCBI chr10:67,717,808...67,741,141
Ensembl chr10:67,717,812...67,798,414
G
Manf
mesencephalic astrocyte-derived neurotrophic factor
IEP
protein:increased expression:brain
RGD
PMID:19773801
RGD:2325809
NCBI chr 8:107,500,856...107,551,595
Ensembl chr 8:107,548,352...107,551,438
G
Map2
microtubule-associated protein 2
IEP
protein:increased expression:serum
RGD
PMID:21948028
RGD:6483082
NCBI chr 9:67,723,422...67,981,886
Ensembl chr 9:67,723,371...67,979,809
G
Mapk8
mitogen-activated protein kinase 8
IDA ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:20302854 PMID:16699462
RGD:1582310
NCBI chr16:8,638,897...8,721,960
Ensembl chr16:8,638,924...8,721,981
G
Mapk8ip3
mitogen-activated protein kinase 8 interacting protein 3
IDA
protein:increased activity:hippocampus
RGD
PMID:16805806
RGD:2293339
NCBI chr10:13,918,417...13,958,335
Ensembl chr10:13,918,400...13,958,273
G
Mapk9
mitogen-activated protein kinase 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19667931 PMID:20302854
NCBI chr10:34,169,661...34,211,138
Ensembl chr10:34,169,675...34,210,178
G
Mb
myoglobin
ISO
RGD
PMID:12788661
RGD:1582427
NCBI chr 7:108,759,903...108,767,134
Ensembl chr 7:108,759,904...108,767,383
G
Mbl1
mannose binding lectin 1
ISO
protein:decreased expression:serum
RGD
PMID:16982912 PMID:15509537
RGD:1582132 , RGD:6903263
NCBI chr16:17,029,146...17,035,187
Ensembl chr16:17,029,118...17,035,174
G
Mbl2
mannose binding lectin 2
ISO
protein:increased expression:serum
RGD
PMID:15882434 PMID:15509537
RGD:6903262 , RGD:6903263
NCBI chr 1:228,016,439...228,024,736
G
Mc1r
melanocortin 1 receptor
no_association
ISO
RGD
PMID:18757499
RGD:5687323
NCBI chr19:51,452,448...51,455,375
Ensembl chr19:51,453,239...51,454,192
G
Mdk
midkine
ISO
RGD
PMID:15780085
RGD:1582475
NCBI chr 3:77,901,134...77,903,997
Ensembl chr 3:77,901,158...77,903,130
G
Met
MET proto-oncogene, receptor tyrosine kinase
IEP
mRNA:increased expression:retina (rat)
RGD
PMID:17113948
RGD:2317505
NCBI chr 4:45,790,456...45,898,139
Ensembl chr 4:45,790,791...45,897,876
G
Mif
macrophage migration inhibitory factor
disease_progression
ISO
RGD
PMID:18055556
RGD:4891010
NCBI chr20:12,790,919...12,791,784
Ensembl chr20:12,790,902...12,799,504
G
Mir148b
microRNA 148b
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30308185
NCBI chr 7:134,421,398...134,421,494
Ensembl chr 7:134,421,398...134,421,494
G
Mmp3
matrix metallopeptidase 3
IEP
protein:increased protein, activity:brain
RGD
PMID:15099024
RGD:2325962
NCBI chr 8:4,640,397...4,653,963
Ensembl chr 8:4,640,416...4,653,961
G
Mmp9
matrix metallopeptidase 9
ISO IMP
CTD Direct Evidence: marker/mechanism associated with lung injury; mRNA, protein:increased expression:lung protein:increased expression:limb muscle (mouse)
CTD RGD
PMID:23075401 PMID:16551680 PMID:19545667 PMID:16251419
RGD:1582618 , RGD:5129531 , RGD:1582631
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
G
Mpo
myeloperoxidase
IEP ISO
protein:increased activity:lung CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:8869312 PMID:10706834 PMID:12024109 PMID:16971220 PMID:19058328 PMID:20863214 PMID:21470877 More...
RGD:5130958
NCBI chr10:72,594,883...72,608,862
Ensembl chr10:72,594,661...72,604,819
G
Mt-atp6
mitochondrially encoded ATP synthase membrane subunit 6
IEP
RGD
PMID:20450733
RGD:5490294
NCBI chr MT:7,919...8,599 NCBI chr MT:7,919...8,599 NCBI chr MT:7,919...8,599
Ensembl chr MT:7,919...8,599
G
Mt-atp8
mitochondrially encoded ATP synthase membrane subunit 8
IEP
RGD
PMID:20450733
RGD:5490294
NCBI chr MT:7,758...7,961 NCBI chr MT:7,758...7,961 NCBI chr MT:7,758...7,961
Ensembl chr MT:7,758...7,961
G
Mt-cyb
mitochondrially encoded cytochrome b
IEP
mRNA:decreased expression:kidney
RGD
PMID:7692737
RGD:2298967
NCBI chr MT:14,136...15,278 NCBI chr MT:14,136...15,278 NCBI chr MT:14,136...15,278 NCBI chr MT:14,136...15,278
Ensembl chr MT:14,136...15,278
G
Mt2A
metallothionein 2A
ISO
mRNA:increased expression:cerebrum (mouse)
RGD
PMID:12122050
RGD:6483850
NCBI chr19:10,832,009...10,832,783
Ensembl chr19:10,832,002...10,832,784
G
Mt3
metallothionein 3
ISO
RGD
PMID:19635467
RGD:6480529
NCBI chr19:10,848,754...10,850,158
Ensembl chr19:10,848,755...10,850,158
G
Muc1
mucin 1, cell surface associated
IEP
RGD
PMID:23977093
RGD:7349380
NCBI chr 2:174,635,989...174,640,738
Ensembl chr 2:174,635,995...174,640,733
G
Myd88
MYD88, innate immune signal transduction adaptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25780291
NCBI chr 8:119,074,439...119,078,508
Ensembl chr 8:119,074,437...119,079,415
G
Nes
nestin
IEP
protein:increased expression:cerebral cortex
RGD
PMID:17569338
RGD:1642074
NCBI chr 2:173,437,867...173,447,777
Ensembl chr 2:173,438,734...173,447,777
G
Nod2
nucleotide-binding oligomerization domain containing 2
IEP
protein:increased expression:small intestine
RGD
PMID:20107953
RGD:5131440
NCBI chr19:18,382,369...18,422,817
Ensembl chr19:18,382,439...18,417,177
G
Nos1
nitric oxide synthase 1
IMP
RGD
PMID:17451676
RGD:1642142
NCBI chr12:38,615,111...38,795,492
Ensembl chr12:38,626,714...38,710,945
G
Nos2
nitric oxide synthase 2
IEP ISO
mRNA:increased expression:liver CTD Direct Evidence: marker/mechanism protein:increased expression:venule, arteriole, endothelium (mouse) mRNA, protein:increased expression:liver
CTD RGD
PMID:10383581 PMID:19673871 PMID:23061969 PMID:23075401 PMID:11592783 PMID:22019501 PMID:14599979 More...
RGD:2325259 , RGD:5509100 , RGD:1580938
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
G
Nos3
nitric oxide synthase 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21968084
NCBI chr 4:10,793,834...10,814,170
Ensembl chr 4:10,793,834...10,814,166
G
Nox4
NADPH oxidase 4
IEP
mRNA:increased expression:cerebral cortex
RGD
PMID:18438942
RGD:2324666
NCBI chr 1:140,900,886...141,078,844
Ensembl chr 1:140,901,097...141,077,406
G
Oga
O-GlcNAcase
IMP
RGD
PMID:16899550
RGD:2305957
NCBI chr 1:244,598,285...244,633,835
Ensembl chr 1:244,598,292...244,634,359
G
Oprm1
opioid receptor, mu 1
IEP
mRNA, protein:decreased expression:hippocampus
RGD
PMID:17360495
RGD:2316611
NCBI chr 1:43,160,057...43,413,409
Ensembl chr 1:43,160,057...43,413,409
G
Otc
ornithine transcarbamylase
IEP
protein:increased activity:serum
RGD
PMID:1499453
RGD:4144083
NCBI chr X:12,453,834...12,529,954
Ensembl chr X:12,453,834...12,566,918
G
Oxt
oxytocin/neurophysin I prepropeptide
IMP
RGD
PMID:18403049
RGD:2304111
NCBI chr 3:117,782,650...117,783,490
Ensembl chr 3:117,782,650...117,783,490
G
Parp1
poly (ADP-ribose) polymerase 1
ISO IEP
CTD Direct Evidence: marker/mechanism protein:increased expression:liver (rat)
CTD RGD
PMID:15696051 PMID:16798486 PMID:9390645 PMID:21850691
RGD:5510018 , RGD:5510020
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
G
Pcsk2
proprotein convertase subtilisin/kexin type 2
IEP ISO
RGD
PMID:19142196 PMID:19142196
RGD:6483555 , RGD:6483555
NCBI chr 3:130,880,422...131,183,127
Ensembl chr 3:130,880,422...131,183,127
G
Pde5a
phosphodiesterase 5A
IMP
RGD
PMID:19474186
RGD:2314462
NCBI chr 2:210,858,515...211,003,480
Ensembl chr 2:210,858,063...210,999,701
G
Pecam1
platelet and endothelial cell adhesion molecule 1
IMP IEP ISO
protein:decreased expression:lung (rat) protein:increased expression:brain (mouse)
RGD
PMID:12121711 PMID:21872880 PMID:22382321
RGD:2311660 , RGD:6771206 , RGD:6766379
NCBI chr10:91,590,521...91,652,279
Ensembl chr10:91,590,521...91,652,116
G
Pik3r1
phosphoinositide-3-kinase regulatory subunit 1
IEP
proetin:decreased dimerization:skeletal muscle (rat)
RGD
PMID:19100383
RGD:4108481
NCBI chr 2:32,878,942...32,963,668
Ensembl chr 2:32,882,032...32,963,631
G
Pink1
PTEN induced kinase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:35312153
NCBI chr 5:150,530,523...150,542,635
Ensembl chr 5:150,530,523...150,542,635
G
Pklr
pyruvate kinase L/R
IEP
RGD
PMID:17013507
RGD:1625588
NCBI chr 2:174,543,008...174,551,863
Ensembl chr 2:174,543,039...174,551,870
G
Pla2g2a
phospholipase A2 group IIA
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12967936
NCBI chr 5:151,076,442...151,079,019
Ensembl chr 5:151,076,442...151,079,014
G
Pla2g4a
phospholipase A2 group IVA
IDA
protein:increased activity:alveolar macrophage
RGD
PMID:1642455
RGD:1642456
NCBI chr13:61,877,818...62,022,261
Ensembl chr13:61,877,813...62,022,266
G
Plat
plasminogen activator, tissue type
IDA ISO
CTD Direct Evidence: therapeutic
CTD RGD
PMID:9472885 PMID:15223382
RGD:2311674
NCBI chr16:69,240,582...69,265,177
Ensembl chr16:69,240,585...69,268,223
G
Plau
plasminogen activator, urokinase
IEP ISO
protein:increased expression:spinal cord (rat) CTD Direct Evidence: therapeutic
CTD RGD
PMID:15181847 PMID:19663807 PMID:18586014
RGD:6483808 , RGD:6483830
NCBI chr15:3,456,230...3,462,732
Ensembl chr15:3,456,232...3,462,775
G
Plaur
plasminogen activator, urokinase receptor
ISO
RGD
PMID:18606671
RGD:6483829
NCBI chr 1:80,053,440...80,068,384
Ensembl chr 1:80,050,324...80,068,595
G
Pld2
phospholipase D2
IEP
protein:increased expression:hippocampus CA1, hippocampus granule cell layer mRNA:decreased expression:brainstem, cerebellum
RGD
PMID:17393174 PMID:17024567
RGD:2299901 , RGD:2299902
NCBI chr10:55,256,326...55,274,192
Ensembl chr10:55,256,359...55,272,808
G
Pnmt
phenylethanolamine-N-methyltransferase
ISO
protein:increased expression:medulla oblongata (human)
RGD
PMID:21061149
RGD:5128821
NCBI chr10:83,383,019...83,386,557
Ensembl chr10:83,384,923...83,386,556
G
Polb
DNA polymerase beta
IEP
protein:increased expression:cerebral cortex
RGD
PMID:17412650
RGD:2302580
NCBI chr16:69,379,438...69,402,710
Ensembl chr16:69,379,400...69,404,812
G
Ppara
peroxisome proliferator activated receptor alpha
IDA ISO
liver ischemia/reperfusion injury CTD Direct Evidence: therapeutic
CTD RGD
PMID:19151258 PMID:21305343
RGD:5509942
NCBI chr 7:116,832,405...116,900,878
Ensembl chr 7:116,832,756...116,895,346
G
Pparg
peroxisome proliferator-activated receptor gamma
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:12468449 PMID:24011919 PMID:24433871
NCBI chr 4:148,423,102...148,548,471
Ensembl chr 4:148,423,194...148,548,468
G
Ppp3ca
protein phosphatase 3 catalytic subunit alpha
IDA
RGD
PMID:14762344
RGD:1580702
NCBI chr 2:225,165,981...225,440,978
Ensembl chr 2:225,165,766...225,438,974
G
Ppp3cb
protein phosphatase 3 catalytic subunit beta
ISO
RGD
PMID:14615291
RGD:1580705
NCBI chr15:3,759,950...3,804,976
Ensembl chr15:3,760,030...3,804,981
G
Prdx6
peroxiredoxin 6
ISO
RGD
PMID:16766642
RGD:1580710
NCBI chr13:73,528,746...73,539,295
Ensembl chr13:73,528,210...73,539,355
G
Prkca
protein kinase C, alpha
IMP
RGD
PMID:17905752
RGD:2292474
NCBI chr10:92,889,390...93,288,013
Ensembl chr10:92,894,012...93,288,012
G
Prss1
serine protease 1
IEP
RGD
PMID:11062314
RGD:1599961
NCBI chr 4:70,364,589...70,367,792
Ensembl chr 4:70,364,586...70,367,792
G
Ptafr
platelet-activating factor receptor
treatment
ISO IMP
RGD
PMID:12812996 PMID:11139461
RGD:1581279 , RGD:10043168
NCBI chr 5:144,765,770...144,795,057
Ensembl chr 5:144,765,976...144,795,251
G
Pten
phosphatase and tensin homolog
IMP ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:19038262 PMID:17239858
RGD:2292538
NCBI chr 1:230,630,443...230,697,070
Ensembl chr 1:230,630,338...230,696,838
G
Ptges
prostaglandin E synthase
IEP ISO
RGD
PMID:12431630 PMID:16864802
RGD:2300116 , RGD:2300094
NCBI chr 3:14,177,892...14,189,236
G
Ptgs1
prostaglandin-endoperoxide synthase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:10594344 PMID:16385084
RGD:5688223
NCBI chr 3:19,584,015...19,605,589
Ensembl chr 3:19,584,015...19,605,586
G
Ptgs2
prostaglandin-endoperoxide synthase 2
IEP ISO IMP IDA
protein:decreased expression:kidney CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:10588920 PMID:10594344 PMID:11567657 PMID:16386242 PMID:18258783 PMID:19673871 PMID:21394482 PMID:21944479 PMID:16247333 More...
RGD:5135045 , RGD:5508180 , RGD:1580660
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
G
Ptk2
protein tyrosine kinase 2
IEP
protein:increased tyrosine phosphorylation:kidney
RGD
PMID:17620366
RGD:2292577
NCBI chr 7:105,126,725...105,331,848
Ensembl chr 7:105,126,728...105,331,783
G
Ptk2b
protein tyrosine kinase 2 beta
IDA
protein:increased phosphorylation:hippocampus
RGD
PMID:15970382
RGD:1642621
NCBI chr15:40,360,722...40,481,235
Ensembl chr15:40,360,723...40,481,282
G
Rela
RELA proto-oncogene, NF-kB subunit
IEP ISO
protein:increased expression:nucleus, liver CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:20302854 PMID:23743330 PMID:18621400
RGD:2298777
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
G
S100b
S100 calcium binding protein B
IEP
RGD
PMID:18840784
RGD:5508834
NCBI chr20:12,372,866...12,381,619
Ensembl chr20:12,372,881...12,394,743
G
S1pr1
sphingosine-1-phosphate receptor 1
ISO
RGD
PMID:16403835
RGD:1580913
NCBI chr 2:203,624,752...203,629,110
Ensembl chr 2:203,621,587...203,629,681
G
Scfd1
sec1 family domain containing 1
IEP
protein:increased expression:cerebral cortex
RGD
PMID:9195952
RGD:633771
NCBI chr 6:68,795,810...68,874,076
Ensembl chr 6:68,795,878...68,874,078
G
Sele
selectin E
IEP ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:17112405 PMID:23743330 PMID:19489247
RGD:2313598
NCBI chr13:76,402,841...76,412,741
Ensembl chr13:76,403,304...76,412,741
G
Sell
selectin L
IEP
RGD
PMID:19489247
RGD:2313598
NCBI chr13:76,416,969...76,436,444
Ensembl chr13:76,416,915...76,436,456
G
Selp
selectin P
IEP ISO
RGD
PMID:18521901 PMID:21701413
RGD:2312314 , RGD:6218990
NCBI chr13:76,476,229...76,511,846
Ensembl chr13:76,476,295...76,511,845
G
Serpine2
serpin family E member 2
IEP
RGD
PMID:8261109
RGD:2317936
NCBI chr 9:81,124,746...81,188,866
Ensembl chr 9:81,124,804...81,188,826
G
Serping1
serpin family G member 1
treatment
ISO
RGD
PMID:23991040
RGD:8661644
NCBI chr 3:69,842,726...69,852,583
Ensembl chr 3:69,842,739...69,852,034
G
Sftpc
surfactant protein C
IDA
mRNA:decreased expression:lung
RGD
PMID:20560845
RGD:4144062
NCBI chr15:45,596,565...45,599,615
Ensembl chr15:45,596,574...45,610,777
G
Si
sucrase-isomaltase
IEP
RGD
PMID:9724271
RGD:1625550
NCBI chr 2:157,505,893...157,586,228
Ensembl chr 2:157,506,342...157,585,260
G
Sirt7
sirtuin 7
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:28675767
NCBI chr10:105,896,476...105,903,301
Ensembl chr10:105,896,476...105,903,172
G
Slc2a1
solute carrier family 2 member 1
IEP
mRNA, protein:increased expression:brain
RGD
PMID:19781384
RGD:2313601
NCBI chr 5:132,717,196...132,745,416
Ensembl chr 5:132,717,196...132,745,416
G
Slc2a3
solute carrier family 2 member 3
IEP
mRNA, protein:increased expression:brain
RGD
PMID:19781384
RGD:2313601
NCBI chr 4:155,960,944...156,026,000
Ensembl chr 4:155,960,946...156,025,472
G
Slc30a4
solute carrier family 30 member 4
IEP
mRNA:increased expression:brain
RGD
PMID:18289514
RGD:2299950
NCBI chr 3:109,753,270...109,775,306
Ensembl chr 3:109,753,273...109,775,306
G
Slc34a1
solute carrier family 34 member 1
IEP
protein:decreased expression:renal proximal tubule
RGD
PMID:15775707
RGD:2311304
NCBI chr17:9,218,876...9,233,852
Ensembl chr17:9,218,876...9,233,852
G
Slc6a11
solute carrier family 6 member 11
IEP
RGD
PMID:13678673
RGD:1299345
NCBI chr 4:147,297,972...147,413,319
Ensembl chr 4:147,297,969...147,413,443
G
Slc8a1
solute carrier family 8 member A1
IEP
RGD
PMID:18037393
RGD:2316975
NCBI chr 6:13,194,609...13,547,369
Ensembl chr 6:13,194,662...13,535,628
G
Slc8a2
solute carrier family 8 member A2
IEP
RGD
PMID:18037393
RGD:2316975
NCBI chr 1:76,816,583...76,852,928
Ensembl chr 1:76,808,725...76,847,072
G
Slc8a3
solute carrier family 8 member A3
IEP
RGD
PMID:18037393
RGD:2316975
NCBI chr 6:100,874,359...101,007,989
Ensembl chr 6:100,874,369...101,007,508
G
Slc9a1
solute carrier family 9 member A1
IMP ISO
CTD Direct Evidence: therapeutic
CTD RGD
PMID:19027022 PMID:20337040
RGD:6771332
NCBI chr 5:145,576,341...145,629,630
Ensembl chr 5:145,576,334...145,629,624
G
Slco1b2
solute carrier organic anion transporter family member 1B2
IEP
mRNA:decreased expression:liver
RGD
PMID:16858290
RGD:2303111
NCBI chr 4:174,551,463...174,619,988
Ensembl chr 4:174,551,480...174,619,981
G
Slk
STE20-like kinase
IEP
protein:increased expression:kidney
RGD
PMID:12965890
RGD:2304069
NCBI chr 1:246,473,712...246,529,643
Ensembl chr 1:246,473,712...246,526,530
G
Slpi
secretory leukocyte peptidase inhibitor
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:8215636
NCBI chr 3:153,082,208...153,084,457
Ensembl chr 3:153,082,369...153,084,453
G
Socs1
suppressor of cytokine signaling 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:25780291
NCBI chr10:4,882,651...4,884,342
Ensembl chr10:4,882,560...4,884,383
G
Socs3
suppressor of cytokine signaling 3
IDA
associated with Brain Ischemia;mRNA, protein:increased expression:cerebral cortex
RGD
PMID:12437578
RGD:632385
NCBI chr10:103,193,909...103,197,322
Ensembl chr10:103,193,537...103,197,787
G
Socs4
suppressor of cytokine signaling 4
IEP
mRNA:increased expression:hippocampus
RGD
PMID:17880360
RGD:2303397
NCBI chr15:20,523,406...20,537,889
Ensembl chr15:20,523,183...20,542,494
G
Sod1
superoxide dismutase 1
ISO
CTD Direct Evidence: marker/mechanism|therapeutic
CTD RGD
PMID:15364863 PMID:16397181 PMID:23061969 PMID:23743330 PMID:15364863
RGD:1580834
NCBI chr11:29,456,673...29,462,249
Ensembl chr11:29,456,558...29,462,249
G
Sod2
superoxide dismutase 2
IEP ISO
protein:increased expression:liver CTD Direct Evidence: marker/mechanism|therapeutic
CTD RGD
PMID:8215636 PMID:16682413 PMID:19193722 PMID:19917352 PMID:21940958 PMID:23743330 PMID:15612529 PMID:15087276 More...
RGD:1582141 , RGD:1581259
NCBI chr 1:47,638,318...47,645,163
Ensembl chr 1:47,636,528...47,645,189
G
Sod3
superoxide dismutase 3
ISO
RGD
PMID:15778274
RGD:1581264
NCBI chr14:58,610,104...58,615,845
Ensembl chr14:58,609,958...58,615,990
G
Spp1
secreted phosphoprotein 1
ISO
RGD
PMID:20548025
RGD:6903275
NCBI chr14:5,308,885...5,315,120
Ensembl chr14:5,308,885...5,315,162
G
Src
SRC proto-oncogene, non-receptor tyrosine kinase
IEP
protein:increased phosphorylation:hippocampus CA1 (rat)
RGD
PMID:20197063
RGD:2325012
NCBI chr 3:146,091,969...146,139,492
Ensembl chr 3:146,091,841...146,139,476
G
Stat1
signal transducer and activator of transcription 1
IDA IEP
protein:increased serine phosphorylation:brain protein:increased phosphorylation:kidney
RGD
PMID:15262323 PMID:17670769
RGD:1600103 , RGD:2291900
NCBI chr 9:49,419,561...49,459,969
Ensembl chr 9:49,419,340...49,588,540
G
Stat2
signal transducer and activator of transcription 2
IEP
mRNA:increased expression:hippocampus
RGD
PMID:17880360
RGD:2303397
NCBI chr 7:702,565...718,349
Ensembl chr 7:702,495...718,967
G
Stat3
signal transducer and activator of transcription 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21940958
NCBI chr10:85,811,206...85,863,057
Ensembl chr10:85,811,218...85,863,057
G
Stat5a
signal transducer and activator of transcription 5A
IEP
mRNA:increased expression:hippocampus
RGD
PMID:17880360
RGD:2303397
NCBI chr10:85,785,537...85,809,869
Ensembl chr10:85,785,537...85,809,866
G
Stat5b
signal transducer and activator of transcription 5B
IEP
mRNA:increased expression:hippocampus
RGD
PMID:17880360
RGD:2303397
NCBI chr10:85,704,841...85,775,856
Ensembl chr10:85,705,670...85,775,668
G
Stat6
signal transducer and activator of transcription 6
IEP
mRNA:increased expression:hippocampus
RGD
PMID:17880360
RGD:2303397
NCBI chr 7:63,480,229...63,497,551
Ensembl chr 7:63,479,642...63,498,495
G
Stc1
stanniocalcin 1
IEP
mRNA:increased expression:cerebral cortex
RGD
PMID:15485913
RGD:2324700
NCBI chr15:44,299,591...44,311,695
Ensembl chr15:44,299,621...44,310,264
G
Stc2
stanniocalcin 2
IEP
mRNA, protein:increased expression:cerebral cortex
RGD
PMID:15485913
RGD:2324700
NCBI chr10:16,251,046...16,260,815
Ensembl chr10:16,250,853...16,262,973
G
Sult1e1
sulfotransferase family 1E member 1
IEP ISO
protein:increased expression:serum CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:25922074 PMID:16908442
RGD:2302564
NCBI chr14:20,422,324...20,439,562
Ensembl chr14:20,422,324...20,439,275
G
Tbxas1
thromboxane A synthase 1
IDA
associated with Cholestasis, Extrahepatic
RGD
PMID:15000260 PMID:8680115
RGD:1601451 , RGD:1601475
NCBI chr 4:67,664,963...67,837,096
Ensembl chr 4:67,665,007...67,837,096
G
Tert
telomerase reverse transcriptase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16968891
NCBI chr 1:29,637,213...29,659,561
Ensembl chr 1:29,637,506...29,659,561
G
Tfam
transcription factor A, mitochondrial
IDA
RGD
PMID:22266265
RGD:6767573
NCBI chr20:17,356,243...17,368,293
Ensembl chr20:17,356,197...17,368,292
G
Tgfbr2
transforming growth factor, beta receptor 2
IEP
RGD
PMID:15613744
RGD:1579926
NCBI chr 8:115,794,537...115,883,615
Ensembl chr 8:115,794,537...115,883,228
G
Th
tyrosine hydroxylase
ISO
protein:increased expression:medulla oblongata (human)
RGD
PMID:21061149
RGD:5128821
NCBI chr 1:198,071,500...198,078,832
Ensembl chr 1:198,071,503...198,109,767
G
Thbd
thrombomodulin
ISO
RGD
PMID:19342415
RGD:5131887
NCBI chr 3:135,863,366...135,867,018
Ensembl chr 3:135,862,835...135,867,193
G
Thbs1
thrombospondin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16526316
NCBI chr 3:105,056,293...105,071,445
Ensembl chr 3:105,056,292...105,071,440
G
Thy1
Thy-1 cell surface antigen
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23075401
NCBI chr 8:44,389,495...44,394,688
Ensembl chr 8:44,389,513...44,394,659
G
Ticam1
TIR domain containing adaptor molecule 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25780291
NCBI chr 9:1,102,559...1,111,023
Ensembl chr 9:1,102,366...1,123,147
G
Timp3
TIMP metallopeptidase inhibitor 3
IEP
protein:decreased expression:brain
RGD
PMID:17551674
RGD:2290424
NCBI chr 7:17,520,827...17,571,850
Ensembl chr 7:17,521,919...17,571,839
G
Tjp1
tight junction protein 1
IEP
protein:decreased expression:brain, endothelial cell
RGD
PMID:19374856 PMID:19929946
RGD:2325135 , RGD:2325127
NCBI chr 1:118,849,838...119,094,492
Ensembl chr 1:118,849,838...119,094,432
G
Tlr2
toll-like receptor 2
IEP ISO
mRNA, protein:increased expression:kidney CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:25780291 PMID:15912106
RGD:2312727
NCBI chr 2:169,200,620...169,206,819
Ensembl chr 2:169,197,419...169,206,630
G
Tlr3
toll-like receptor 3
IEP
protein:increased expression:liver (rat)
RGD
PMID:21355876
RGD:5128693
NCBI chr16:46,821,980...46,837,900
Ensembl chr16:46,822,039...46,836,545
G
Tlr4
toll-like receptor 4
IEP ISO
protein:increased expression:liver CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:25780291 PMID:27064547 PMID:19473433 PMID:17126102
RGD:2312503 , RGD:4144169
NCBI chr 5:80,145,867...80,159,501
Ensembl chr 5:80,145,826...80,159,628
G
Tmbim6
transmembrane BAX inhibitor motif containing 6
IEP
protein:increased expression:liver
RGD
PMID:18005084
RGD:2291961
NCBI chr 7:130,527,313...130,542,567
Ensembl chr 7:130,527,316...130,543,633
G
Tnf
tumor necrosis factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:10706834 PMID:12024109 PMID:15829914 PMID:16971220 PMID:17112405 PMID:18460982 PMID:19058328 PMID:23743330 PMID:23875703 PMID:24898700 More...
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Tnfrsf1a
TNF receptor superfamily member 1A
IEP
RGD
PMID:17109621
RGD:1624182
NCBI chr 4:158,150,815...158,163,592
Ensembl chr 4:158,150,820...158,163,591
G
Tp53
tumor protein p53
IEP
protein:increased expression:brain, mitochondrion
RGD
PMID:17661174
RGD:2290568
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
G
Trpc6
transient receptor potential cation channel, subfamily C, member 6
treatment
IDA
RGD
PMID:20554625
RGD:4891135
NCBI chr 8:5,759,387...5,864,000
Ensembl chr 8:5,758,935...5,828,092
G
Trpm7
transient receptor potential cation channel, subfamily M, member 7
IEP
mRNA,protein:increased expression:hippocampus
RGD
PMID:18395621
RGD:5684390
NCBI chr 3:114,046,258...114,134,799
Ensembl chr 3:114,046,258...114,135,190
G
Txn1
thioredoxin 1
IEP
mRNA:decreased expression:cerebral cortex
RGD
PMID:19128823
RGD:5685030
NCBI chr 5:72,712,334...72,724,564
Ensembl chr 5:72,711,933...72,724,629
G
Txn2
thioredoxin 2
IEP
mRNA:decreased expression:cerebral cortex
RGD
PMID:19128823
RGD:5685030
NCBI chr 7:109,496,772...109,510,378
Ensembl chr 7:109,496,761...109,510,359
G
Txnrd1
thioredoxin reductase 1
IEP
mRNA:decreased expression:cerebral cortex mRNA:decreased expression:spinal cord
RGD
PMID:19128823 PMID:19409971
RGD:5685030 , RGD:5685028
NCBI chr 7:20,830,042...20,914,990
Ensembl chr 7:20,830,045...20,907,863
G
Txnrd2
thioredoxin reductase 2
IEP
mRNA:decreased expression:cerebral cortex
RGD
PMID:19128823
RGD:5685030
NCBI chr11:82,519,996...82,568,156
Ensembl chr11:82,519,999...82,568,156
G
Vcam1
vascular cell adhesion molecule 1
IEP
mRNA:increased expression:kidney
RGD
PMID:18813897
RGD:2313108
NCBI chr 2:204,038,120...204,057,852
Ensembl chr 2:204,038,114...204,057,958
G
Vegfc
vascular endothelial growth factor C
IEP
RGD
PMID:18704465
RGD:2315487
NCBI chr16:37,712,251...37,827,845
Ensembl chr16:37,712,262...37,827,848
G
Vegfd
vascular endothelial growth factor D
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16526316
NCBI chr X:30,073,122...30,108,413
Ensembl chr X:30,074,163...30,108,295
G
Vim
vimentin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23075401
NCBI chr17:76,668,701...76,677,186
Ensembl chr17:76,668,647...76,677,187
G
Vip
vasoactive intestinal peptide
ISO
RGD
PMID:21693218
RGD:5685379
NCBI chr 1:42,064,878...42,073,219
Ensembl chr 1:42,065,120...42,073,216
G
Wnt3a
Wnt family member 3A
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:23875703
NCBI chr10:44,034,174...44,078,366
Ensembl chr10:44,034,194...44,078,324
G
Xdh
xanthine dehydrogenase
treatment
IDA ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:12910483 PMID:23403765
RGD:7247700
NCBI chr 6:21,530,463...21,592,172
Ensembl chr 6:21,530,113...21,592,268
G
Xrcc1
X-ray repair cross complementing 1
IEP
protein:increased expression:brain
RGD
PMID:17412650
RGD:2302580
NCBI chr 1:80,140,495...80,168,705
Ensembl chr 1:80,141,207...80,168,701
G
Zfp354a
zinc finger protein 354A
IEP
mRNA:decreased expression:kidney
RGD
PMID:8382778
RGD:1300202
NCBI chr10:35,396,242...35,408,069
Ensembl chr10:35,396,231...35,408,068
G
F3
coagulation factor III, tissue factor
IEP
RGD
PMID:9916935
RGD:11341701
NCBI chr 2:209,827,061...209,838,666
Ensembl chr 2:209,826,959...209,838,668
G
Hnrnpk
heterogeneous nuclear ribonucleoprotein K
ISO
RGD
PMID:21489814
RGD:155260371
NCBI chr17:6,262,936...6,275,001
Ensembl chr17:6,262,998...6,274,997
G
Pdgfd
platelet derived growth factor D
ISO
RGD
PMID:19213942
RGD:9854642
NCBI chr 8:3,488,448...3,722,395
Ensembl chr 8:3,488,423...3,722,395
G
Ager
advanced glycosylation end product-specific receptor
treatment
IEP
RGD
PMID:22217518 PMID:23769041
RGD:7245568 , RGD:8695995
NCBI chr20:4,148,150...4,151,361
Ensembl chr20:4,147,890...4,151,078
G
C3
complement C3
treatment
IDA
RGD
PMID:25122638
RGD:11040803
NCBI chr 9:2,087,437...2,114,366
Ensembl chr 9:2,087,437...2,114,429
G
Cd40
CD40 molecule
treatment
IDA
RGD
PMID:22826618
RGD:11352297
NCBI chr 3:153,790,372...153,805,279
Ensembl chr 3:153,790,449...153,805,534
G
Cd40lg
CD40 ligand
treatment
IDA
liver
RGD
PMID:22826618
RGD:11352297
NCBI chr X:135,127,052...135,138,768
Ensembl chr X:135,126,969...135,138,306
G
F7
coagulation factor VII
treatment
ISO
human protein in a rat model
RGD
PMID:12095034
RGD:11049508
NCBI chr16:76,489,775...76,500,636
Ensembl chr16:76,489,717...76,500,610
G
Hmgb1
high mobility group box 1
treatment
IEP
RGD
PMID:22217518
RGD:7245568
NCBI chr12:5,972,950...5,979,658
Ensembl chr12:5,901,586...5,978,565 Ensembl chr16:5,901,586...5,978,565
G
Kcnn4
potassium calcium-activated channel subfamily N member 4
ameliorates
IMP
RGD
PMID:24312257
RGD:401700379
NCBI chr 1:79,956,380...79,974,354
Ensembl chr 1:79,959,322...79,974,340
G
Mtor
mechanistic target of rapamycin kinase
treatment
IDA
RGD
PMID:23985719
RGD:10041002
NCBI chr 5:158,884,856...158,994,311
Ensembl chr 5:158,884,804...158,994,311
G
Tnf
tumor necrosis factor
treatment
IMP
RGD
PMID:24598936
RGD:10450586
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Aco1
aconitase 1
IEP
RGD
PMID:20176611
RGD:11541086
NCBI chr 5:55,259,841...55,315,872
Ensembl chr 5:55,259,827...55,316,391
G
Alb
albumin
disease_progression
ISO
RGD
PMID:24370342
RGD:11035281
NCBI chr14:17,607,397...17,622,814
Ensembl chr14:17,607,381...17,622,836
G
Ccl3
C-C motif chemokine ligand 3
ISO
RGD
PMID:17298994
RGD:7241819
NCBI chr10:68,451,388...68,452,938
Ensembl chr10:68,451,388...68,452,938
G
Ccn2
cellular communication network factor 2
disease_progression
IEP
mRNA, protein:increased expression:kidney (rat)
RGD
PMID:19921985
RGD:150517553
NCBI chr 1:20,802,199...20,805,315
Ensembl chr 1:20,802,199...20,805,734
G
Clu
clusterin
treatment
IEP
RGD
PMID:22494435
RGD:9068431
NCBI chr15:40,161,068...40,200,315
Ensembl chr15:40,174,617...40,200,315
G
Cs
citrate synthase
treatment
IDA
RGD
PMID:20005400
RGD:243048470
NCBI chr 7:758,074...791,421
Ensembl chr 7:758,345...791,421
G
Mmp3
matrix metallopeptidase 3
ISO
RGD
PMID:22845765
RGD:7241226
NCBI chr 8:4,640,397...4,653,963
Ensembl chr 8:4,640,416...4,653,961
G
Mmp7
matrix metallopeptidase 7
treatment
IDA
RGD
PMID:18209025
RGD:9685339
NCBI chr 8:4,848,186...4,855,908
Ensembl chr 8:4,848,186...4,855,902
G
Pdgfa
platelet derived growth factor subunit A
IEP
RGD
PMID:11889420
RGD:11080974
NCBI chr12:15,645,549...15,667,056
Ensembl chr12:15,645,541...15,666,497
G
Pdgfb
platelet derived growth factor subunit B
IEP
mRNA:increased expression:kidney:
RGD
PMID:15785371 PMID:11889420
RGD:10449491 , RGD:11080974
NCBI chr 7:111,539,444...111,557,984
Ensembl chr 7:111,540,345...111,557,984
G
Pdgfra
platelet derived growth factor receptor alpha
IEP
RGD
PMID:11889420
RGD:11080974
NCBI chr14:33,005,838...33,054,347
Ensembl chr14:33,005,839...33,054,335
G
Pdgfrb
platelet derived growth factor receptor beta
IEP
RGD
PMID:11889420
RGD:11080974
NCBI chr18:54,499,962...54,538,840
Ensembl chr18:54,499,964...54,538,843
G
Plau
plasminogen activator, urokinase
ISO
protein:increased secretion:T lymphocyte (human)
RGD
PMID:16387096
RGD:7241259
NCBI chr15:3,456,230...3,462,732
Ensembl chr15:3,456,232...3,462,775
G
Pparg
peroxisome proliferator-activated receptor gamma
ISO
protein:increased expression:kidney:
RGD
PMID:16221712
RGD:13208600
NCBI chr 4:148,423,102...148,548,471
Ensembl chr 4:148,423,194...148,548,468
G
Serpine1
serpin family E member 1
treatment
ISO
protein:increased expression:kidney:
RGD
PMID:16221712 PMID:18192922
RGD:13208600 , RGD:13208601
NCBI chr12:19,601,272...19,611,657
Ensembl chr12:19,601,272...19,611,657
G
Epas1
endothelial PAS domain protein 1
IEP
mRNA:increased expression:lung
RGD
PMID:22305384
RGD:10395369
NCBI chr 6:7,790,236...7,871,717
Ensembl chr 6:7,790,647...7,871,228
G
Kit
KIT proto-oncogene receptor tyrosine kinase
IEP
mRNA,protein:decreased expression:stomach:
RGD
PMID:20040059
RGD:12911222
NCBI chr14:32,547,459...32,624,694
Ensembl chr14:32,548,877...32,624,652
G
Kitlg
KIT ligand
IEP
mRNA:decreased expression:stomach:
RGD
PMID:20040059
RGD:12911222
NCBI chr 7:34,896,075...34,977,215
Ensembl chr 7:34,896,053...34,977,214
G
Ace
angiotensin I converting enzyme
IEP
RGD
PMID:15001561
RGD:13515113
NCBI chr10:90,910,316...90,930,437
Ensembl chr10:90,910,316...90,931,131
G
Agt
angiotensinogen
IEP
protein:increased expression:plasma
RGD
PMID:15001561
RGD:13515113
NCBI chr19:52,529,139...52,549,618
Ensembl chr19:52,529,185...52,540,977
G
Ahr
aryl hydrocarbon receptor
treatment
IEP
RGD
PMID:22079846
RGD:401794136
NCBI chr 6:52,234,089...52,271,568
Ensembl chr 6:52,234,089...52,271,568
G
Atp5f1d
ATP synthase F1 subunit delta
treatment
IEP
RGD
PMID:24232000
RGD:13792678
NCBI chr 7:9,560,604...9,565,919
Ensembl chr 7:9,560,608...9,565,929
G
Casp3
caspase 3
treatment
IEP
RGD
PMID:23946597
RGD:13782356
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Casp9
caspase 9
treatment
IEP
RGD
PMID:23946597
RGD:13782356
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
G
Ccl2
C-C motif chemokine ligand 2
IEP
mRNA:increased expression:small intestine
RGD
PMID:18475188
RGD:2307016
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
G
Cd14
CD14 molecule
IEP
protein:increased expression:heart, kidney, liver, lung
RGD
PMID:22493902
RGD:9685194
NCBI chr18:28,335,522...28,337,383
Ensembl chr18:28,335,340...28,337,261
G
Cldn1
claudin 1
IEP
protein:decreased expression:colon:
RGD
PMID:19929946
RGD:2325127
NCBI chr11:74,421,569...74,436,728
Ensembl chr11:74,421,569...74,436,724
G
Cldn3
claudin 3
IEP
protein:decreased expression:colon:
RGD
PMID:19929946
RGD:2325127
NCBI chr12:21,708,538...21,710,010
Ensembl chr12:21,708,398...21,711,001
G
Cldn5
claudin 5
IEP
protein:decreased expression:colon:
RGD
PMID:19929946
RGD:2325127
NCBI chr11:82,212,822...82,214,248
Ensembl chr11:82,211,475...82,214,992
G
Crp
C-reactive protein
IEP
protein:increased expression:intestine:
RGD
PMID:17981193
RGD:5129536
NCBI chr13:85,135,384...85,175,178
Ensembl chr13:85,124,977...85,175,178
G
Csf3
colony stimulating factor 3
treatment
ISO
RGD
PMID:9117128
RGD:11039476
NCBI chr10:83,660,787...83,664,569
Ensembl chr10:83,661,207...83,663,603
G
Cyp1a2
cytochrome P450, family 1, subfamily a, polypeptide 2
treatment
IEP
RGD
PMID:22079846
RGD:401794136
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
G
F7
coagulation factor VII
ISO
human protein in a rat model
RGD
PMID:22920553
RGD:11041662
NCBI chr16:76,489,775...76,500,636
Ensembl chr16:76,489,717...76,500,610
G
Faslg
Fas ligand
treatment
IEP
RGD
PMID:29170412
RGD:13792603
NCBI chr13:74,151,519...74,172,760
Ensembl chr13:74,154,954...74,162,215
G
Gpt
glutamic--pyruvic transaminase
IEP
protein:increased expression:serum
RGD
PMID:16557159
RGD:401717563
NCBI chr 7:108,416,646...108,419,495
Ensembl chr 7:108,416,642...108,419,494
G
Hmgb1
high mobility group box 1
IEP
RGD
PMID:22093738
RGD:10402181
NCBI chr12:5,972,950...5,979,658
Ensembl chr12:5,901,586...5,978,565 Ensembl chr16:5,901,586...5,978,565
G
Hmox1
heme oxygenase 1
treatment
IEP
RGD
PMID:19362701
RGD:10766423
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
G
Hp
haptoglobin
treatment
IEP
RGD
PMID:11922743
RGD:11041790
NCBI chr19:37,539,626...37,544,178
Ensembl chr19:37,539,627...37,544,523
G
Icam1
intercellular adhesion molecule 1
treatment
IEP
RGD
PMID:12095141 PMID:22079846
RGD:11522715 , RGD:401794136
NCBI chr 8:19,553,063...19,565,438
Ensembl chr 8:19,553,645...19,565,438
G
Il6
interleukin 6
treatment
IDA IEP
RGD
PMID:11959089 PMID:22079846
RGD:11062110 , RGD:401794136
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
G
Jak2
Janus kinase 2
IMP
RGD
PMID:22777122
RGD:10403072
NCBI chr 1:226,995,334...227,054,381
Ensembl chr 1:226,995,334...227,054,189
G
Lbp
lipopolysaccharide binding protein
IEP
protein:increased expression:heart, kidney, liver, lung
RGD
PMID:22493902
RGD:9685194
NCBI chr 3:146,953,889...146,981,032
Ensembl chr 3:146,954,015...146,981,586
G
Mbl2
mannose binding lectin 2
severity
ISO
DNA:polymorphisms:exon:
RGD
PMID:19477015
RGD:12910933
NCBI chr 1:228,016,439...228,024,736
G
Mir155
microRNA 155
ISO
miRNA:increased expression:Peyer's patch
RGD
PMID:30206757
RGD:21409753
NCBI chr11:23,774,654...23,774,718
Ensembl chr11:23,774,654...23,774,718
G
Mir21
microRNA 21
IEP
RGD
PMID:30309483
RGD:41410822
NCBI chr10:71,405,257...71,405,348
Ensembl chr10:71,405,257...71,405,348
G
Nfkbia
NFKB inhibitor alpha
treatment
IEP
RGD
PMID:22079846
RGD:401794136
NCBI chr 6:72,858,713...72,861,941
Ensembl chr 6:72,858,712...72,861,941
G
Nos3
nitric oxide synthase 3
treatment
IDA
RGD
PMID:16610051
RGD:7777112
NCBI chr 4:10,793,834...10,814,170
Ensembl chr 4:10,793,834...10,814,166
G
Nqo1
NAD(P)H quinone dehydrogenase 1
treatment
IEP
RGD
PMID:28382390
RGD:13440093
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
G
Nr1h4
nuclear receptor subfamily 1, group H, member 4
disease_progression
IEP
mRNA:decreased expression:liver (rat)
RGD
PMID:23331901
RGD:15042883
NCBI chr 7:23,846,122...23,942,085
Ensembl chr 7:23,846,122...23,942,047
G
Parg
poly (ADP-ribose) glycohydrolase
treatment
IMP
RGD
PMID:15791006
RGD:13514040
NCBI chr16:7,436,429...7,544,276
Ensembl chr16:7,436,476...7,544,273
G
Ppp1r15a
protein phosphatase 1, regulatory subunit 15A
ISO
mRNA:increased expression:jejunum (human)
RGD
PMID:20965186
RGD:9999150
NCBI chr 1:96,000,053...96,003,128
Ensembl chr 1:96,000,058...96,003,171
G
Proc
protein C, inactivator of coagulation factors Va and VIIIa
treatment
ISO
RGD
PMID:15187522
RGD:11250409
NCBI chr18:23,764,367...23,774,816
Ensembl chr18:23,764,368...23,775,133
G
Rela
RELA proto-oncogene, NF-kB subunit
treatment
IEP
RGD
PMID:22079846
RGD:401794136
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
G
Serpinc1
serpin family C member 1
treatment
IEP
RGD
PMID:21046505
RGD:11035258
NCBI chr13:73,257,208...73,271,476
Ensembl chr13:73,257,179...73,284,293
G
Serpine1
serpin family E member 1
IDA
protein:increased activity:plasma (rat)
RGD
PMID:12717359
RGD:11081012
NCBI chr12:19,601,272...19,611,657
Ensembl chr12:19,601,272...19,611,657
G
Socs1
suppressor of cytokine signaling 1
treatment
IEP
RGD
PMID:27538408
RGD:151347179
NCBI chr10:4,882,651...4,884,342
Ensembl chr10:4,882,560...4,884,383
G
Tnf
tumor necrosis factor
treatment
IEP
RGD
PMID:22079846
RGD:401794136
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Traf6
TNF receptor associated factor 6
IEP
RGD
PMID:27538408
RGD:151347179
NCBI chr 3:87,963,517...87,988,316
Ensembl chr 3:87,963,514...87,983,507
G
Trem1
triggering receptor expressed on myeloid cells 1
ameliorates
IDA
associated with mesenteric vascular occlusion;
RGD
PMID:18091551
RGD:127284848
NCBI chr 9:12,763,819...12,779,285
Ensembl chr 9:12,763,819...12,779,203
G
Vwf
von Willebrand factor
IEP
protein:increased expression:plasma:
RGD
PMID:10365842
RGD:11080742
NCBI chr 4:158,360,152...158,491,539
Ensembl chr 4:158,360,152...158,491,539
G
Xdh
xanthine dehydrogenase
treatment
IEP
RGD
PMID:23010742
RGD:13209016
NCBI chr 6:21,530,463...21,592,172
Ensembl chr 6:21,530,113...21,592,268
G
Ace
angiotensin I converting enzyme
IMP
RGD
PMID:21680852
RGD:6893484
NCBI chr10:90,910,316...90,930,437
Ensembl chr10:90,910,316...90,931,131
G
Ace2
angiotensin converting enzyme 2
IEP
mRNA:decreased expression:kidney
RGD
PMID:20528771
RGD:9685432
NCBI chr X:30,293,597...30,340,961
Ensembl chr X:30,293,589...30,340,977
G
Acta1
actin, alpha 1, skeletal muscle
ameliorates
ISO
RGD
PMID:24920753
RGD:329845564
NCBI chr19:51,883,709...51,886,735
Ensembl chr19:51,883,715...51,886,742
G
Acvr2b
activin A receptor type 2B
treatment
ISO
human construct in rat model
RGD
PMID:27732750
RGD:329322881
NCBI chr 8:119,138,901...119,178,477
Ensembl chr 8:119,138,812...119,170,458
G
Adam17
ADAM metallopeptidase domain 17
treatment
IEP
RGD
PMID:22015440
RGD:13703100
NCBI chr 6:40,872,936...40,920,700
Ensembl chr 6:40,872,856...40,920,639
G
Adam2
ADAM metallopeptidase domain 2
IEP
RGD
PMID:11967014
RGD:10047130
NCBI chr15:40,242,651...40,284,025
Ensembl chr15:40,242,783...40,283,952
G
Adamts1
ADAM metallopeptidase with thrombospondin type 1 motif, 1
IEP
RGD
PMID:18272597
RGD:9684850
NCBI chr11:24,932,227...24,941,068
Ensembl chr11:24,931,761...24,941,103
G
Adipoq
adiponectin, C1Q and collagen domain containing
treatment
ISO
RGD
PMID:21412771
RGD:8695946
NCBI chr11:77,721,912...77,735,644
Ensembl chr11:77,721,912...77,735,564
G
Adm
adrenomedullin
treatment
IEP ISO
protein:increased expression:serum:
RGD
PMID:20538296 PMID:20538296
RGD:7364948 , RGD:7364948
NCBI chr 1:164,745,484...164,747,655
Ensembl chr 1:164,745,466...164,747,654
G
Akr1a1
aldo-keto reductase family 1 member A1
ISO
RGD
PMID:31089212
RGD:27226686
NCBI chr 5:130,092,945...130,130,277
Ensembl chr 5:130,092,732...130,113,674
G
Aldh2
aldehyde dehydrogenase 2 family member
ISO
RGD
PMID:22022451
RGD:7241603
NCBI chr12:34,949,549...34,982,527
Ensembl chr12:34,901,219...34,982,521
G
Anxa1
annexin A1
treatment
IDA
RGD
PMID:20953576
RGD:7421585
NCBI chr 1:217,861,175...217,877,205
Ensembl chr 1:217,861,175...217,877,343
G
Anxa5
annexin A5
ISO
RGD
PMID:21918686
RGD:7242028
NCBI chr 2:119,314,007...119,344,703
Ensembl chr 2:119,314,007...119,353,369
G
Apaf1
apoptotic peptidase activating factor 1
treatment
IEP
RGD
PMID:26362957
RGD:13703110
NCBI chr 7:25,494,143...25,579,540
Ensembl chr 7:25,494,609...25,579,540
G
Apoa1
apolipoprotein A1
treatment
ISO
RGD
PMID:18535924
RGD:7241574
NCBI chr 8:46,527,251...46,529,035
Ensembl chr 8:46,527,144...46,529,035
G
Atm
ATM serine/threonine kinase
IEP
protein:increased expression:kidney
RGD
PMID:22768306
RGD:10053607
NCBI chr 8:53,828,741...53,932,773
Ensembl chr 8:53,831,093...53,932,437
G
Bax
BCL2 associated X, apoptosis regulator
treatment
IEP
RGD
PMID:23151253
RGD:10054101
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
G
Bcl2
BCL2, apoptosis regulator
treatment
IEP
RGD
PMID:18221257 PMID:29285062
RGD:2293026 , RGD:13792599
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
Bdkrb1
bradykinin receptor B1
ISO
RGD
PMID:18725957
RGD:7241559
NCBI chr 6:124,510,827...124,514,475
Ensembl chr 6:124,510,870...124,513,747
G
Becn1
beclin 1
treatment
IEP
RGD
PMID:26412257
RGD:11561958
NCBI chr10:86,231,387...86,246,742
Ensembl chr10:86,231,388...86,246,742
G
Bmi1
BMI1 proto-oncogene, polycomb ring finger
ISO
mRNA:altered expression:kidney (mouse)
RGD
PMID:18467665
RGD:155631277
NCBI chr17:81,332,175...81,341,625
Ensembl chr17:81,332,214...81,388,690
G
Bnip3
BCL2 interacting protein 3
IEP
mRNA, protein:increased expression:kidney
RGD
PMID:23698117
RGD:11561968
NCBI chr 1:193,708,164...193,725,348
Ensembl chr 1:193,708,167...193,725,359
G
C3
complement C3
treatment
IEP
RGD
PMID:19691975
RGD:7411689
NCBI chr 9:2,087,437...2,114,366
Ensembl chr 9:2,087,437...2,114,429
G
Calca
calcitonin-related polypeptide alpha
IMP
RGD
PMID:19194162
RGD:7204479
NCBI chr 1:168,878,212...168,883,176
Ensembl chr 1:168,878,214...168,883,105
G
Casp3
caspase 3
treatment
IEP
RGD
PMID:23151253
RGD:10054101
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Casp7
caspase 7
IEP
RGD
PMID:17596683
RGD:5684536
NCBI chr 1:255,437,438...255,476,737
Ensembl chr 1:255,437,172...255,476,729
G
Ccl11
C-C motif chemokine ligand 11
treatment
ISO
RGD
PMID:22160777
RGD:7247742
NCBI chr10:67,028,328...67,032,929
Ensembl chr10:67,028,328...67,032,926
G
Ccl2
C-C motif chemokine ligand 2
ameliorates treatment
ISO IDA
mRNA, protein:increased expression:kidney, lung, serum
RGD
PMID:24920753 PMID:20396927 PMID:18650485
RGD:329845564 , RGD:4891433 , RGD:11526113
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
G
Ccn1
cellular communication network factor 1
ameliorates
ISO
RGD
PMID:24920753
RGD:329845564
NCBI chr 2:234,562,410...234,565,370
Ensembl chr 2:234,562,408...234,565,484
G
Cd14
CD14 molecule
ISO
mRNA,protein:increased expression:kidney
RGD
PMID:10966493
RGD:7204444
NCBI chr18:28,335,522...28,337,383
Ensembl chr18:28,335,340...28,337,261
G
Cd40
CD40 molecule
treatment
IMP
RGD
PMID:25993320
RGD:11251055
NCBI chr 3:153,790,372...153,805,279
Ensembl chr 3:153,790,449...153,805,534
G
Cfb
complement factor B
ISO
RGD
PMID:16467447 PMID:12538716
RGD:7242709 , RGD:7242734
NCBI chr20:3,970,643...3,976,510
Ensembl chr20:3,951,474...3,976,505
G
Cfh
complement factor H
treatment
IEP ISO
protein:decreased expression:serum:
RGD
PMID:20538296 PMID:20538296
RGD:7364948 , RGD:7364948
NCBI chr13:51,512,376...51,613,829
Ensembl chr13:51,511,828...51,613,838
G
Ciita
class II, major histocompatibility complex, transactivator
ISO
RGD
PMID:14569092
RGD:7242896
NCBI chr10:5,139,947...5,187,493
Ensembl chr10:5,140,178...5,187,440
G
Cited1
Cbp/p300-interacting transactivator with Glu/Asp-rich carboxy-terminal domain 1
ISO
mRNA:altered expression:kidney (mouse)
RGD
PMID:18467665
RGD:155631277
NCBI chr X:67,350,376...67,355,072
Ensembl chr X:67,350,373...67,355,162
G
Col1a1
collagen type I alpha 1 chain
ameliorates
ISO
RGD
PMID:24920753
RGD:329845564
NCBI chr10:79,883,622...79,900,625
Ensembl chr10:79,883,622...79,900,624
G
Col3a1
collagen type III alpha 1 chain
ameliorates
ISO
RGD
PMID:24920753
RGD:329845564
NCBI chr 9:47,374,611...47,410,547
Ensembl chr 9:47,374,593...47,410,547
G
Csf1
colony stimulating factor 1
ISO
mRNA:increased expression:kidney
RGD
PMID:23143303 PMID:19196448
RGD:7257565 , RGD:7257570
NCBI chr 2:195,377,215...195,396,608
Ensembl chr 2:195,377,215...195,411,704
G
Csf1r
colony stimulating factor 1 receptor
ISO
RGD
PMID:23143303
RGD:7257565
NCBI chr18:54,546,673...54,590,418
Ensembl chr18:54,546,659...54,590,415
G
Ctla4
cytotoxic T-lymphocyte-associated protein 4
ISO
RGD
PMID:22189844 PMID:9407517
RGD:7204675 , RGD:7204727
NCBI chr 9:62,318,874...62,325,978
Ensembl chr 9:62,319,312...62,324,963
G
Cxcl2
C-X-C motif chemokine ligand 2
ameliorates
ISO
RGD
PMID:24920753
RGD:329845564
NCBI chr14:17,181,030...17,183,075
Ensembl chr14:17,181,062...17,183,075
G
Cxcr2
C-X-C motif chemokine receptor 2
ISO
RGD
PMID:20038794
RGD:7257679
NCBI chr 9:75,729,493...75,735,868
Ensembl chr 9:75,729,115...75,739,425
G
Cxcr4
C-X-C motif chemokine receptor 4
IEP
protein:increased expression:kidney
RGD
PMID:29073721
RGD:13825150
NCBI chr13:40,077,976...40,081,883
Ensembl chr13:40,077,976...40,081,883
G
Cyp19a1
cytochrome P450, family 19, subfamily a, polypeptide 1
treatment
IMP
RGD
PMID:23552495
RGD:7244372
NCBI chr 8:54,552,978...54,580,375
Ensembl chr 8:54,553,165...54,580,758
G
Daxx
death-domain associated protein
ISO
protein:increased expression:kidney:
RGD
PMID:18480747 PMID:18480747
RGD:9587836 , RGD:9587836
NCBI chr20:4,970,090...4,976,145
Ensembl chr20:4,970,092...4,975,843
G
Ddr1
discoidin domain receptor tyrosine kinase 1
ISO
protein:increased expression:kidney (mouse)
RGD
PMID:31383731
RGD:151347540
NCBI chr20:3,042,494...3,064,442
Ensembl chr20:3,044,320...3,064,468
G
Dhfr
dihydrofolate reductase
treatment
IEP
mRNA,protein:decreased expression:kidney:
RGD
PMID:18408363
RGD:11040540
NCBI chr 2:23,585,876...23,611,199
Ensembl chr 2:23,586,031...23,613,713
G
Drd3
dopamine receptor D3
treatment
IDA
RGD
PMID:25989500
RGD:13506961
NCBI chr11:56,879,689...56,931,901
Ensembl chr11:56,879,689...56,940,596
G
Eed
embryonic ectoderm development
ISO
mRNA:altered expression:kidney (mouse)
RGD
PMID:18467665
RGD:155631277
NCBI chr 1:143,867,875...143,895,008
Ensembl chr 1:143,867,875...143,894,974
G
Egln1
egl-9 family hypoxia-inducible factor 1
IEP
mRNA, protein:decreased expression:kidney
RGD
PMID:19349364
RGD:11252083
NCBI chr19:52,867,900...52,907,308
Ensembl chr19:52,869,486...52,907,777
G
Egln3
egl-9 family hypoxia-inducible factor 3
IEP
mRNA, protein:decreased expression:kidney
RGD
PMID:19349364
RGD:11252083
NCBI chr 6:71,650,297...71,675,766
Ensembl chr 6:71,650,297...71,675,766
G
Elane
elastase, neutrophil expressed
treatment
IMP
RGD
PMID:16980042
RGD:10450580
NCBI chr 7:9,817,251...9,819,174
Ensembl chr 7:9,817,252...9,819,100
G
Eng
endoglin
IEP ISO
mRNA, protein:increased expression:kidney (rat)
RGD
PMID:16751653 PMID:16751653
RGD:7248779 , RGD:7248779
NCBI chr 3:15,934,566...15,972,618
Ensembl chr 3:15,934,518...15,973,230
G
Ep300
E1A binding protein p300
IEP
protein:altered localization:kidney (rat)
RGD
PMID:23936185
RGD:7257563
NCBI chr 7:113,108,476...113,178,529
Ensembl chr 7:113,106,247...113,136,088 Ensembl chr 7:113,106,247...113,136,088
G
Epo
erythropoietin
treatment
ISO
RGD
PMID:19961832 PMID:25581532
RGD:10401077 , RGD:11041698
NCBI chr12:19,204,258...19,207,948
Ensembl chr12:19,204,508...19,207,946
G
Ezh2
enhancer of zeste 2 polycomb repressive complex 2 subunit
ISO
mRNA:altered expression:kidney (mouse)
RGD
PMID:18467665
RGD:155631277
NCBI chr 4:76,624,399...76,687,362
Ensembl chr 4:76,624,399...76,687,362
G
F3
coagulation factor III, tissue factor
IEP
protein:decreased expression:lung
RGD
PMID:25883098
RGD:11341735
NCBI chr 2:209,827,061...209,838,666
Ensembl chr 2:209,826,959...209,838,668
G
Fas
Fas cell surface death receptor
treatment
IEP
RGD
PMID:29285062
RGD:13792599
NCBI chr 1:231,798,963...231,832,591
Ensembl chr 1:231,798,960...231,832,591
G
Faslg
Fas ligand
treatment
IEP
RGD
PMID:29285062
RGD:13792599
NCBI chr13:74,151,519...74,172,760
Ensembl chr13:74,154,954...74,162,215
G
Fcgr1a
Fc gamma receptor 1A
treatment
ISO
RGD
PMID:22402584
RGD:9685699
NCBI chr 2:183,851,075...183,860,077
Ensembl chr 2:183,851,077...183,859,994
G
Fga
fibrinogen alpha chain
IEP
mRNA,protein:increased expression:kidney
RGD
PMID:21685370
RGD:7175292
NCBI chr 2:168,374,120...168,381,523
Ensembl chr 2:168,374,120...168,381,528
G
Fgb
fibrinogen beta chain
treatment
IEP ISO
mRNA, protein:increased expression:kidney
RGD
PMID:21685370 PMID:21685370
RGD:7175292 , RGD:7175292
NCBI chr 2:168,394,901...168,402,863
Ensembl chr 2:168,394,916...168,405,979
G
Fgfr2
fibroblast growth factor receptor 2
exacerbates ameliorates
ISO IMP
protein:increased phosphorylation:kidney (mouse)
RGD
PMID:20591940 PMID:22688984 PMID:29344510 PMID:32523960
RGD:155663667 , RGD:155882537 , RGD:155782904 , RGD:155782882
NCBI chr 1:184,745,418...184,850,655
Ensembl chr 1:184,745,420...184,850,626
G
Fgg
fibrinogen gamma chain
IEP
mRNA,protein:increased expression:kidney
RGD
PMID:21685370
RGD:7175292
NCBI chr 2:168,354,880...168,362,325
Ensembl chr 2:168,355,013...168,362,322
G
Fn1
fibronectin 1
IEP
RGD
PMID:11352844
RGD:7205629
NCBI chr 9:73,196,044...73,264,695
Ensembl chr 9:73,196,044...73,264,678
G
Fos
Fos proto-oncogene, AP-1 transcription factor subunit
ISO
RGD
PMID:19095962
RGD:7242184
NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036
G
Gfer
growth factor, augmenter of liver regeneration
treatment
IEP ISO
protein:increased expression:kidney:
RGD
PMID:20332418 PMID:20332418
RGD:9685723 , RGD:9685723
NCBI chr10:13,718,489...13,721,782
Ensembl chr10:13,718,489...13,720,869
G
Glo1
glyoxalase 1
IMP
RGD
PMID:19211689
RGD:7242566
NCBI chr20:8,663,617...8,681,661
Ensembl chr20:8,662,801...8,681,649
G
Gpx3
glutathione peroxidase 3
IEP
protein:decreased expression:kidney mRNA:decreased expression:kidney
RGD
PMID:37033969 PMID:22442209
RGD:401827821 , RGD:401827906
NCBI chr10:39,028,624...39,036,695
Ensembl chr10:39,028,570...39,037,035
G
Gsr
glutathione-disulfide reductase
treatment
IEP
RGD
PMID:24630969
RGD:10401866
NCBI chr16:58,482,209...58,525,256
Ensembl chr16:58,482,505...58,525,661
G
Gstm1
glutathione S-transferase mu 1
IEP
mRNA, protein:decreased expression:kidney
RGD
PMID:29137244
RGD:158014894
NCBI chr 2:195,649,845...195,655,402
Ensembl chr 2:195,649,845...195,655,411
G
Gstt1
glutathione S-transferase theta 1
IEP
protein:decreased expression:kidney
RGD
PMID:37033969
RGD:401827821
NCBI chr20:12,856,613...12,873,586
Ensembl chr20:12,856,669...12,873,585
G
H2ax
H2A.X variant histone
treatment
IEP
RGD
PMID:23726287
RGD:8693706
NCBI chr 8:44,671,907...44,673,262
Ensembl chr 8:44,671,786...44,673,239
G
Has1
hyaluronan synthase 1
IEP
RGD
PMID:22529164
RGD:9588636
NCBI chr 1:58,693,411...58,705,653
Ensembl chr 1:58,693,411...58,705,397
G
Has2
hyaluronan synthase 2
IEP
RGD
PMID:22529164
RGD:9588636
NCBI chr 7:88,113,326...88,139,337
Ensembl chr 7:88,113,326...88,128,933
G
Havcr1
hepatitis A virus cellular receptor 1
IEP ISO
protein:increased expression:urine:
RGD
PMID:23552495 PMID:23019274 PMID:23085062
RGD:7244372 , RGD:7245495 , RGD:7245489
NCBI chr10:31,118,667...31,151,730
Ensembl chr10:31,119,088...31,151,698
G
Hif1a
hypoxia inducible factor 1 subunit alpha
treatment severity
IDA IMP
RGD
PMID:17519789 PMID:22432008
RGD:1626334 , RGD:9068883
NCBI chr 6:92,624,059...92,669,262
Ensembl chr 6:92,624,390...92,669,261
G
Hmox1
heme oxygenase 1
treatment
IMP
RGD
PMID:21291499
RGD:10755580
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
G
Hsf1
heat shock transcription factor 1
IEP
protein:increased expression:kidney (rat)
RGD
PMID:23102208
RGD:10402775
NCBI chr 7:108,196,040...108,223,011
Ensembl chr 7:108,196,056...108,223,011
G
Hspa8
heat shock protein family A (Hsp70) member 8
IEP
RGD
PMID:7569112
RGD:7242788
NCBI chr 8:41,183,397...41,187,260
Ensembl chr 8:41,183,264...41,187,259
G
Hyal1
hyaluronidase 1
IEP
RGD
PMID:22529164
RGD:9588636
NCBI chr 8:108,250,668...108,254,519
Ensembl chr 8:108,250,667...108,260,210
G
Hyal2
hyaluronidase 2
IEP
RGD
PMID:22529164
RGD:9588636
NCBI chr 8:108,241,895...108,246,853
Ensembl chr 8:108,243,133...108,246,850
G
Ifng
interferon gamma
treatment
ISO
RGD
PMID:28355607
RGD:14975115
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
G
Igf1r
insulin-like growth factor 1 receptor
IEP
mRNA: increased expression: kidney: 3 and 5 days post ischemia
RGD
PMID:10990448
RGD:7242905
NCBI chr 1:121,549,831...121,838,548
Ensembl chr 1:121,550,743...121,831,777
G
Ikbkb
inhibitor of nuclear factor kappa B kinase subunit beta
treatment
IMP
RGD
PMID:19546526
RGD:7495779
NCBI chr16:69,319,487...69,373,251
Ensembl chr16:69,319,554...69,373,250
G
Il10
interleukin 10
treatment
IDA ISO
RGD
PMID:24079335 PMID:28664613
RGD:7364864 , RGD:14975137
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
G
Il12b
interleukin 12B
ameliorates
ISO
RGD
PMID:24920753
RGD:329845564
NCBI chr10:28,888,832...28,903,802
Ensembl chr10:28,893,008...28,902,903
G
Il18
interleukin 18
treatment
IMP
RGD
PMID:22089199
RGD:8655971
NCBI chr 8:50,904,630...50,932,887
Ensembl chr 8:50,906,960...50,932,887
G
Il1b
interleukin 1 beta
ameliorates
IDA ISO
RGD
PMID:20030532 PMID:24920753
RGD:7175501 , RGD:329845564
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
G
Il1rn
interleukin 1 receptor antagonist
ISO
rat model treated with human protein mouse model treated with human protein
RGD
PMID:18363573 PMID:9555664 PMID:16849996
RGD:6907101 , RGD:6909149 , RGD:6907359
NCBI chr 3:7,111,567...7,127,451
Ensembl chr 3:7,111,550...7,127,445
G
Il6
interleukin 6
ameliorates
ISO
RGD
PMID:24920753
RGD:329845564
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
G
Inhbb
inhibin subunit beta B
IEP
protein:increased expression:serum (rat)
RGD
PMID:27732750
RGD:329322881
NCBI chr13:30,530,860...30,536,566
Ensembl chr13:30,530,860...30,537,832
G
Itgb2
integrin subunit beta 2
ISO IMP
Associated with renal transplant patients
RGD
PMID:20504838 PMID:11007822
RGD:6907049 , RGD:6907073
NCBI chr20:11,061,394...11,097,656
Ensembl chr20:11,061,430...11,097,600
G
Kcnj11
potassium inwardly-rectifying channel, subfamily J, member 11
IEP
protein:decreased expression:kidney
RGD
PMID:21250976
RGD:7297045
NCBI chr 1:96,591,048...96,594,574
Ensembl chr 1:96,591,049...96,594,082
G
Kl
Klotho
treatment
IEP ISO
mRNA,protein:decreased expression:renal tubule:
RGD
PMID:16204278 PMID:16204278
RGD:10403064 , RGD:10403064
NCBI chr12:490,402...531,417
Ensembl chr12:490,399...530,080
G
Kmt2a
lysine methyltransferase 2A
ISO
protein:increased expression:kidney (mouse)
RGD
PMID:31570196
RGD:155888490
NCBI chr 8:45,116,763...45,193,320
Ensembl chr 8:45,118,814...45,193,181
G
Lcn2
lipocalin 2
IEP ISO
protein:increased expression:urine: mRNA,protein:increased expression:kidney,urine mRNA,protein:increased expression:kidney:
RGD
PMID:23364806 PMID:27800610 PMID:20181666 PMID:23085062
RGD:7245469 , RGD:126790572 , RGD:126779563 , RGD:7245489
NCBI chr 3:15,680,688...15,684,033
Ensembl chr 3:15,680,687...15,684,095
G
Lep
leptin
resistance
IDA
RGD
PMID:22969992
RGD:6909133
NCBI chr 4:57,661,127...57,675,262
Ensembl chr 4:57,661,131...57,675,262
G
Lgals3
galectin 3
IEP
mRNA:increased expression:kidney
RGD
PMID:10980121
RGD:9685228
NCBI chr15:20,620,083...20,632,019
Ensembl chr15:20,607,692...20,632,025
G
Map1lc3a
microtubule-associated protein 1 light chain 3 alpha
treatment
ISO IEP
RGD
PMID:20075199 PMID:26412257
RGD:11561916 , RGD:11561958
NCBI chr 3:143,783,024...143,784,670
Ensembl chr 3:143,783,024...143,784,670
G
Map3k5
mitogen-activated protein kinase kinase kinase 5
treatment
IMP
RGD
PMID:23952292
RGD:10412647
NCBI chr 1:14,685,776...14,904,935
Ensembl chr 1:14,685,492...14,904,800
G
Mc1r
melanocortin 1 receptor
IEP
protein:decreased expression:kidney outer medulla
RGD
PMID:18790174
RGD:5687322
NCBI chr19:51,452,448...51,455,375
Ensembl chr19:51,453,239...51,454,192
G
Mir146a
microRNA 146a
treatment
IEP
RGD
PMID:27760486
RGD:155882556
NCBI chr10:27,848,516...27,848,610
Ensembl chr10:27,848,516...27,848,610
G
Mir320a
microRNA 320a
treatment
IEP
RGD
PMID:31089916 PMID:27760486
RGD:155882543 , RGD:155882556
NCBI chr15:45,516,392...45,516,473
Ensembl chr15:45,516,392...45,516,473
G
Mir381
microRNA 381
IEP
RNA:decreased expression:kidney
RGD
PMID:29073721
RGD:13825150
NCBI chr 6:128,740,976...128,741,036
G
Mir423
microRNA 423
treatment
IMP
RGD
PMID:29137244
RGD:158014894
NCBI chr10:61,914,142...61,914,220
Ensembl chr10:61,914,133...61,914,226
G
Mir494
microRNA 494
ameliorates
ISO
RGD
PMID:23160513
RGD:155883172
NCBI chr 6:128,728,710...128,728,792
Ensembl chr 6:128,728,709...128,728,793
G
Mpo
myeloperoxidase
IEP ISO
protein:increased activity:kidney
RGD
PMID:22950848 PMID:18055546
RGD:6909167 , RGD:7174699
NCBI chr10:72,594,883...72,608,862
Ensembl chr10:72,594,661...72,604,819
G
Muc1
mucin 1, cell surface associated
treatment
IDA
RGD
PMID:22019164
RGD:7245959
NCBI chr 2:174,635,989...174,640,738
Ensembl chr 2:174,635,995...174,640,733
G
Myc
MYC proto-oncogene, bHLH transcription factor
IEP
mRNA:increased expression:kidney (rat)
RGD
PMID:17220792
RGD:7207777
NCBI chr 7:93,593,705...93,598,633
Ensembl chr 7:93,593,705...93,598,630
G
Ndufb8
NADH:ubiquinone oxidoreductase subunit B8
IEP ISO
RGD
PMID:24096033 PMID:22160772
RGD:13801197 , RGD:13801199
NCBI chr 1:243,408,656...243,413,715
Ensembl chr 1:243,408,619...243,413,817
G
Nes
nestin
IEP
RGD
PMID:24503548
RGD:11570523
NCBI chr 2:173,437,867...173,447,777
Ensembl chr 2:173,438,734...173,447,777
G
Nfe2l2
NFE2 like bZIP transcription factor 2
treatment
IEP
RGD
PMID:31089916
RGD:155882543
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
G
Nos2
nitric oxide synthase 2
treatment
IEP
RGD
PMID:18408363
RGD:11040540
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
G
Nos3
nitric oxide synthase 3
treatment
IEP
RGD
PMID:29291552 PMID:18408363
RGD:13504682 , RGD:11040540
NCBI chr 4:10,793,834...10,814,170
Ensembl chr 4:10,793,834...10,814,166
G
Nox1
NADPH oxidase 1
treatment
IEP
RGD
PMID:34244746
RGD:329955363
NCBI chr X:97,279,058...97,332,291
Ensembl chr X:97,279,056...97,302,236
G
Nppa
natriuretic peptide A
ISO
RGD
PMID:20471588
RGD:7247717
NCBI chr 5:158,429,042...158,430,351
Ensembl chr 5:158,429,042...158,430,351
G
Nqo1
NAD(P)H quinone dehydrogenase 1
treatment
IEP
RGD
PMID:21545725
RGD:11035217
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
G
Nr4a1
nuclear receptor subfamily 4, group A, member 1
severity
ISO
mRNA:increased expression:kidney
RGD
PMID:22343121 PMID:22343121
RGD:14700869 , RGD:14700869
NCBI chr 7:132,368,399...132,389,300
Ensembl chr 7:132,374,840...132,389,297
G
Ogg1
8-oxoguanine DNA glycosylase
IEP
RGD
PMID:12531391
RGD:2317150
NCBI chr 4:146,474,701...146,481,959
Ensembl chr 4:146,474,750...146,484,766
G
Pax2
paired box 2
IEP
mRNA, protein:increased expression:kidney
RGD
PMID:12444203
RGD:727468
NCBI chr 1:243,616,509...243,697,454
Ensembl chr 1:243,616,606...243,695,321
G
Pdgfb
platelet derived growth factor subunit B
IEP
mRNA,protein:increased expression:tubule, S3 segment:
RGD
PMID:10550325
RGD:8554477
NCBI chr 7:111,539,444...111,557,984
Ensembl chr 7:111,540,345...111,557,984
G
Pdgfra
platelet derived growth factor receptor alpha
IEP
mRNA:increased expression:kidney
RGD
PMID:10550325
RGD:8554477
NCBI chr14:33,005,838...33,054,347
Ensembl chr14:33,005,839...33,054,335
G
Pdgfrb
platelet derived growth factor receptor beta
IMP IEP
mRNA:increased expression:kidney
RGD
PMID:12819032 PMID:10550325
RGD:1580850 , RGD:8554477
NCBI chr18:54,499,962...54,538,840
Ensembl chr18:54,499,964...54,538,843
G
Peg10
paternally expressed 10
ISO
mRNA:increased expression:kidney (mouse)
RGD
PMID:16778176
RGD:401851077
NCBI chr 4:32,842,441...32,855,639
Ensembl chr 4:32,848,493...32,852,621
G
Pkd2
polycystin 2, transient receptor potential cation channel
IEP
protein:increased expression:kidney (rat)
RGD
PMID:12454224
RGD:1580868
NCBI chr14:5,237,135...5,280,455
Ensembl chr14:5,237,135...5,280,825
G
Ppargc1a
PPARG coactivator 1 alpha
treatment
IDA
RGD
PMID:24918615
RGD:10059636
NCBI chr14:58,860,752...59,516,525
Ensembl chr14:58,861,144...59,512,656
G
Ptgis
prostaglandin I2 synthase
ISO
mRNA:increased expression:kidney (mouse)
RGD
PMID:30413885
RGD:401959745
NCBI chr 3:155,928,564...155,964,228
Ensembl chr 3:155,916,412...155,965,451
G
Rnls
renalase, FAD-dependent amine oxidase
ISO
mRNA,protein:decreased expression:kidney,plasma:
RGD
PMID:23393318 PMID:23393318
RGD:7327166 , RGD:7327166
NCBI chr 1:231,037,481...231,309,855
Ensembl chr 1:231,037,486...231,309,823
G
Serpina1
serpin family A member 1
treatment
ISO
RGD
PMID:28235038
RGD:14695051
NCBI chr 6:122,866,314...122,888,339
Ensembl chr 6:122,866,312...122,888,339
G
Serpinc1
serpin family C member 1
severity
IMP
RGD
PMID:26108065 PMID:26108065
RGD:11354006 , RGD:11354006
NCBI chr13:73,257,208...73,271,476
Ensembl chr13:73,257,179...73,284,293
G
Serpinc1em2Mcwi
serpin family C member 1; ZFN induced mutant 2, Medical College of Wisconsin
IMP
RGD
PMID:26108065
RGD:11354006
G
Serpine1
serpin family E member 1
ameliorates
ISO
RGD
PMID:24920753
RGD:329845564
NCBI chr12:19,601,272...19,611,657
Ensembl chr12:19,601,272...19,611,657
G
Shh
sonic hedgehog signaling molecule
ISO
mRNA, protein:increased expression:kidney
RGD
PMID:24744439
RGD:12859042
NCBI chr 4:6,954,017...6,963,170
Ensembl chr 4:6,954,017...6,963,170
G
Sirt1
sirtuin 1
treatment
IEP
RGD
PMID:22324445
RGD:9495930
NCBI chr20:25,307,225...25,329,273
Ensembl chr20:25,306,917...25,329,260
G
Six2
SIX homeobox 2
ISO
mRNA:altered expression:kidney (mouse)
RGD
PMID:18467665
RGD:155631277
NCBI chr 6:8,974,859...8,981,345
Ensembl chr 6:8,967,157...8,981,193
G
Slc22a1
solute carrier family 22 member 1
IEP
RGD
PMID:21835768
RGD:7243877
NCBI chr 1:48,076,657...48,103,679
Ensembl chr 1:48,076,666...48,103,678
G
Slc22a2
solute carrier family 22 member 2
IEP
RGD
PMID:21835768
RGD:7243877
NCBI chr 1:48,121,061...48,163,268
Ensembl chr 1:48,121,061...48,163,268
G
Slc34a1
solute carrier family 34 member 1
IEP
protein:decreased expression:renal proximal tubule, brush border membrane (rat)
RGD
PMID:15775707
RGD:2311304
NCBI chr17:9,218,876...9,233,852
Ensembl chr17:9,218,876...9,233,852
G
Src
SRC proto-oncogene, non-receptor tyrosine kinase
IEP
RGD
PMID:12819032
RGD:1580850
NCBI chr 3:146,091,969...146,139,492
Ensembl chr 3:146,091,841...146,139,476
G
Stat6
signal transducer and activator of transcription 6
severity
ISO
RGD
PMID:12709397
RGD:7244143
NCBI chr 7:63,480,229...63,497,551
Ensembl chr 7:63,479,642...63,498,495
G
Suz12
SUZ12 polycomb repressive complex 2 subunit
ISO
mRNA:altered expression:kidney (mouse)
RGD
PMID:18467665
RGD:155631277
NCBI chr10:64,967,035...65,012,916
Ensembl chr10:64,966,967...65,012,738
G
Tfpi
tissue factor pathway inhibitor
ISO
RGD
PMID:11796005
RGD:11062062
NCBI chr 3:69,533,156...69,582,547
Ensembl chr 3:69,533,156...69,576,880
G
Tgfb1
transforming growth factor, beta 1
ameliorates
ISO
RGD
PMID:24920753
RGD:329845564
NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847
G
Tlr2
toll-like receptor 2
treatment severity
IDA ISO
RGD
PMID:23239000 PMID:11801667 PMID:20130923 PMID:22750071 PMID:23023072
RGD:7207892 , RGD:7241087 , RGD:7240552 , RGD:7207896 , RGD:7207894
NCBI chr 2:169,200,620...169,206,819
Ensembl chr 2:169,197,419...169,206,630
G
Tlr4
toll-like receptor 4
treatment
IDA ISO
RGD
PMID:23239000 PMID:11801667 PMID:20130923
RGD:7207892 , RGD:7241087 , RGD:7240552
NCBI chr 5:80,145,867...80,159,501
Ensembl chr 5:80,145,826...80,159,628
G
Tnf
tumor necrosis factor
ameliorates
IEP ISO
protein:increased expression:serum
RGD
PMID:19925291 PMID:24920753
RGD:2315112 , RGD:329845564
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Tnfrsf1a
TNF receptor superfamily member 1A
ISO
mRNA:increased expression:lung
RGD
PMID:22728466
RGD:7245543
NCBI chr 4:158,150,815...158,163,592
Ensembl chr 4:158,150,820...158,163,591
G
Vcam1
vascular cell adhesion molecule 1
IEP
protein:increased expression:kidney
RGD
PMID:20164827
RGD:7240507
NCBI chr 2:204,038,120...204,057,852
Ensembl chr 2:204,038,114...204,057,958
G
Vwf
von Willebrand factor
IEP
protein:increased expression:serum:
RGD
PMID:12684225
RGD:11080744
NCBI chr 4:158,360,152...158,491,539
Ensembl chr 4:158,360,152...158,491,539
G
Wt1
WT1 transcription factor
ISO
mRNA:altered expression:kidney (mouse)
RGD
PMID:18467665
RGD:155631277
NCBI chr 3:91,566,540...91,613,653
Ensembl chr 3:91,567,001...91,613,643
G
Xdh
xanthine dehydrogenase
treatment
IMP
associated with Diabetes Mellitus, Type 2
RGD
PMID:22995295 PMID:20616412
RGD:7247637 , RGD:7247695
NCBI chr 6:21,530,463...21,592,172
Ensembl chr 6:21,530,113...21,592,268
G
Zfp667
zinc finger protein 667
ameliorates
ISO
RGD
PMID:24920753
RGD:329845564
NCBI chr 1:67,601,803...67,622,041
Ensembl chr 1:67,601,807...67,622,041
G
Gpt
glutamic--pyruvic transaminase
treatment
IEP
RGD
PMID:36495512
RGD:401717522
NCBI chr 7:108,416,646...108,419,495
Ensembl chr 7:108,416,642...108,419,494
G
Adipoq
adiponectin, C1Q and collagen domain containing
treatment
IDA
RGD
PMID:23762489
RGD:8695935
NCBI chr11:77,721,912...77,735,644
Ensembl chr11:77,721,912...77,735,564
G
Adm
adrenomedullin
treatment
IEP ISO
mRNA,protein:increased expression:liver,plasma:
RGD
PMID:19212187 PMID:19212187
RGD:7364958 , RGD:7364958
NCBI chr 1:164,745,484...164,747,655
Ensembl chr 1:164,745,466...164,747,654
G
Ager
advanced glycosylation end product-specific receptor
IEP
mRNA:increased expression:liver
RGD
PMID:21431875
RGD:10402078
NCBI chr20:4,148,150...4,151,361
Ensembl chr20:4,147,890...4,151,078
G
Aldh2
aldehyde dehydrogenase 2 family member
treatment
ISO IEP
protein:altered expression:liver (mouse) protein:altered expression:liver (rat)
RGD
PMID:30671488 PMID:29589772
RGD:15036807 , RGD:14975297
NCBI chr12:34,949,549...34,982,527
Ensembl chr12:34,901,219...34,982,521
G
Atf6
activating transcription factor 6
ameliorates
ISO
RGD
PMID:34144219
RGD:329812011
NCBI chr13:82,927,579...83,106,381
Ensembl chr13:82,930,034...83,107,177
G
Atg13
autophagy related 13
ameliorates
ISO
RGD
PMID:34400126
RGD:329902072
NCBI chr 3:77,647,069...77,681,028
Ensembl chr 3:77,645,790...77,681,043
G
Atg16l1
autophagy related 16-like 1
ameliorates
ISO
RGD
PMID:34400126
RGD:329902072
NCBI chr 9:88,420,737...88,457,530
Ensembl chr 9:88,422,038...88,457,529
G
Atg4d
autophagy related 4D, cysteine peptidase
ameliorates
ISO
RGD
PMID:34400126
RGD:329902072
NCBI chr 8:19,807,733...19,817,321
Ensembl chr 8:19,807,766...19,817,321
G
Atg7
autophagy related 7
ameliorates
ISO
RGD
PMID:34400126
RGD:329902072
NCBI chr 4:147,718,663...147,925,656
Ensembl chr 4:147,718,752...147,925,593
G
Bad
BCL2-associated agonist of cell death
treatment
IEP
mRNA:increased expression:liver associated with Non-alcoholic Fatty Liver Disease
RGD
PMID:22647552 PMID:22847887
RGD:10053673 , RGD:10053710
NCBI chr 1:204,133,502...204,142,829
Ensembl chr 1:204,131,501...204,142,823
G
Bax
BCL2 associated X, apoptosis regulator
ameliorates treatment
IEP ISO
mRNA:increased expression:liver associated with Non-alcoholic Fatty Liver Disease
RGD
PMID:22647552 PMID:34144219 PMID:21092002 PMID:22847887
RGD:10053673 , RGD:329812011 , RGD:5134995 , RGD:10053710
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
G
Bcl2
BCL2, apoptosis regulator
treatment ameliorates
IDA ISO IEP
associated with Non-alcoholic Fatty Liver Disease
RGD
PMID:22847887 PMID:34144219 PMID:21092002
RGD:10053710 , RGD:329812011 , RGD:5134995
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
Bcl2l1
Bcl2-like 1
treatment
IEP
associated with Non-alcoholic Fatty Liver Disease
RGD
PMID:22847887
RGD:10053710
NCBI chr 3:141,253,508...141,304,582
Ensembl chr 3:141,253,523...141,303,479
G
Becn1
beclin 1
ameliorates
ISO
RGD
PMID:34400126
RGD:329902072
NCBI chr10:86,231,387...86,246,742
Ensembl chr10:86,231,388...86,246,742
G
C3
complement C3
treatment
IEP
RGD
PMID:19854450
RGD:11040888
NCBI chr 9:2,087,437...2,114,366
Ensembl chr 9:2,087,437...2,114,429
G
Casp12
caspase 12
treatment
IEP
RGD
PMID:29428101
RGD:13782166
NCBI chr 8:2,642,296...2,669,549
Ensembl chr 8:2,642,434...2,674,037
G
Casp3
caspase 3
ameliorates
ISO
RGD
PMID:34144219
RGD:329812011
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Casp8
caspase 8
treatment
IEP ISO
RGD
PMID:23423194 PMID:15300206
RGD:8661760 , RGD:14695087
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
G
Casp9
caspase 9
treatment ameliorates
IEP ISO
RGD
PMID:23364428 PMID:34144219
RGD:13782358 , RGD:329812011
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
G
Ccl2
C-C motif chemokine ligand 2
ameliorates treatment severity
IEP ISO
mRNA, protein:increased expression:liver, serum (rat)
RGD
PMID:9500701 PMID:34400126 PMID:10630515 PMID:27229110
RGD:8549627 , RGD:329902072 , RGD:14995929 , RGD:14995460
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
G
Ccl5
C-C motif chemokine ligand 5
treatment severity
ISO
RGD
PMID:28623253 PMID:28623253
RGD:14995305 , RGD:14995305
NCBI chr10:68,322,826...68,327,380
Ensembl chr10:68,322,829...68,327,377
G
Ccl7
C-C motif chemokine ligand 7
ameliorates
ISO
RGD
PMID:34400126
RGD:329902072
NCBI chr10:67,016,446...67,018,296
Ensembl chr10:67,016,446...67,018,303
G
Ccn1
cellular communication network factor 1
ameliorates
ISO
RGD
PMID:34144219
RGD:329812011
NCBI chr 2:234,562,410...234,565,370
Ensembl chr 2:234,562,408...234,565,484
G
Ccr1
C-C motif chemokine receptor 1
ameliorates
ISO
RGD
PMID:34400126
RGD:329902072
NCBI chr 8:123,556,286...123,561,841
G
Ccr2
C-C motif chemokine receptor 2
severity
ISO
RGD
PMID:27229110
RGD:14995460
NCBI chr 8:123,734,465...123,742,483
Ensembl chr 8:123,734,430...123,742,100
G
Cd14
CD14 molecule
IDA
RGD
PMID:22564590
RGD:7183676
NCBI chr18:28,335,522...28,337,383
Ensembl chr18:28,335,340...28,337,261
G
Cd40
CD40 molecule
treatment
IMP
RGD
PMID:14741776
RGD:8547795
NCBI chr 3:153,790,372...153,805,279
Ensembl chr 3:153,790,449...153,805,534
G
Cfh
complement factor H
treatment
IEP ISO
mRNA,protein:decreased expression:liver,plasma:
RGD
PMID:19212187 PMID:19212187
RGD:7364958 , RGD:7364958
NCBI chr13:51,512,376...51,613,829
Ensembl chr13:51,511,828...51,613,838
G
Cs
citrate synthase
IDA
RGD
PMID:25416448
RGD:13504849
NCBI chr 7:758,074...791,421
Ensembl chr 7:758,345...791,421
G
Cst3
cystatin C
ameliorates
ISO
RGD
PMID:34400126
RGD:329902072
NCBI chr 3:136,336,923...136,340,796
Ensembl chr 3:136,336,920...136,340,822
G
Cxcl1
C-X-C motif chemokine ligand 1
treatment ameliorates
IDA ISO
RGD
PMID:21092002 PMID:34400126
RGD:5134995 , RGD:329902072
NCBI chr14:17,193,364...17,195,143
Ensembl chr14:17,193,365...17,195,215
G
Cxcl10
C-X-C motif chemokine ligand 10
treatment ameliorates
ISO
RGD
PMID:18041715 PMID:34400126
RGD:27095942 , RGD:329902072
NCBI chr14:15,704,772...15,706,969
Ensembl chr14:15,704,758...15,706,975
G
Cxcl2
C-X-C motif chemokine ligand 2
ameliorates
ISO
RGD
PMID:34400126
RGD:329902072
NCBI chr14:17,181,030...17,183,075
Ensembl chr14:17,181,062...17,183,075
G
Cxcl6
C-X-C motif chemokine ligand 6
ameliorates
ISO
RGD
PMID:34400126
RGD:329902072
NCBI chr14:17,310,790...17,312,250
Ensembl chr14:17,310,426...17,313,093
G
Cxcl9
C-X-C motif chemokine ligand 9
ameliorates
ISO
RGD
PMID:34400126
RGD:329902072
NCBI chr14:15,722,868...15,727,779
Ensembl chr14:15,722,908...15,728,435
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
IEP
mRNA:decreased expression:lung
RGD
PMID:19595018
RGD:2314952
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
G
Ddit3
DNA-damage inducible transcript 3
ameliorates
ISO
RGD
PMID:34144219
RGD:329812011
NCBI chr 7:63,115,645...63,121,203
Ensembl chr 7:63,116,380...63,121,201
G
Eif2ak3
eukaryotic translation initiation factor 2 alpha kinase 3
ameliorates
ISO
RGD
PMID:34144219
RGD:329812011
NCBI chr 4:102,805,495...102,866,914
Ensembl chr 4:102,805,510...102,866,911
G
Elane
elastase, neutrophil expressed
IMP
RGD
PMID:10588515
RGD:10450560
NCBI chr 7:9,817,251...9,819,174
Ensembl chr 7:9,817,252...9,819,100
G
Epo
erythropoietin
treatment
ISO
RGD
PMID:25769561
RGD:15090809
NCBI chr12:19,204,258...19,207,948
Ensembl chr12:19,204,508...19,207,946
G
Epor
erythropoietin receptor
IEP
protein:increased phosphorylation:liver:
RGD
PMID:25769561
RGD:15090809
NCBI chr 8:20,489,678...20,494,257
Ensembl chr 8:20,489,678...20,494,257
G
F3
coagulation factor III, tissue factor
treatment
IMP
RGD
PMID:11750579
RGD:11341708
NCBI chr 2:209,827,061...209,838,666
Ensembl chr 2:209,826,959...209,838,668
G
Fadd
Fas associated via death domain
treatment
IEP
RGD
PMID:23423194
RGD:8661760
NCBI chr 1:199,743,200...199,745,746
Ensembl chr 1:199,739,994...199,745,653
G
Fas
Fas cell surface death receptor
treatment
IMP IEP
protein:increased expression:liver
RGD
PMID:17235585 PMID:18561025 PMID:16222447
RGD:2290283 , RGD:14700680 , RGD:1600351
NCBI chr 1:231,798,963...231,832,591
Ensembl chr 1:231,798,960...231,832,591
G
Faslg
Fas ligand
treatment
IMP
RGD
PMID:18561025
RGD:14700680
NCBI chr13:74,151,519...74,172,760
Ensembl chr13:74,154,954...74,162,215
G
Fga
fibrinogen alpha chain
IEP
mRNA:increased expression:liver (rat)
RGD
PMID:23503399
RGD:9685021
NCBI chr 2:168,374,120...168,381,523
Ensembl chr 2:168,374,120...168,381,528
G
Fn1
fibronectin 1
IDA
RGD
PMID:12651615
RGD:7205470
NCBI chr 9:73,196,044...73,264,695
Ensembl chr 9:73,196,044...73,264,678
G
Gpt
glutamic--pyruvic transaminase
treatment
IEP
RGD
PMID:22564598 PMID:13678701
RGD:329970282 , RGD:329970285
NCBI chr 7:108,416,646...108,419,495
Ensembl chr 7:108,416,642...108,419,494
G
Gsk3b
glycogen synthase kinase 3 beta
treatment
IDA
associated with nonalcoholic fatty liver disease
RGD
PMID:28807209
RGD:13792730
NCBI chr11:62,498,997...62,648,665
Ensembl chr11:62,504,316...62,648,646
G
Gstm1
glutathione S-transferase mu 1
IEP
mRNA:decreased expression:lung
RGD
PMID:19595018
RGD:2314952
NCBI chr 2:195,649,845...195,655,402
Ensembl chr 2:195,649,845...195,655,411
G
H2ax
H2A.X variant histone
treatment
IEP
RGD
PMID:23792534
RGD:8693718
NCBI chr 8:44,671,907...44,673,262
Ensembl chr 8:44,671,786...44,673,239
G
Hmgb1
high mobility group box 1
treatment
IMP IEP
protein:increased oxidation:liver mRNA, protein:increased expression, altered localization:serum, hepatocyte, cytoplasm
RGD
PMID:24578610 PMID:22514737 PMID:21431875
RGD:10402068 , RGD:10402175 , RGD:10402078
NCBI chr12:5,972,950...5,979,658
Ensembl chr12:5,901,586...5,978,565 Ensembl chr16:5,901,586...5,978,565
G
Hmox1
heme oxygenase 1
treatment
IEP
RGD
PMID:20446775
RGD:10755725
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
G
Hp
haptoglobin
treatment
IEP
RGD
PMID:17187421 PMID:21699906
RGD:1626366 , RGD:11041815
NCBI chr19:37,539,626...37,544,178
Ensembl chr19:37,539,627...37,544,523
G
Icam1
intercellular adhesion molecule 1
treatment
IMP IEP
associated with Intestinal Reperfusion Injury;protein:increased expression:liver
RGD
PMID:7884306 PMID:8780571
RGD:11520784 , RGD:14402044
NCBI chr 8:19,553,063...19,565,438
Ensembl chr 8:19,553,645...19,565,438
G
Idh2
isocitrate dehydrogenase (NADP(+)) 2
severity
ISO
RGD
PMID:28938192
RGD:14985248
NCBI chr 1:134,038,644...134,057,969
Ensembl chr 1:134,029,772...134,058,025
G
Ikbkg
inhibitor of nuclear factor kappa B kinase regulatory subunit gamma
treatment
IDA
RGD
PMID:22381173
RGD:12791280
NCBI chr X:152,216,485...152,241,476
Ensembl chr X:152,216,596...152,239,499
G
Il10
interleukin 10
treatment
IDA
RGD
PMID:21911118
RGD:7364839
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
G
Il18
interleukin 18
treatment
IEP ISO
RGD
PMID:25919765 PMID:14999688
RGD:14696667 , RGD:14696668
NCBI chr 8:50,904,630...50,932,887
Ensembl chr 8:50,906,960...50,932,887
G
Il18bp
interleukin 18 binding protein
IEP
mRNA,protein:increased expression:liver
RGD
PMID:25919765
RGD:14696667
NCBI chr 1:156,372,923...156,374,963
Ensembl chr 1:156,372,883...156,374,963
G
Il1a
interleukin 1 alpha
treatment
IEP IDA
mRNA:increased expression:lung protein:increased expression:serum
RGD
PMID:19595018 PMID:9840148 PMID:19283466
RGD:2314952 , RGD:11059517 , RGD:6907377
NCBI chr 3:116,526,601...116,537,055
Ensembl chr 3:116,526,604...116,536,822
G
Il1b
interleukin 1 beta
ameliorates treatment
IDA ISO
associated with Cholestasis
RGD
PMID:21468628 PMID:34400126 PMID:32155285
RGD:7175318 , RGD:329902072 , RGD:155260323
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
G
Il1rn
interleukin 1 receptor antagonist
treatment
ISO IMP
rat model treated with human protein
RGD
PMID:9000676 PMID:12451245
RGD:6909138 , RGD:8551710
NCBI chr 3:7,111,567...7,127,451
Ensembl chr 3:7,111,550...7,127,445
G
Il6
interleukin 6
treatment ameliorates
IDA ISO
RGD
PMID:24752458 PMID:34400126 PMID:34144219 PMID:32155285
RGD:11062134 , RGD:329902072 , RGD:329812011 , RGD:155260323
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
G
Irf8
interferon regulatory factor 8
ameliorates
ISO
RGD
PMID:34400126
RGD:329902072
NCBI chr19:48,790,581...48,812,363
Ensembl chr19:48,790,588...48,811,829
G
Itgam
integrin subunit alpha M
treatment exacerbates
IMP IEP
protein:increased expression:neutrophil (rat)
RGD
PMID:8387952 PMID:11447039
RGD:329901847 , RGD:329901849
NCBI chr 1:182,659,047...182,709,501
Ensembl chr 1:182,659,000...182,709,503
G
Jak2
Janus kinase 2
treatment
IDA
RGD
PMID:22288937
RGD:10403073
NCBI chr 1:226,995,334...227,054,381
Ensembl chr 1:226,995,334...227,054,189
G
Lamp2
lysosomal-associated membrane protein 2
ameliorates
ISO
RGD
PMID:34400126
RGD:329902072
NCBI chr X:117,173,097...117,222,090
Ensembl chr X:117,057,606...117,260,522
G
Lbp
lipopolysaccharide binding protein
IEP
mRNA, protein:increased expression:liver
RGD
PMID:12134092
RGD:9685192
NCBI chr 3:146,953,889...146,981,032
Ensembl chr 3:146,954,015...146,981,586
G
Map1lc3b
microtubule-associated protein 1 light chain 3 beta
ameliorates
ISO
RGD
PMID:34400126
RGD:329902072
NCBI chr19:49,665,795...49,673,655
Ensembl chr19:49,665,791...49,677,690
G
Map3k7
mitogen activated protein kinase kinase kinase 7
ameliorates exacerbates
ISO
protein:increased phosphorylation:liver (mouse)
RGD
PMID:30076625 PMID:30622220
RGD:155804280 , RGD:155882441
NCBI chr 5:46,356,973...46,415,597
Ensembl chr 5:46,357,931...46,415,597
G
Mapk8
mitogen-activated protein kinase 8
IEP
protein:increased activity:liver:
RGD
PMID:11679968
RGD:10412680
NCBI chr16:8,638,897...8,721,960
Ensembl chr16:8,638,924...8,721,981
G
Mfn2
mitofusin 2
treatment
IEP
mRNA, protein:decreased expression:liver (rat)
RGD
PMID:27363631 PMID:24898700
RGD:12910833 , RGD:13204829
NCBI chr 5:158,304,285...158,335,502
Ensembl chr 5:158,304,287...158,335,342
G
Mir145
microRNA 145
IEP
mRNA:decreased expression:small intestine (rat)
RGD
PMID:23166305
RGD:155230822
NCBI chr18:55,099,640...55,099,727
Ensembl chr18:55,099,640...55,099,727
G
Mir155
microRNA 155
ISO
RGD
PMID:28640790
RGD:21079442
NCBI chr11:23,774,654...23,774,718
Ensembl chr11:23,774,654...23,774,718
G
Mir21
microRNA 21
IEP
RNA:increased expression:liver
RGD
PMID:29187695
RGD:41410824
NCBI chr10:71,405,257...71,405,348
Ensembl chr10:71,405,257...71,405,348
G
Mir210
microRNA 210
treatment
ISO
RGD
PMID:32155285
RGD:155260323
NCBI chr 1:196,326,343...196,326,452
Ensembl chr 1:196,326,337...196,326,454
G
Mir223
microRNA 223
ISO
RNA:increased expression:liver RNA:increased expression:serum,liver
RGD
PMID:19104939 PMID:28646120
RGD:13831297 , RGD:21408574
NCBI chr X:61,141,887...61,141,996
Ensembl chr X:61,141,887...61,141,996
G
Mir34a
microRNA 34a
IEP
miRNA:increased expression:liver
RGD
PMID:28963950
RGD:14695005
NCBI chr 5:160,533,002...160,533,103
Ensembl chr 5:160,533,002...160,533,103
G
Mmp15
matrix metallopeptidase 15
IEP
mRNA:increased expression:lung
RGD
PMID:19595018
RGD:2314952
NCBI chr19:9,663,449...9,684,943
Ensembl chr19:9,663,449...9,684,943
G
Mmp9
matrix metallopeptidase 9
treatment
IEP
associated with Fatty Liver;mRNA, protein:decreased expression, decreased activity:liver
RGD
PMID:17255325
RGD:8547976
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
G
Muc1
mucin 1, cell surface associated
IEP
mRNA, protein:decreased expression:bile duct
RGD
PMID:21775928
RGD:7364757
NCBI chr 2:174,635,989...174,640,738
Ensembl chr 2:174,635,995...174,640,733
G
Muc3
mucin 3
IEP
mRNA, protein:decreased expression:bile duct
RGD
PMID:21775928
RGD:7364757
NCBI chr12:19,527,251...19,536,924
Ensembl chr12:19,527,321...19,538,522
G
Muc4
mucin 4, cell surface associated
IEP
mRNA:decreased expression:bile duct
RGD
PMID:21775928
RGD:7364757
NCBI chr11:68,008,245...68,053,242
G
Nfatc1
nuclear factor of activated T-cells 1
ISO
mRNA,protein:increased expression:liver:
RGD
PMID:36092961
RGD:268357360
NCBI chr18:74,046,422...74,156,041
Ensembl chr18:74,046,904...74,156,028
G
Nfe2l2
NFE2 like bZIP transcription factor 2
treatment
IEP
RGD
PMID:22288937 PMID:31952110
RGD:10403073 , RGD:21201304
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
G
Nos3
nitric oxide synthase 3
treatment
IEP
RGD
PMID:28966130
RGD:13450941
NCBI chr 4:10,793,834...10,814,170
Ensembl chr 4:10,793,834...10,814,166
G
Pf4
platelet factor 4
exacerbates
ISO
RGD
PMID:25440775
RGD:329901829
NCBI chr14:17,298,304...17,299,220
Ensembl chr14:17,298,308...17,299,365
G
Proc
protein C, inactivator of coagulation factors Va and VIIIa
treatment
ISO
RGD
PMID:12605111 PMID:18507760
RGD:11100021 , RGD:11100046
NCBI chr18:23,764,367...23,774,816
Ensembl chr18:23,764,368...23,775,133
G
Rab10
RAB10, member RAS oncogene family
ameliorates
ISO
RGD
PMID:34400126
RGD:329902072
NCBI chr 6:26,267,081...26,319,739
Ensembl chr 6:26,266,859...26,320,193
G
Rab8b
RAB8B, member RAS oncogene family
ameliorates
ISO
RGD
PMID:34400126
RGD:329902072
NCBI chr 8:67,458,921...67,536,466
Ensembl chr 8:67,458,923...67,536,384
G
Selplg
selectin P ligand
ameliorates
IMP
RGD
PMID:16365457
RGD:401717523
NCBI chr12:42,796,690...42,809,908
Ensembl chr12:42,796,580...42,812,585
G
Serpinc1
serpin family C member 1
treatment
IEP ISO
RGD
PMID:24726586 PMID:8589354
RGD:10450597 , RGD:11038771
NCBI chr13:73,257,208...73,271,476
Ensembl chr13:73,257,179...73,284,293
G
Serpine1
serpin family E member 1
IEP
protein:increased activity:plasma (rat)
RGD
PMID:12353078
RGD:8547901
NCBI chr12:19,601,272...19,611,657
Ensembl chr12:19,601,272...19,611,657
G
Serping1
serpin family G member 1
treatment
ISO
RGD
PMID:16367929
RGD:1580273
NCBI chr 3:69,842,726...69,852,583
Ensembl chr 3:69,842,739...69,852,034
G
Sirt1
sirtuin 1
treatment
IEP
RGD
PMID:24557422
RGD:9497542
NCBI chr20:25,307,225...25,329,273
Ensembl chr20:25,306,917...25,329,260
G
Slpi
secretory leukocyte peptidase inhibitor
IEP
RGD
PMID:19595018
RGD:2314952
NCBI chr 3:153,082,208...153,084,457
Ensembl chr 3:153,082,369...153,084,453
G
Sod1
superoxide dismutase 1
treatment
ISO
human gene in a rat model
RGD
PMID:16555330 PMID:11779401
RGD:8655889 , RGD:1581095
NCBI chr11:29,456,673...29,462,249
Ensembl chr11:29,456,558...29,462,249
G
Sod3
superoxide dismutase 3
treatment
ISO
human gene in a rat model
RGD
PMID:11779401
RGD:1581095
NCBI chr14:58,610,104...58,615,845
Ensembl chr14:58,609,958...58,615,990
G
Tert
telomerase reverse transcriptase
treatment
ISO
RGD
PMID:19545665
RGD:11038676
NCBI chr 1:29,637,213...29,659,561
Ensembl chr 1:29,637,506...29,659,561
G
Tfpi
tissue factor pathway inhibitor
ISO
RGD
PMID:9921794
RGD:11062061
NCBI chr 3:69,533,156...69,582,547
Ensembl chr 3:69,533,156...69,576,880
G
Tlr2
toll-like receptor 2
treatment
ISO IEP
RGD
PMID:16038046 PMID:25769561
RGD:15090805 , RGD:15090809
NCBI chr 2:169,200,620...169,206,819
Ensembl chr 2:169,197,419...169,206,630
G
Tlr4
toll-like receptor 4
treatment severity
IEP ISO
mRNA:increased expression:liver protein:increased expression:membrane raft:
RGD
PMID:21431875 PMID:21693218 PMID:22797797 PMID:23395256 PMID:27064547
RGD:10402078 , RGD:5685379 , RGD:14697702 , RGD:14697699 , RGD:14697698
NCBI chr 5:80,145,867...80,159,501
Ensembl chr 5:80,145,826...80,159,628
G
Tnf
tumor necrosis factor
treatment
IEP ISO IMP
protein:increased expression:serum (rat)
RGD
PMID:24726586 PMID:32155285 PMID:11592783 PMID:19357028 PMID:11129814 PMID:21125813 PMID:10454827 PMID:15457564 PMID:17164725 More...
RGD:10450597 , RGD:155260323 , RGD:2325259 , RGD:15039406 , RGD:14995473 , RGD:14995447 , RGD:14985258 , RGD:14985257 , RGD:14696803
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Tnfrsf1a
TNF receptor superfamily member 1A
IEP
protein:increased localization:mitochondrion
RGD
PMID:23423194
RGD:8661760
NCBI chr 4:158,150,815...158,163,592
Ensembl chr 4:158,150,820...158,163,591
G
Tradd
TNFRSF1A-associated via death domain
treatment
IEP
RGD
PMID:23423194
RGD:8661760
NCBI chr19:33,136,148...33,142,714
Ensembl chr19:33,136,138...33,142,638
G
Ucp2
uncoupling protein 2
IEP
mRNA:increased expression:liver
RGD
PMID:22195248
RGD:7175309
NCBI chr 1:154,839,242...154,845,612
Ensembl chr 1:154,839,209...154,845,611
G
Vegfa
vascular endothelial growth factor A
IEP
RGD
PMID:26451003
RGD:15036791
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
G
Xdh
xanthine dehydrogenase
treatment
IEP
RGD
PMID:24768926
RGD:13209011
NCBI chr 6:21,530,463...21,592,172
Ensembl chr 6:21,530,113...21,592,268
G
Bax
BCL2 associated X, apoptosis regulator
treatment ameliorates
IEP ISO
RGD
PMID:23953793 PMID:34238924
RGD:10054119 , RGD:153350155
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
G
Bcl2
BCL2, apoptosis regulator
treatment
IEP
RGD
PMID:23953793
RGD:10054119
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
Casp3
caspase 3
treatment
IEP
RGD
PMID:23953793
RGD:10054119
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Col1a1
collagen type I alpha 1 chain
ISO
mRNA:increased expression:lung (mouse)
RGD
PMID:34238924
RGD:153350155
NCBI chr10:79,883,622...79,900,625
Ensembl chr10:79,883,622...79,900,624
G
Col3a1
collagen type III alpha 1 chain
ISO
mRNA:increased expression:lung (mouse)
RGD
PMID:34238924
RGD:153350155
NCBI chr 9:47,374,611...47,410,547
Ensembl chr 9:47,374,593...47,410,547
G
Crebbp
CREB binding protein
ameliorates
ISO
RGD
PMID:34238924
RGD:153350155
NCBI chr10:11,335,551...11,461,888
Ensembl chr10:11,335,953...11,461,888
G
Egr1
early growth response 1
treatment
IMP IEP
RGD
PMID:22878149 PMID:23232597
RGD:10395282 , RGD:10395299
NCBI chr18:26,462,967...26,466,766
Ensembl chr18:26,462,981...26,466,766
G
Elane
elastase, neutrophil expressed
treatment
IMP
RGD
PMID:17888675
RGD:10450582
NCBI chr 7:9,817,251...9,819,174
Ensembl chr 7:9,817,252...9,819,100
G
Fgfr2
fibroblast growth factor receptor 2
ISO
mRNA:increased expression:lung (rat)
RGD
PMID:35600952
RGD:155663563
NCBI chr 1:184,745,418...184,850,655
Ensembl chr 1:184,745,420...184,850,626
G
Hmgb1
high mobility group box 1
IEP
protein:increased expression:lung
RGD
PMID:22115333
RGD:10402095
NCBI chr12:5,972,950...5,979,658
Ensembl chr12:5,901,586...5,978,565 Ensembl chr16:5,901,586...5,978,565
G
Hmox1
heme oxygenase 1
IEP
protein:increased expression:lung
RGD
PMID:21227458
RGD:10755577
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
G
Icam1
intercellular adhesion molecule 1
treatment
IEP
RGD
PMID:22503847
RGD:7240537
NCBI chr 8:19,553,063...19,565,438
Ensembl chr 8:19,553,645...19,565,438
G
Il1b
interleukin 1 beta
ameliorates
IDA ISO IEP
protein:increased expression:lung (rat)
RGD
PMID:23142117 PMID:34238924 PMID:23122581
RGD:7183185 , RGD:153350155 , RGD:7204125
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
G
Il4
interleukin 4
treatment
IDA
RGD
PMID:24365768
RGD:10402797
NCBI chr10:37,771,203...37,776,750
Ensembl chr10:37,771,203...37,776,750
G
Il6
interleukin 6
ameliorates
ISO
RGD
PMID:34238924
RGD:153350155
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
G
Kras
KRAS proto-oncogene, GTPase
ameliorates
ISO
RGD
PMID:34238924
RGD:153350155
NCBI chr 4:178,185,418...178,218,484
G
Mmp9
matrix metallopeptidase 9
IEP
protein:increased activity:lung
RGD
PMID:18694576
RGD:5129703
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
G
Myc
MYC proto-oncogene, bHLH transcription factor
treatment
IEP
RGD
PMID:22503847
RGD:7240537
NCBI chr 7:93,593,705...93,598,633
Ensembl chr 7:93,593,705...93,598,630
G
Nos3
nitric oxide synthase 3
IMP ISO
mRNA:increased expression:lung (mouse)
RGD
PMID:20815765 PMID:25382268
RGD:4892012 , RGD:11533932
NCBI chr 4:10,793,834...10,814,170
Ensembl chr 4:10,793,834...10,814,166
G
Nqo1
NAD(P)H quinone dehydrogenase 1
treatment
IEP
RGD
PMID:21781312
RGD:6771212
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
G
Pecam1
platelet and endothelial cell adhesion molecule 1
IDA IEP
protein:increased expression:alveolar macrophage (rat)
RGD
PMID:21781312 PMID:16449942
RGD:6771212 , RGD:11541083
NCBI chr10:91,590,521...91,652,279
Ensembl chr10:91,590,521...91,652,116
G
Proc
protein C, inactivator of coagulation factors Va and VIIIa
treatment
ISO
RGD
PMID:19782612
RGD:11100035
NCBI chr18:23,764,367...23,774,816
Ensembl chr18:23,764,368...23,775,133
G
Serpine1
serpin family E member 1
treatment
ISO IDA
protein:increased expression:plasma (human)
RGD
PMID:17846288 PMID:11606484
RGD:8547720 , RGD:11080966
NCBI chr12:19,601,272...19,611,657
Ensembl chr12:19,601,272...19,611,657
G
Tlr4
toll-like receptor 4
treatment
IEP
RGD
PMID:22115333
RGD:10402095
NCBI chr 5:80,145,867...80,159,501
Ensembl chr 5:80,145,826...80,159,628
G
Tnf
tumor necrosis factor
ameliorates
IMP ISO
RGD
PMID:17294835 PMID:34238924
RGD:4143397 , RGD:153350155
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Zfp36
zinc finger protein 36
exacerbates
ISO
RGD
PMID:34238924
RGD:153350155
NCBI chr 1:83,669,084...83,671,564
Ensembl chr 1:83,669,084...83,671,564
G
Abcc8
ATP binding cassette subfamily C member 8
ISO
RGD
PMID:18316485
RGD:2301903
NCBI chr 1:96,598,568...96,679,563
Ensembl chr 1:96,598,647...96,679,510
G
Acvr2b
activin A receptor type 2B
treatment
ISO
human construct in mouse model mRNA, protein:decreased expression:heart (mouse)
RGD
PMID:30765322 PMID:30765322
RGD:329849112 , RGD:329849112
NCBI chr 8:119,138,901...119,178,477
Ensembl chr 8:119,138,812...119,170,458
G
Ada
adenosine deaminase
IDA
protein:increased expression
RGD
PMID:16641873
RGD:1624305
NCBI chr 3:152,398,745...152,422,854
Ensembl chr 3:152,398,747...152,447,088
G
Adipoq
adiponectin, C1Q and collagen domain containing
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:16155579
NCBI chr11:77,721,912...77,735,644
Ensembl chr11:77,721,912...77,735,564
G
Adrb1
adrenoceptor beta 1
IMP ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:10900253 PMID:17201736
RGD:5129149
NCBI chr 1:255,771,962...255,774,973
Ensembl chr 1:255,771,597...255,807,259
G
Adrb2
adrenoceptor beta 2
IDA
RGD
PMID:16269402
RGD:1598746
NCBI chr18:55,642,459...55,644,501
Ensembl chr18:55,502,903...55,644,512
G
Ager
advanced glycosylation end product-specific receptor
IEP
protein:increased expression:heart (rat)
RGD
PMID:16505177
RGD:1625342
NCBI chr20:4,148,150...4,151,361
Ensembl chr20:4,147,890...4,151,078
G
Agl
amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase
IMP
RGD
PMID:9281456
RGD:1598779
NCBI chr 2:204,705,053...204,760,966
Ensembl chr 2:204,705,053...204,760,828
G
Agt
angiotensinogen
ISO
CTD Direct Evidence: marker/mechanism|therapeutic
CTD
PMID:2535056 PMID:19166939
NCBI chr19:52,529,139...52,549,618
Ensembl chr19:52,529,185...52,540,977
G
Agtr1a
angiotensin II receptor, type 1a
IEP
protein:increased expression:myocardium
RGD
PMID:21078800
RGD:5129194
NCBI chr17:34,173,446...34,226,892
Ensembl chr17:34,174,429...34,226,946
G
Ahr
aryl hydrocarbon receptor
treatment
IMP
RGD
PMID:35788946
RGD:401793705
NCBI chr 6:52,234,089...52,271,568
Ensembl chr 6:52,234,089...52,271,568
G
Aifm1
apoptosis inducing factor, mitochondria associated 1
IEP ISO
protein:decreased expression:mitochondrion:
RGD
PMID:23685150 PMID:23685150
RGD:10053560 , RGD:10053560
NCBI chr X:127,650,223...127,689,356
Ensembl chr X:127,650,226...127,689,256
G
Akt1
AKT serine/threonine kinase 1
IDA
protein:increased phosphorylation:heart left ventricle
RGD
PMID:20217242
RGD:5509104
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
G
Akt2
AKT serine/threonine kinase 2
IDA
RGD
PMID:16418318
RGD:2313347
NCBI chr 1:82,877,228...82,933,828
Ensembl chr 1:82,883,547...82,933,817
G
Alb
albumin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:9572063
NCBI chr14:17,607,397...17,622,814
Ensembl chr14:17,607,381...17,622,836
G
Aldh2
aldehyde dehydrogenase 2 family member
IDA
RGD
PMID:23468836
RGD:7241598
NCBI chr12:34,949,549...34,982,527
Ensembl chr12:34,901,219...34,982,521
G
Alox5
arachidonate 5-lipoxygenase
IMP
RGD
PMID:20011686
RGD:2317527
NCBI chr 4:149,531,329...149,578,696
Ensembl chr 4:149,531,515...149,578,743
G
Angpt2
angiopoietin 2
IEP
mRNA, protein:increased expression:myocardium (rat)
RGD
PMID:12737621
RGD:1601505
NCBI chr16:71,088,364...71,138,805
Ensembl chr16:71,088,364...71,138,804
G
Ank1
ankyrin 1
IDA
RGD
PMID:9378703
RGD:1599110
NCBI chr16:68,876,294...69,054,963
Ensembl chr16:68,877,504...69,054,759
G
Ank2
ankyrin 2
IDA
RGD
PMID:9378703
RGD:1599110
NCBI chr 2:215,378,028...215,954,015
Ensembl chr 2:215,379,680...215,862,923
G
Ankrd1
ankyrin repeat domain 1
IEP
protein:decreased expression:myocardium
RGD
PMID:19299913
RGD:5133278
NCBI chr 1:233,815,851...233,834,891
Ensembl chr 1:233,815,851...233,834,919
G
Anxa1
annexin A1
treatment
IEP ISO
protein:increased expression:heart, leukocyte
RGD
PMID:11641252 PMID:22924634 PMID:22924634
RGD:2306910 , RGD:7421655 , RGD:7421655
NCBI chr 1:217,861,175...217,877,205
Ensembl chr 1:217,861,175...217,877,343
G
Apex1
apurinic/apyrimidinic endodeoxyribonuclease 1
IEP
protein:altered localization:cytoplasm
RGD
PMID:17602955
RGD:2315672
NCBI chr15:24,144,595...24,146,785
Ensembl chr15:24,144,362...24,146,785
G
Arrb2
arrestin, beta 2
IEP
RGD
PMID:29016703
RGD:13506827
NCBI chr10:55,146,887...55,154,854
Ensembl chr10:55,146,818...55,154,850
G
Atf3
activating transcription factor 3
IEP
RGD
PMID:11485922
RGD:7327201
NCBI chr13:102,751,278...102,800,520
Ensembl chr13:102,751,321...102,764,631
G
Atp1a1
ATPase Na+/K+ transporting subunit alpha 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:29702141
NCBI chr 2:189,020,722...189,048,826
Ensembl chr 2:189,020,722...189,048,837
G
Atp2a1
ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 1
IMP
RGD
PMID:17630344
RGD:13782075
NCBI chr 1:181,026,606...181,044,859
Ensembl chr 1:181,026,608...181,044,838
G
Atp2a2
ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2
treatment
ISO IEP
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:10734148 PMID:28637456
RGD:13782080
NCBI chr12:34,072,710...34,122,142
Ensembl chr12:34,072,683...34,122,101
G
Atp5f1d
ATP synthase F1 subunit delta
treatment
IEP
protein:decreased expression:myocardium (rat)
RGD
PMID:26109848 PMID:25305180
RGD:13792666 , RGD:13792676
NCBI chr 7:9,560,604...9,565,919
Ensembl chr 7:9,560,608...9,565,929
G
Bad
BCL2-associated agonist of cell death
treatment
IEP IDA
protein:increased expression, decreased serine phosphorylation:heart
RGD
PMID:15339931 PMID:23364609
RGD:2292700 , RGD:10053674
NCBI chr 1:204,133,502...204,142,829
Ensembl chr 1:204,131,501...204,142,823
G
Bax
BCL2 associated X, apoptosis regulator
treatment
IEP ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:20026869 PMID:21223820 PMID:25547710 PMID:31583047
RGD:10054103 , RGD:13782178 , RGD:155230831
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
G
Bcl2
BCL2, apoptosis regulator
treatment
IEP IDA
RGD
PMID:16289365 PMID:23364609 PMID:20821058 PMID:31583047
RGD:1599484 , RGD:10053674 , RGD:11561911 , RGD:155230831
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
Bcl2l1
Bcl2-like 1
treatment
IDA
RGD
PMID:12668130
RGD:11035287
NCBI chr 3:141,253,508...141,304,582
Ensembl chr 3:141,253,523...141,303,479
G
Becn1
beclin 1
treatment
IDA ISO
RGD
PMID:20821058 PMID:20812860
RGD:11561911 , RGD:11561944
NCBI chr10:86,231,387...86,246,742
Ensembl chr10:86,231,388...86,246,742
G
Bid
BH3 interacting domain death agonist
IDA IEP
protein:increased cleavage:heart:
RGD
PMID:19940077 PMID:11934844
RGD:2317561 , RGD:13782263
NCBI chr 4:154,113,198...154,136,353
Ensembl chr 4:154,113,198...154,134,720
G
Blk
BLK proto-oncogene, Src family tyrosine kinase
IEP
mRNA:increased expression:left ventricle (rat)
RGD
PMID:17562528
RGD:1642307
NCBI chr15:37,626,746...37,665,053
Ensembl chr15:37,627,039...37,665,031
G
Bnip3
BCL2 interacting protein 3
treatment
IMP IEP
protein:decreased expression:myocardium (human)
RGD
PMID:16645637 PMID:28661226
RGD:11561983 , RGD:155260328
NCBI chr 1:193,708,164...193,725,348
Ensembl chr 1:193,708,167...193,725,359
G
Brd4
bromodomain containing 4
ISO
mRNA,protein:increased expression:heart
RGD
PMID:33982231
RGD:155883171
NCBI chr 7:11,216,446...11,296,029
Ensembl chr 7:11,216,446...11,295,539
G
Btg2
BTG anti-proliferation factor 2
IEP
mRNA:increased expression:heart
RGD
PMID:12909328
RGD:2289075
NCBI chr13:45,531,881...45,535,642
Ensembl chr13:45,531,925...45,535,628
G
C3
complement C3
IEP
protein:increased expression:myocardium
RGD
PMID:11560858
RGD:1582136
NCBI chr 9:2,087,437...2,114,366
Ensembl chr 9:2,087,437...2,114,429
G
C5
complement C5
treatment
IDA IMP
RGD
PMID:9631876 PMID:23067403
RGD:1600666 , RGD:7411626
NCBI chr 3:18,270,696...18,361,994
Ensembl chr 3:18,270,696...18,361,994
G
Casp1
caspase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:14998631
NCBI chr 8:2,587,812...2,597,403
Ensembl chr 8:2,587,831...2,597,383
G
Casp12
caspase 12
treatment
IEP ISO
protein:increased activity:myocardium CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:14998631 PMID:19406177 PMID:25547710
RGD:2311458 , RGD:13782178
NCBI chr 8:2,642,296...2,669,549
Ensembl chr 8:2,642,434...2,674,037
G
Casp3
caspase 3
treatment ameliorates
IMP ISO IEP
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:14998631 PMID:18470603 PMID:29538428 PMID:30259997
RGD:2293314 , RGD:13782276 , RGD:329337366
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Casp7
caspase 7
treatment
ISO IEP
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:14998631 PMID:29538428
RGD:13782276
NCBI chr 1:255,437,438...255,476,737
Ensembl chr 1:255,437,172...255,476,729
G
Casp8
caspase 8
ISO IEP
CTD Direct Evidence: marker/mechanism protein:increased activity:cardiomyocyte
CTD RGD
PMID:14998631 PMID:11934844
RGD:13782263
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
G
Casp9
caspase 9
treatment ameliorates
ISO IEP
CTD Direct Evidence: marker/mechanism protein:increased activity:cardiomyocyte,endothelial cell
CTD RGD
PMID:14998631 PMID:11934844 PMID:29538428 PMID:30259997
RGD:13782263 , RGD:13782276 , RGD:329337366
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
G
Casr
calcium-sensing receptor
IEP
protein:increased expression:ventricular myocardium (rat)
RGD
PMID:21766206
RGD:7205698
NCBI chr11:64,235,251...64,304,811
Ensembl chr11:64,235,251...64,304,811
G
Cast
calpastatin
ameliorates
IEP ISO
human transcript overexpression in rat model
RGD
PMID:12482022 PMID:14519437
RGD:5683872 , RGD:405101692
NCBI chr 2:3,973,112...4,082,658
Ensembl chr 2:3,973,112...4,082,659
G
Cat
catalase
IEP ISO
CTD Direct Evidence: therapeutic
CTD RGD
PMID:21600015 PMID:11510883
RGD:1581149
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
G
Cbl
Cbl proto-oncogene
severity
ISO
RGD
PMID:24583314
RGD:11251947
NCBI chr 8:44,487,824...44,571,620
Ensembl chr 8:44,489,410...44,571,176
G
Ccl2
C-C motif chemokine ligand 2
IEP ISO
mRNA:increased expression:heart (rat) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:12087064 PMID:10908159
RGD:8549625
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
G
Ccr2
C-C motif chemokine receptor 2
ISO
protein:decreased expression:monocyte:
RGD
PMID:15786508
RGD:4892017
NCBI chr 8:123,734,465...123,742,483
Ensembl chr 8:123,734,430...123,742,100
G
Ccr5
C-C motif chemokine receptor 5
treatment
ISO IEP
protein:decreased expression:blood, monocyte (human)
RGD
PMID:15786508 PMID:23456481
RGD:4892017 , RGD:8552227
NCBI chr 8:123,752,423...123,757,538
Ensembl chr 8:123,752,325...123,759,260
G
Cflar
CASP8 and FADD-like apoptosis regulator
treatment
IEP
RGD
PMID:18466417
RGD:11341714
NCBI chr 9:60,185,338...60,236,173
Ensembl chr 9:60,185,452...60,237,034
G
Cnr1
cannabinoid receptor 1
IMP
RGD
PMID:18771032
RGD:2316217
NCBI chr 5:48,408,543...48,436,099
Ensembl chr 5:48,408,574...48,435,099
G
Cnr2
cannabinoid receptor 2
IMP
RGD
PMID:17950273
RGD:2316224
NCBI chr 5:148,125,222...148,151,548
Ensembl chr 5:148,125,604...148,151,548
G
Cobll1
cordon-bleu WH2 repeat protein-like 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:34355838
NCBI chr 3:49,753,260...49,915,168
Ensembl chr 3:49,753,262...49,915,194
G
Crebbp
CREB binding protein
treatment
IEP
RGD
PMID:24338162
RGD:153352322
NCBI chr10:11,335,551...11,461,888
Ensembl chr10:11,335,953...11,461,888
G
Crp
C-reactive protein
IEP
protein:increased expression:serum
RGD
PMID:21122204
RGD:5128547
NCBI chr13:85,135,384...85,175,178
Ensembl chr13:85,124,977...85,175,178
G
Cx3cr1
C-X3-C motif chemokine receptor 1
ISO
protein:decreased expression:blood, monocyte
RGD
PMID:15786508
RGD:4892017
NCBI chr 8:119,785,726...119,799,431
Ensembl chr 8:119,782,595...119,800,014
G
Cxcl1
C-X-C motif chemokine ligand 1
IMP
RGD
PMID:11342480
RGD:5135269
NCBI chr14:17,193,364...17,195,143
Ensembl chr14:17,193,365...17,195,215
G
Cxcl2
C-X-C motif chemokine ligand 2
IMP
RGD
PMID:11342480
RGD:5135269
NCBI chr14:17,181,030...17,183,075
Ensembl chr14:17,181,062...17,183,075
G
Cxcl6
C-X-C motif chemokine ligand 6
IMP
RGD
PMID:11342480
RGD:5135269
NCBI chr14:17,310,790...17,312,250
Ensembl chr14:17,310,426...17,313,093
G
Cybb
cytochrome b-245 beta chain
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19207477
NCBI chr X:13,358,101...13,392,570
Ensembl chr X:13,359,430...13,392,586
G
Diablo
diablo, IAP-binding mitochondrial protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:14998631
NCBI chr12:33,055,784...33,070,401
Ensembl chr12:33,055,263...33,070,387
G
Dnm1l
dynamin 1-like
ameliorates
ISO
RGD
PMID:30259997
RGD:329337366
NCBI chr11:84,581,216...84,632,382
Ensembl chr11:84,581,216...84,631,482
G
Ece1
endothelin converting enzyme 1
IMP IEP
RGD
PMID:18586023 PMID:12193087
RGD:4892580 , RGD:7244160
NCBI chr 5:150,077,679...150,179,375
Ensembl chr 5:150,077,644...150,179,371
G
Edn1
endothelin 1
IEP ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:15642760 PMID:16700825 PMID:18586023
RGD:4892580
NCBI chr17:22,454,924...22,460,812
Ensembl chr17:22,454,420...22,460,885
G
Ednra
endothelin receptor type A
IMP
RGD
PMID:18586023
RGD:4892580
NCBI chr19:30,233,540...30,303,727
Ensembl chr19:30,233,571...30,297,049
G
Ednrb
endothelin receptor type B
IMP
RGD
PMID:21048781
RGD:4892332
NCBI chr15:80,640,839...80,672,115
Ensembl chr15:80,643,043...80,672,115
G
Egln1
egl-9 family hypoxia-inducible factor 1
susceptibility
ISO
RGD
PMID:20185832
RGD:11251775
NCBI chr19:52,867,900...52,907,308
Ensembl chr19:52,869,486...52,907,777
G
Ephx2
epoxide hydrolase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19834332
NCBI chr15:40,289,901...40,327,632
Ensembl chr15:40,289,902...40,327,615
G
Esr1
estrogen receptor 1
IMP
RGD
PMID:18314151
RGD:4892299
NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
G
Esr2
estrogen receptor 2
ISO
RGD
PMID:18656630
RGD:5508820
NCBI chr 6:94,858,438...94,909,630
Ensembl chr 6:94,809,547...94,908,919
G
Fadd
Fas associated via death domain
treatment
ISO IEP
RGD
PMID:26038570 PMID:26948086
RGD:11341801 , RGD:13792504
NCBI chr 1:199,743,200...199,745,746
Ensembl chr 1:199,739,994...199,745,653
G
Fas
Fas cell surface death receptor
treatment
IDA
RGD
PMID:21316771
RGD:8686424
NCBI chr 1:231,798,963...231,832,591
Ensembl chr 1:231,798,960...231,832,591
G
Fis1
fission, mitochondrial 1
ameliorates
ISO
RGD
PMID:30259997
RGD:329337366
NCBI chr12:19,708,560...19,723,392
Ensembl chr12:19,708,558...19,723,377
G
Gapdh
glyceraldehyde-3-phosphate dehydrogenase
treatment
IEP
RGD
PMID:27129213
RGD:11574725
NCBI chr 4:157,962,312...157,967,158
Ensembl chr 4:157,962,343...157,966,235
G
Gcg
glucagon
treatment
ISO
RGD
PMID:24125539
RGD:10402369
NCBI chr 3:47,113,914...47,122,958
Ensembl chr 3:47,113,914...47,122,929
G
Gdf11
growth differentiation factor 11
ISO
mRNA, protein:decreased expression:heart (mouse)
RGD
PMID:30765322
RGD:329849112
NCBI chr 7:1,311,732...1,325,211
Ensembl chr 7:1,311,732...1,320,725
G
Gja1
gap junction protein, alpha 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17445419
NCBI chr20:35,756,007...35,768,481
Ensembl chr20:35,755,991...35,768,582
G
Glrx
glutaredoxin
IEP
mRNA:decreased expression:heart:
RGD
PMID:18163565
RGD:2306160
NCBI chr 2:5,341,873...5,351,686
Ensembl chr 2:5,341,885...5,351,680
G
Gpx3
glutathione peroxidase 3
ISO
RGD
PMID:11043918
RGD:401827843
NCBI chr10:39,028,624...39,036,695
Ensembl chr10:39,028,570...39,037,035
G
Grk2
G protein-coupled receptor kinase 2
treatment susceptibility severity
IMP ISO IDA
associated with Diabetes Mellitus, Experimental associated with Hypertension protein:increased expression:heart, mitochondrion (mouse)
RGD
PMID:27865836 PMID:27601479 PMID:27296507 PMID:24170934 PMID:23467820
RGD:13513990 , RGD:13513993 , RGD:13513995 , RGD:13792704 , RGD:13792779
NCBI chr 1:201,580,823...201,601,580
Ensembl chr 1:201,581,480...201,601,582
G
Gsk3b
glycogen synthase kinase 3 beta
treatment
IDA IEP
RGD
PMID:20217242 PMID:29978610 PMID:26918336
RGD:5509104 , RGD:13792725 , RGD:13792772
NCBI chr11:62,498,997...62,648,665
Ensembl chr11:62,504,316...62,648,646
G
Gsr
glutathione-disulfide reductase
treatment
IEP
RGD
PMID:24769323
RGD:10401892
NCBI chr16:58,482,209...58,525,256
Ensembl chr16:58,482,505...58,525,661
G
H19
H19 imprinted maternally expressed transcript
ameliorates
ISO
RGD
PMID:31284127
RGD:158013771
NCBI chr 1:197,730,698...197,733,374
Ensembl chr 1:197,730,698...197,733,134
G
H2ax
H2A.X variant histone
treatment
IDA
RGD
PMID:23108649
RGD:8693739
NCBI chr 8:44,671,907...44,673,262
Ensembl chr 8:44,671,786...44,673,239
G
Hdac3
histone deacetylase 3
ameliorates
ISO
RGD
PMID:33982231
RGD:155883171
NCBI chr18:29,770,637...29,789,850
Ensembl chr18:29,770,636...29,793,856
G
Hif1a
hypoxia inducible factor 1 subunit alpha
treatment
IEP IDA ISO
mRNA:increased expression:heart protein:increased expression:myocardium CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:18549825 PMID:22050707 PMID:12189448 PMID:19727523 PMID:20170615
RGD:1626327 , RGD:5147885 , RGD:9068872
NCBI chr 6:92,624,059...92,669,262
Ensembl chr 6:92,624,390...92,669,261
G
Hmgb1
high mobility group box 1
treatment
IEP IDA ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:21113057 PMID:23531454 PMID:19540007
RGD:10402066 , RGD:10402170
NCBI chr12:5,972,950...5,979,658
Ensembl chr12:5,901,586...5,978,565 Ensembl chr16:5,901,586...5,978,565
G
Hmox1
heme oxygenase 1
treatment
IDA IEP ISO
RGD
PMID:12709584 PMID:22179023 PMID:23921302
RGD:1598392 , RGD:10755573 , RGD:10755585
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
G
Hrh2
histamine receptor H 2
susceptibility
ISO
RGD
PMID:23467745
RGD:9685524
NCBI chr17:10,366,004...10,407,791
Ensembl chr17:10,368,298...10,407,631
G
Hrh3
histamine receptor H3
IDA
RGD
PMID:15076218
RGD:1626433
NCBI chr 3:167,191,551...167,196,642
Ensembl chr 3:167,191,558...167,196,642
G
Hsf1
heat shock transcription factor 1
ISO
RGD
PMID:22426029
RGD:10402789
NCBI chr 7:108,196,040...108,223,011
Ensembl chr 7:108,196,056...108,223,011
G
Hspa1a
heat shock protein family A (Hsp70) member 1A
treatment
IEP
RGD
PMID:20501665
RGD:10003160
NCBI chr20:3,870,765...3,873,221
Ensembl chr20:3,856,006...3,873,227
G
Hspa5
heat shock protein family A (Hsp70) member 5
treatment
IEP
RGD
PMID:24129401 PMID:25547710
RGD:11354962 , RGD:13782178
NCBI chr 3:18,055,507...18,059,969
Ensembl chr 3:18,055,405...18,059,891
G
Htra2
HtrA serine peptidase 2
ISO
protein:increased expression:myocardium, cytosol (mouse)
RGD
PMID:15611365
RGD:5688376
NCBI chr 4:115,556,914...115,560,202
Ensembl chr 4:115,556,916...115,560,095
G
Icam1
intercellular adhesion molecule 1
IEP ISO
protein:increased expression:heart (rat) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:12087064 PMID:20851484
RGD:4145348
NCBI chr 8:19,553,063...19,565,438
Ensembl chr 8:19,553,645...19,565,438
G
Il10
interleukin 10
treatment
IEP IDA
protein:increased expression:plasma
RGD
PMID:19275881 PMID:23840272
RGD:2311056 , RGD:7365001
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
G
Il17a
interleukin 17A
treatment
IMP
RGD
PMID:22030025
RGD:9068944
NCBI chr 9:23,144,402...23,147,889
Ensembl chr 9:23,144,402...23,147,889
G
Il18
interleukin 18
ISO IDA
RGD
PMID:19164288 PMID:19805173
RGD:4889578 , RGD:4889400
NCBI chr 8:50,904,630...50,932,887
Ensembl chr 8:50,906,960...50,932,887
G
Il18bp
interleukin 18 binding protein
ISO
mRNA:increased expression:heart
RGD
PMID:19164288 PMID:19805173
RGD:4889578 , RGD:4889400
NCBI chr 1:156,372,923...156,374,963
Ensembl chr 1:156,372,883...156,374,963
G
Il18rap
interleukin 18 receptor accessory protein
ISO
RGD
PMID:19164288
RGD:4889578
NCBI chr 9:42,768,112...42,800,964
Ensembl chr 9:42,768,220...42,800,959
G
Il1a
interleukin 1 alpha
treatment
ISO IEP
RGD
PMID:8576926 PMID:7622355
RGD:7794741 , RGD:7794764
NCBI chr 3:116,526,601...116,537,055
Ensembl chr 3:116,526,604...116,536,822
G
Il1b
interleukin 1 beta
treatment
IEP
mRNA:increased expression:heart
RGD
PMID:17134725 PMID:31583047
RGD:1626628 , RGD:155230831
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
G
Il1rl2
interleukin 1 receptor-like 2
IMP
compared to Wild Type in cardiopulmonary bypass model
RGD
PMID:32048631
RGD:126925167
NCBI chr 9:42,591,658...42,639,351
Ensembl chr 9:42,591,934...42,636,667
G
Il1rl2tm1(Myh6-cre)Mhzh
interleukin 1 receptor-like 2; tm1 (Myh6-cre), Mhzh
IMP
compared to Wild Type in cardiopulmonary bypass model
RGD
PMID:32048631
RGD:126925167
G
Il1rn
interleukin 1 receptor antagonist
ISO
rat model treated with human protein
RGD
PMID:22649318
RGD:7174360
NCBI chr 3:7,111,567...7,127,451
Ensembl chr 3:7,111,550...7,127,445
G
Il36rn
interleukin 36 receptor antagonist
IMP
RGD
PMID:32048631
RGD:126925167
NCBI chr 3:7,044,419...7,051,016
Ensembl chr 3:7,044,406...7,051,016
G
Il36rntm1(Myh6-cre)Mhzh
interleukin 36 receptor antagonist; tm1, Mhzh
IMP
RGD
PMID:32048631
RGD:126925167
G
Il6
interleukin 6
treatment
IDA IEP
RGD
PMID:27087891 PMID:31583047
RGD:11062149 , RGD:155230831
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
G
Il6r
interleukin 6 receptor
ISO
RGD
PMID:16056242
RGD:1625435
NCBI chr 2:175,289,157...175,347,719
Ensembl chr 2:175,298,686...175,347,536
G
Inhba
inhibin subunit beta A
ISO
mRNA, protein:increased expression:heart (mouse)
RGD
PMID:30765322
RGD:329849112
NCBI chr17:49,091,635...49,111,573
Ensembl chr17:49,095,920...49,108,982
G
Irak1
interleukin-1 receptor-associated kinase 1
IEP
protein:increased activity:ventricle myocardium (rat)
RGD
PMID:15793310
RGD:1579809
NCBI chr X:151,768,621...151,778,521
Ensembl chr X:151,768,777...151,778,521
G
Irf9
interferon regulatory factor 9
ameliorates exacerbates
ISO
protein:increased expression:left ventricular free wall
RGD
PMID:25150882 PMID:25150882 PMID:25150882
RGD:125093742 , RGD:125093742 , RGD:125093742
NCBI chr15:29,095,474...29,101,924
Ensembl chr15:29,095,789...29,101,236
G
Jak2
Janus kinase 2
treatment
IMP
associated with Diabetes Mellitus, Experimental
RGD
PMID:23796350 PMID:23747931
RGD:8694332 , RGD:10403071
NCBI chr 1:226,995,334...227,054,381
Ensembl chr 1:226,995,334...227,054,189
G
Kcnj11
potassium inwardly-rectifying channel, subfamily J, member 11
ISO
RGD
PMID:17906066
RGD:7297046
NCBI chr 1:96,591,048...96,594,574
Ensembl chr 1:96,591,049...96,594,082
G
Kcnj8
potassium inwardly-rectifying channel, subfamily J, member 8
IDA
RGD
PMID:12234964
RGD:729109
NCBI chr 4:175,508,908...175,515,829
Ensembl chr 4:175,508,912...175,515,603
G
Klrk1
killer cell lectin like receptor K1
treatment
IMP
RGD
PMID:23953572
RGD:9685183
NCBI chr 4:163,079,887...163,092,434
Ensembl chr 4:163,081,927...163,092,459
G
Kng1
kininogen 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:2535056 PMID:7856280
NCBI chr11:77,812,757...77,835,555
Ensembl chr11:77,812,752...77,835,555
G
Lep
leptin
IEP
RGD
PMID:21122204
RGD:5128547
NCBI chr 4:57,661,127...57,675,262
Ensembl chr 4:57,661,131...57,675,262
G
Lepr
leptin receptor
IEP
mRNA:decreased expression:heart mRNA:altered expression:heart
RGD
PMID:15284063 PMID:17134725
RGD:5129123 , RGD:1626628
NCBI chr 5:116,294,409...116,477,904
Ensembl chr 5:116,289,823...116,475,908
G
Lum
lumican
IDA
RGD
PMID:11348051
RGD:1582122
NCBI chr 7:32,358,990...32,365,794
Ensembl chr 7:32,358,614...32,365,793
G
Map1lc3a
microtubule-associated protein 1 light chain 3 alpha
treatment
IEP ISO
protein:increased expression:heart
RGD
PMID:20821058 PMID:20812860
RGD:11561911 , RGD:11561944
NCBI chr 3:143,783,024...143,784,670
Ensembl chr 3:143,783,024...143,784,670
G
Map2k6
mitogen-activated protein kinase kinase 6
ISO
RGD
PMID:14749328 PMID:15492008
RGD:7495840 , RGD:1582277
NCBI chr10:95,373,304...95,490,406
Ensembl chr10:95,373,204...95,488,293
G
Map3k5
mitogen-activated protein kinase kinase kinase 5
treatment
IEP
RGD
PMID:31583047
RGD:155230831
NCBI chr 1:14,685,776...14,904,935
Ensembl chr 1:14,685,492...14,904,800
G
Mapk1
mitogen activated protein kinase 1
treatment
IDA
RGD
PMID:15653762 PMID:25345742
RGD:1582282 , RGD:13800900
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
G
Mapk14
mitogen activated protein kinase 14
ISO
RGD
PMID:14749328
RGD:7495840
NCBI chr20:6,749,646...6,810,590
Ensembl chr20:6,749,670...6,810,589
G
Mapk3
mitogen activated protein kinase 3
treatment
IEP IDA
RGD
PMID:29741915 PMID:28814571 PMID:25345742
RGD:13800564 , RGD:13800874 , RGD:13800900
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
G
Mapk8
mitogen-activated protein kinase 8
treatment
IDA IEP
RGD
PMID:15309413 PMID:12883833 PMID:31583047
RGD:1582311 , RGD:1582312 , RGD:155230831
NCBI chr16:8,638,897...8,721,960
Ensembl chr16:8,638,924...8,721,981
G
Mb
myoglobin
ISO IDA
RGD
PMID:15132981 PMID:11972171
RGD:1582385 , RGD:1582431
NCBI chr 7:108,759,903...108,767,134
Ensembl chr 7:108,759,904...108,767,383
G
Mbl1
mannose binding lectin 1
IDA ISO IMP
RGD
PMID:11560858 PMID:15972690 PMID:20216929
RGD:1582136 , RGD:1582131 , RGD:4889154
NCBI chr16:17,029,146...17,035,187
Ensembl chr16:17,029,118...17,035,174
G
Mbl2
mannose binding lectin 2
treatment
ISO
RGD
PMID:25482922
RGD:11530049
NCBI chr 1:228,016,439...228,024,736
G
Mdm2
MDM2 proto-oncogene
IEP
protein:increased serine phosphorylation:heart ventricle (rat)
RGD
PMID:14644432
RGD:2317401
NCBI chr 7:53,290,660...53,315,205
Ensembl chr 7:53,290,664...53,314,915
G
Mfn2
mitofusin 2
treatment
IEP
RGD
PMID:24721408
RGD:13204835
NCBI chr 5:158,304,285...158,335,502
Ensembl chr 5:158,304,287...158,335,342
G
Mir1
microRNA 1
treatment
IMP
RGD
PMID:29741915
RGD:13800564
NCBI chr18:1,887,537...1,887,623
G
Mir10a
microRNA 10a
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22050707
NCBI chr10:81,283,171...81,283,280
Ensembl chr10:81,283,171...81,283,280
G
Mir10b
microRNA 10b
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22050707
NCBI chr 3:59,628,438...59,628,546
Ensembl chr 3:59,628,438...59,628,546
G
Mir126a
microRNA 126a
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22050707
NCBI chr 3:9,415,063...9,415,180
Ensembl chr 3:9,415,063...9,415,180
G
Mir134
microRNA 134
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22050707
NCBI chr 6:128,748,908...128,748,980
G
Mir137
microRNA 137
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22050707
NCBI chr 2:206,480,881...206,480,982
Ensembl chr 2:206,480,884...206,480,985
G
Mir140
microRNA 140
exacerbates
ISO
miRNA:increased expression:heart, endothelial cells (mouse)
RGD
PMID:30259997 PMID:31792649
RGD:329337366 , RGD:329337374
NCBI chr19:35,465,577...35,465,675
Ensembl chr19:35,465,577...35,465,675
G
Mir142
microRNA 142
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22050707
NCBI chr10:72,557,864...72,557,950
Ensembl chr10:72,557,857...72,557,967
G
Mir145
microRNA 145
treatment
IEP
RNA:decreased expression:heart
RGD
PMID:31583047 PMID:33658472
RGD:155230831 , RGD:329955358
NCBI chr18:55,099,640...55,099,727
Ensembl chr18:55,099,640...55,099,727
G
Mir146b
microRNA 146b
IEP
miRNA:increased expression:heart (rat)
RGD
PMID:19380620
RGD:155882541
NCBI chr 1:245,203,438...245,203,525
Ensembl chr 1:245,203,438...245,203,525
G
Mir181c
microRNA 181c
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22050707
NCBI chr19:23,983,523...23,983,628
Ensembl chr19:23,983,523...23,983,628
G
Mir183
microRNA 183
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22050707
NCBI chr 4:58,788,614...58,788,723
Ensembl chr 4:58,788,614...58,788,723
G
Mir186
microRNA 186
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22050707
NCBI chr 2:246,582,806...246,582,891
Ensembl chr 2:246,582,806...246,582,891
G
Mir188
microRNA 188
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22050707
NCBI chr X:15,247,715...15,247,794
Ensembl chr X:15,247,715...15,247,794
G
Mir193a
microRNA 193a
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22050707
NCBI chr10:64,672,343...64,672,454
Ensembl chr10:64,672,343...64,672,454
G
Mir196b
microRNA 196b
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22050707
NCBI chr 4:81,330,487...81,330,571
Ensembl chr 4:81,330,487...81,330,571
G
Mir206
microRNA 206
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22050707
NCBI chr 9:23,094,249...23,094,332
Ensembl chr 9:23,094,249...23,094,332
G
Mir20b
microRNA 20b
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22050707
NCBI chr X:132,422,211...132,422,282
Ensembl chr X:132,422,211...132,422,282
G
Mir21
microRNA 21
exacerbates
ISO IEP
CTD Direct Evidence: marker/mechanism miRNA:increased expression:heart (rat)
CTD RGD
PMID:22050707 PMID:24825878 PMID:19380620
RGD:41404665 , RGD:155882541
NCBI chr10:71,405,257...71,405,348
Ensembl chr10:71,405,257...71,405,348
G
Mir210
microRNA 210
sexual_dimorphism
IEP ISO
miRNA:increased expression:myocardium (human)
RGD
PMID:28661226 PMID:35296158
RGD:155260328 , RGD:155663666
NCBI chr 1:196,326,343...196,326,452
Ensembl chr 1:196,326,337...196,326,454
G
Mir222
microRNA 222
ameliorates
ISO
RGD
PMID:25863248
RGD:152025190
NCBI chr X:3,428,904...3,429,006
Ensembl chr X:3,428,904...3,429,006
G
Mir23b
microRNA 23b
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22050707
NCBI chr17:1,813,667...1,813,763
Ensembl chr17:1,813,667...1,813,763
G
Mir26a
microRNA 26a
treatment
IEP
RGD
PMID:29978610
RGD:13792725
NCBI chr 8:118,755,289...118,755,378
Ensembl chr 8:118,755,289...118,755,378
G
Mir27a
microRNA 27a
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22050707
NCBI chr19:23,954,831...23,954,917
Ensembl chr19:23,954,831...23,954,917
G
Mir27b
microRNA 27b
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22050707
NCBI chr17:1,813,427...1,813,523
Ensembl chr17:1,813,426...1,813,529
G
Mir28
microRNA 28
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22050707
NCBI chr11:75,975,523...75,975,608
Ensembl chr11:75,975,523...75,975,608
G
Mir296
microRNA 296
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22050707
NCBI chr 3:163,051,838...163,051,915
Ensembl chr 3:163,051,838...163,051,915
G
Mir301b
microRNA 301b
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22050707
NCBI chr11:83,879,816...83,879,893
Ensembl chr11:83,879,816...83,879,893
G
Mir30a
microRNA 30a
treatment
IEP
RGD
PMID:25137026
RGD:35673319
NCBI chr 9:25,737,600...25,737,670
Ensembl chr 9:25,737,600...25,737,670
G
Mir30c1
microRNA 30c-1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:34217758
NCBI chr 5:134,349,237...134,349,325
Ensembl chr 5:134,349,237...134,349,325
G
Mir320a
microRNA 320a
treatment ameliorates
IMP ISO
RGD
PMID:27175593 PMID:19380620 PMID:30840298 PMID:25268616
RGD:155882540 , RGD:155882541 , RGD:155882546 , RGD:155882578
NCBI chr15:45,516,392...45,516,473
Ensembl chr15:45,516,392...45,516,473
G
Mir330
microRNA 330
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22050707
NCBI chr 1:78,833,178...78,833,274
Ensembl chr 1:78,833,178...78,833,274
G
Mir331
microRNA 331
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22050707
NCBI chr 7:28,527,390...28,527,485
Ensembl chr 7:28,527,390...28,527,485
G
Mir337
microRNA 337
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22050707
NCBI chr 6:128,538,903...128,538,999
Ensembl chr 6:128,538,902...128,538,998
G
Mir346
microRNA 346
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22050707
NCBI chr16:10,218,118...10,218,215
Ensembl chr16:10,218,118...10,218,215
G
Mir34c
microRNA 34c
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22050707
NCBI chr 8:51,409,726...51,409,802
Ensembl chr 8:51,409,726...51,409,802
G
Mir361
microRNA 361
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22050707
NCBI chr X:78,246,206...78,246,275
Ensembl chr X:78,246,206...78,246,275
G
Mir375
microRNA 375
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22050707
NCBI chr 9:76,457,911...76,457,985
Ensembl chr 9:76,457,911...76,457,985
G
Mir411
microRNA 411
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22050707
NCBI chr 6:128,723,189...128,723,264
Ensembl chr 6:128,723,184...128,723,279
G
Mir429
microRNA 429
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22050707
NCBI chr 5:166,647,459...166,647,543
Ensembl chr 5:166,647,459...166,647,543
G
Mir433
microRNA 433
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22050707
NCBI chr 6:128,545,119...128,545,211
Ensembl chr 6:128,545,112...128,545,217
G
Mir451a
microRNA 451a
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22050707
NCBI chr10:62,961,520...62,961,591
Ensembl chr10:62,961,520...62,961,591
G
Mir494
microRNA 494
ameliorates
ISO
RGD
PMID:33982231 PMID:20837890 PMID:20837890
RGD:155883171 , RGD:155883174 , RGD:155883174
NCBI chr 6:128,728,710...128,728,792
Ensembl chr 6:128,728,709...128,728,793
G
Mir500
microRNA 500
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22050707
NCBI chr X:15,258,778...15,258,857
Ensembl chr X:15,258,768...15,258,859
G
Mir503
microRNA 503
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22050707
NCBI chr X:132,806,303...132,806,373
Ensembl chr X:132,806,303...132,806,373
G
Mir532
microRNA 532
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22050707
NCBI chr X:15,247,315...15,247,393
Ensembl chr X:15,247,315...15,247,393
G
Mir542
microRNA 542
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22050707
NCBI chr X:132,802,623...132,802,701
Ensembl chr X:132,802,623...132,802,701
G
Mir582
microRNA 582
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22050707
NCBI chr 2:40,928,571...40,928,651
Ensembl chr 2:40,928,571...40,928,651
G
Mir598
microRNA 598
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22050707
NCBI chr15:37,962,692...37,962,770
Ensembl chr15:37,962,692...37,962,771
G
Mir743a
microRNA 743a
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:22050707
NCBI chr X:145,402,692...145,402,767
Ensembl chr X:145,402,692...145,402,767
G
Mirlet7i
microRNA let-7i
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22050707
NCBI chr 7:58,642,485...58,642,569
Ensembl chr 7:58,642,480...58,642,571
G
Mki67
marker of proliferation Ki-67
IDA
RGD
PMID:22405128
RGD:6483543
NCBI chr 1:190,496,319...190,522,983
Ensembl chr 1:190,496,319...190,522,762
G
Mmp1
matrix metallopeptidase 1
ISO IEP
RGD
PMID:12892382 PMID:17996137
RGD:1582539 , RGD:7207397
NCBI chr 8:4,658,588...4,679,099
Ensembl chr 8:4,658,588...4,679,097
G
Mmp2
matrix metallopeptidase 2
treatment
ISO IEP
RGD
PMID:16699069 PMID:23889688
RGD:1582614 , RGD:8657084
NCBI chr19:14,154,657...14,182,870
Ensembl chr19:14,154,657...14,182,870
G
Mstn
myostatin
ISO
mRNA, protein:increased expression:heart (mouse)
RGD
PMID:30765322
RGD:329849112
NCBI chr 9:48,452,533...48,458,933
Ensembl chr 9:48,452,533...48,458,933
G
Myd88
MYD88, innate immune signal transduction adaptor
IDA
RGD
PMID:14962484
RGD:1302746
NCBI chr 8:119,074,439...119,078,508
Ensembl chr 8:119,074,437...119,079,415
G
Ncl
nucleolin
IEP
protein:decreased expression:heart
RGD
PMID:23594402
RGD:9686384
NCBI chr 9:86,999,588...87,008,112
Ensembl chr 9:86,998,019...87,008,136
G
Ndufs1
NADH:ubiquinone oxidoreductase core subunit S1
treatment
IDA
RGD
PMID:21700931
RGD:13801200
NCBI chr 9:64,546,430...64,579,751
Ensembl chr 9:64,546,225...64,579,893
G
Nfe2l1
NFE2 like bZIP transcription factor 1
treatment
IEP
RGD
PMID:20501665
RGD:10003160
NCBI chr10:81,796,055...81,812,926
Ensembl chr10:81,800,366...81,832,318
G
Nfe2l2
NFE2 like bZIP transcription factor 2
ISO
RGD
PMID:24915518
RGD:10412738
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
G
Nfkbia
NFKB inhibitor alpha
treatment
IDA
RGD
PMID:19304943
RGD:10413871
NCBI chr 6:72,858,713...72,861,941
Ensembl chr 6:72,858,712...72,861,941
G
Nos2
nitric oxide synthase 2
IEP ISO
mRNA:decreased expression:heart (rat) CTD Direct Evidence: marker/mechanism|therapeutic
CTD RGD
PMID:12003803 PMID:12087064 PMID:14990356 PMID:19207477 PMID:20828608 PMID:21844074 More...
RGD:5509098
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
G
Nos3
nitric oxide synthase 3
treatment
IEP IMP ISO IDA
CTD Direct Evidence: therapeutic
CTD RGD
PMID:12354446 PMID:20828747 PMID:18390819 PMID:29299201 PMID:29274587
RGD:4891991 , RGD:2292091 , RGD:13503347 , RGD:13504684
NCBI chr 4:10,793,834...10,814,170
Ensembl chr 4:10,793,834...10,814,166
G
Nox1
NADPH oxidase 1
IEP
mRNA:increased expression:heart
RGD
PMID:33658472
RGD:329955358
NCBI chr X:97,279,058...97,332,291
Ensembl chr X:97,279,056...97,302,236
G
Nppb
natriuretic peptide B
IDA
RGD
PMID:21168723
RGD:5685663
NCBI chr 5:158,416,813...158,418,175
Ensembl chr 5:158,416,866...158,418,168
G
Nppc
natriuretic peptide C
IDA
RGD
PMID:15337698
RGD:1580149
NCBI chr 9:87,320,051...87,324,251
Ensembl chr 9:87,320,051...87,324,251
G
Npr3
natriuretic peptide receptor 3
IDA
RGD
PMID:15337698
RGD:1580149
NCBI chr 2:60,865,483...60,933,432
Ensembl chr 2:60,870,594...60,932,955
G
Npy1r
neuropeptide Y receptor Y1
IEP
mRNA:decreased expression:heart left ventricle
RGD
PMID:17562528
RGD:1642307
NCBI chr16:23,037,788...23,047,330
Ensembl chr16:23,037,789...23,046,759
G
Olr1
oxidized low density lipoprotein receptor 1
treatment
IMP
RGD
PMID:12384456
RGD:628368
NCBI chr 4:162,926,436...162,949,057
Ensembl chr 4:162,926,439...162,948,523
G
Oprd1
opioid receptor, delta 1
IDA
RGD
PMID:12136724
RGD:2316590
NCBI chr 5:144,306,188...144,340,960
Ensembl chr 5:144,306,188...144,340,960
G
Oxt
oxytocin/neurophysin I prepropeptide
IMP
RGD
PMID:19234577
RGD:2304087
NCBI chr 3:117,782,650...117,783,490
Ensembl chr 3:117,782,650...117,783,490
G
P2ry12
purinergic receptor P2Y12
ISO
RGD
PMID:20431845
RGD:6480645
NCBI chr 2:143,481,468...143,523,340
Ensembl chr 2:143,481,430...143,523,361
G
Parp1
poly (ADP-ribose) polymerase 1
ISO
RGD
PMID:9670921 PMID:23598272
RGD:5683917 , RGD:11073735
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
G
Pawr
pro-apoptotic WT1 regulator
treatment
IMP
RGD
PMID:18055876
RGD:9835369
NCBI chr 7:43,645,028...43,725,033
Ensembl chr 7:43,645,084...43,725,028
G
Pdia3
protein disulfide isomerase family A, member 3
IEP
RGD
PMID:12872233
RGD:1624250
NCBI chr 3:108,388,189...108,412,013
Ensembl chr 3:108,388,245...108,413,236
G
Pecam1
platelet and endothelial cell adhesion molecule 1
IMP
RGD
PMID:8989147
RGD:2311662
NCBI chr10:91,590,521...91,652,279
Ensembl chr10:91,590,521...91,652,116
G
Phlda3
pleckstrin homology-like domain, family A, member 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:34351043
NCBI chr13:47,193,250...47,196,335
Ensembl chr13:47,193,086...47,196,335
G
Pik3cg
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma
ISO
RGD
PMID:20179753
RGD:6482687
NCBI chr 6:48,766,778...48,802,098
Ensembl chr 6:48,766,864...48,802,043
G
Plcd1
phospholipase C, delta 1
IDA
protein:altered activity
RGD
PMID:12623065
RGD:1304368
NCBI chr 8:118,795,196...118,818,186
Ensembl chr 8:118,795,201...118,818,186
G
Pld2
phospholipase D2
IDA
protein:altered activity:sarcolemma, sarcoplasmic reticulum, heart left ventricle
RGD
PMID:15752718
RGD:2299906
NCBI chr10:55,256,326...55,274,192
Ensembl chr10:55,256,359...55,272,808
G
Pln
phospholamban
treatment
IDA ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:10734148 PMID:21934351
RGD:7327186
NCBI chr20:32,629,537...32,639,559
G
Ppara
peroxisome proliferator activated receptor alpha
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:16411023
NCBI chr 7:116,832,405...116,900,878
Ensembl chr 7:116,832,756...116,895,346
G
Ppard
peroxisome proliferator-activated receptor delta
IDA
RGD
PMID:19997057
RGD:2324876
NCBI chr20:6,298,785...6,363,970
Ensembl chr20:6,298,785...6,363,968
G
Pparg
peroxisome proliferator-activated receptor gamma
ISO
RGD
PMID:18562925
RGD:2301853
NCBI chr 4:148,423,102...148,548,471
Ensembl chr 4:148,423,194...148,548,468
G
Ppargc1a
PPARG coactivator 1 alpha
treatment
ISO
RGD
PMID:19096023
RGD:10059669
NCBI chr14:58,860,752...59,516,525
Ensembl chr14:58,861,144...59,512,656
G
Prkaa2
protein kinase AMP-activated catalytic subunit alpha 2
treatment
IEP
RGD
PMID:20501665
RGD:10003160
NCBI chr 5:119,807,992...119,879,987
Ensembl chr 5:119,813,226...119,879,543
G
Prkcb
protein kinase C, beta
IDA
RGD
PMID:15878997
RGD:1625520
NCBI chr 1:176,832,173...177,163,539
Ensembl chr 1:176,832,226...177,163,536
G
Prkcd
protein kinase C, delta
IEP
protein:decreased expression:heart
RGD
PMID:17322024
RGD:1642542
NCBI chr16:5,769,217...5,799,380
Ensembl chr16:5,769,215...5,799,352
G
Prkd1
protein kinase D1
ameliorates
ISO
RGD
PMID:24345679
RGD:307727199
NCBI chr 6:67,725,193...68,039,002
Ensembl chr 6:67,725,905...68,039,042
G
Prkg1
protein kinase cGMP-dependent 1
treatment
IMP
RGD
PMID:18332860 PMID:19845676
RGD:7777120 , RGD:7777130
NCBI chr 1:228,409,605...229,638,794
Ensembl chr 1:228,408,947...229,639,080
G
Procr
protein C receptor
treatment
IDA
RGD
PMID:26994471
RGD:13515126
NCBI chr 3:144,254,596...144,258,863
Ensembl chr 3:144,254,380...144,258,903
G
Pten
phosphatase and tensin homolog
treatment
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:19038262 PMID:20951693
RGD:127285611
NCBI chr 1:230,630,443...230,697,070
Ensembl chr 1:230,630,338...230,696,838
G
Ptger3
prostaglandin E receptor 3
treatment
IMP
RGD
PMID:10193764
RGD:10043342
NCBI chr 2:246,606,131...246,750,970
Ensembl chr 2:246,606,183...246,684,434
G
Ptgs2
prostaglandin-endoperoxide synthase 2
IMP
RGD
PMID:17660401
RGD:2300261
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
G
Rap1a
RAP1A, member of RAS oncogene family
treatment
IDA
RGD
PMID:20501665
RGD:10003160
NCBI chr 2:193,208,631...193,286,513
Ensembl chr 2:193,208,635...193,286,501
G
Rela
RELA proto-oncogene, NF-kB subunit
treatment
IDA IEP
protein:altered localization:nucleus
RGD
PMID:18636044 PMID:31583047
RGD:2298773 , RGD:155230831
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
G
Rhoa
ras homolog family member A
IEP
protein:altered localization:heart
RGD
PMID:17322412
RGD:1642967
NCBI chr 8:108,991,926...109,025,746
Ensembl chr 8:108,991,954...109,025,746
G
Rnf41
ring finger protein 41
severity
ISO
RGD
PMID:21312039
RGD:401827146
NCBI chr 7:838,160...876,869
Ensembl chr 7:838,203...865,511
G
Rnls
renalase, FAD-dependent amine oxidase
ISO
RGD
PMID:21178975 PMID:21178975
RGD:7327174 , RGD:7327174
NCBI chr 1:231,037,481...231,309,855
Ensembl chr 1:231,037,486...231,309,823
G
S100b
S100 calcium binding protein B
IEP
mRNA, protein:increased expression:myocardium
RGD
PMID:21663912
RGD:5508825
NCBI chr20:12,372,866...12,381,619
Ensembl chr20:12,372,881...12,394,743
G
Selp
selectin P
IEP ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:12087064 PMID:21146547
RGD:6480105
NCBI chr13:76,476,229...76,511,846
Ensembl chr13:76,476,295...76,511,845
G
Serpina3n
serine (or cysteine) peptidase inhibitor, clade A, member 3N
ISO
RGD
PMID:7562495
RGD:5147423
NCBI chr 6:123,323,623...123,331,181
Ensembl chr 6:123,323,629...123,332,433
G
Serpine1
serpin family E member 1
treatment
IDA
RGD
PMID:26958805
RGD:11073621
NCBI chr12:19,601,272...19,611,657
Ensembl chr12:19,601,272...19,611,657
G
Serping1
serpin family G member 1
treatment
ISO
RGD
PMID:16942749
RGD:8661647
NCBI chr 3:69,842,726...69,852,583
Ensembl chr 3:69,842,739...69,852,034
G
Sfrp2
secreted frizzled-related protein 2
IEP
RGD
PMID:19109969
RGD:4107088
NCBI chr 2:169,089,517...169,097,064
Ensembl chr 2:169,089,517...169,097,063
G
Sh2b3
SH2B adaptor protein 3
IMP
RGD
PMID:25628389
RGD:12904914
NCBI chr12:34,731,934...34,753,617
Ensembl chr12:34,731,911...34,753,616
G
Sh2b3em2Mcwi
SH2B adaptor protein 3; zinc finger nuclease induced mutant 2, Medical College of Wisconsin
IMP
RGD
PMID:25628389
RGD:12904914
G
Shh
sonic hedgehog signaling molecule
IEP
protein:increased expression:heart
RGD
PMID:18228117
RGD:2306299
NCBI chr 4:6,954,017...6,963,170
Ensembl chr 4:6,954,017...6,963,170
G
Sirt1
sirtuin 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:21060073
NCBI chr20:25,307,225...25,329,273
Ensembl chr20:25,306,917...25,329,260
G
Slc25a4
solute carrier family 25 member 4
treatment
IEP
RGD
PMID:24126566
RGD:9681554
NCBI chr16:46,072,935...46,076,730
Ensembl chr16:46,072,939...46,076,733
G
Slc2a1
solute carrier family 2 member 1
IEP
RGD
PMID:10336852
RGD:12879857
NCBI chr 5:132,717,196...132,745,416
Ensembl chr 5:132,717,196...132,745,416
G
Slc2a4
solute carrier family 2 member 4
IEP
RGD
PMID:10336852
RGD:12879857
NCBI chr10:54,666,015...54,671,581
Ensembl chr10:54,666,015...54,671,565
G
Slc8a1
solute carrier family 8 member A1
IDA IMP ISO
protein:increased activity:cardiac muscle cell CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:15215644 PMID:17267548 PMID:17822695
RGD:1642729 , RGD:1642716
NCBI chr 6:13,194,609...13,547,369
Ensembl chr 6:13,194,662...13,535,628
G
Slc9a1
solute carrier family 9 member A1
IMP
RGD
PMID:22803959
RGD:6771238
NCBI chr 5:145,576,341...145,629,630
Ensembl chr 5:145,576,334...145,629,624
G
Smad1
SMAD family member 1
ISO
RGD
PMID:15911698
RGD:1643233
NCBI chr19:28,513,130...28,573,665
Ensembl chr19:28,513,131...28,573,651
G
Smad3
SMAD family member 3
treatment
IDA
RGD
PMID:22913380
RGD:12903950
NCBI chr 8:64,126,829...64,236,960
Ensembl chr 8:64,110,039...64,236,960
G
Smad4
SMAD family member 4
treatment
IEP
RGD
PMID:22913380
RGD:12903950
NCBI chr18:67,243,742...67,274,438
Ensembl chr18:67,243,742...67,274,438
G
Sod1
superoxide dismutase 1
treatment
ISO IDA
human protein in a rat model
RGD
PMID:19277497 PMID:23629152 PMID:12668130
RGD:8655884 , RGD:8655965 , RGD:11035287
NCBI chr11:29,456,673...29,462,249
Ensembl chr11:29,456,558...29,462,249
G
Sod2
superoxide dismutase 2
treatment
ISO
RGD
PMID:11864929 PMID:12668130
RGD:1581222 , RGD:11035287
NCBI chr 1:47,638,318...47,645,163
Ensembl chr 1:47,636,528...47,645,189
G
Sord
sorbitol dehydrogenase
IEP ISO
protein:increased activity:heart CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:18549825 PMID:14525943
RGD:1601364
NCBI chr 3:109,184,697...109,216,133
Ensembl chr 3:109,184,676...109,216,133
G
Spp1
secreted phosphoprotein 1
ISO
RGD
PMID:15165989
RGD:1581342
NCBI chr14:5,308,885...5,315,120
Ensembl chr14:5,308,885...5,315,162
G
Stat1
signal transducer and activator of transcription 1
IDA
protein:increased phosphorylation:heart
RGD
PMID:16935931
RGD:1600091
NCBI chr 9:49,419,561...49,459,969
Ensembl chr 9:49,419,340...49,588,540
G
Stat3
signal transducer and activator of transcription 3
treatment
IDA
RGD
PMID:23796350
RGD:8694332
NCBI chr10:85,811,206...85,863,057
Ensembl chr10:85,811,218...85,863,057
G
Suv39h1
SUV39H1 histone lysine methyltransferase
treatment
IDA
associated with Diabetes Mellitus, Experimental
RGD
PMID:24752040
RGD:9586740
NCBI chr X:14,421,028...14,433,993
Ensembl chr X:14,421,109...14,433,982
G
Tek
TEK receptor tyrosine kinase
IEP
mRNA, protein:increased expression:ventricle myocardium
RGD
PMID:12737621
RGD:1601505
NCBI chr 5:109,607,077...109,733,805
Ensembl chr 5:109,607,077...109,733,804
G
Tfrc
transferrin receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18549825
NCBI chr11:68,163,413...68,185,257
Ensembl chr11:68,163,413...68,185,257
G
Tgfb1
transforming growth factor, beta 1
treatment
IEP
RGD
PMID:22913380
RGD:12903950
NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847
G
Thbs1
thrombospondin 1
IEP
mRNA:increased expression:heart
RGD
PMID:16179730
RGD:2317960
NCBI chr 3:105,056,293...105,071,445
Ensembl chr 3:105,056,292...105,071,440
G
Timp4
TIMP metallopeptidase inhibitor 4
IEP
protein:increased expression:blood
RGD
PMID:12707244
RGD:2290461
NCBI chr 4:148,306,021...148,312,558
Ensembl chr 4:148,304,490...148,312,558
G
Tlr2
toll-like receptor 2
IEP
RGD
PMID:19274437
RGD:2312688
NCBI chr 2:169,200,620...169,206,819
Ensembl chr 2:169,197,419...169,206,630
G
Tlr4
toll-like receptor 4
IDA
RGD
PMID:14962484
RGD:1302746
NCBI chr 5:80,145,867...80,159,501
Ensembl chr 5:80,145,826...80,159,628
G
Tnc
tenascin C
IEP
RGD
PMID:20554738
RGD:4889599
NCBI chr 5:77,375,851...77,460,712
Ensembl chr 5:77,375,851...77,460,624
G
Tnf
tumor necrosis factor
treatment
IEP
protein:increased expression:serum, heart:
RGD
PMID:24157164 PMID:31583047
RGD:7387274 , RGD:155230831
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Tnni3
troponin I3, cardiac type
ameliorates
ISO
RGD
PMID:30259997
RGD:329337366
NCBI chr 1:69,299,900...69,303,582
Ensembl chr 1:69,299,900...69,303,580
G
Tp53
tumor protein p53
IEP
protein:increased expression:heart
RGD
PMID:18317410
RGD:2290554
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
G
Txn1
thioredoxin 1
IEP
mRNA:decreased expression:heart
RGD
PMID:18045550
RGD:2306159
NCBI chr 5:72,712,334...72,724,564
Ensembl chr 5:72,711,933...72,724,629
G
Txn2
thioredoxin 2
IEP
mRNA, protein:decreased expression:heart
RGD
PMID:18045550
RGD:2306159
NCBI chr 7:109,496,772...109,510,378
Ensembl chr 7:109,496,761...109,510,359
G
Ucn
urocortin
IDA
RGD
PMID:15806110
RGD:1642783
NCBI chr 6:25,238,120...25,238,950
Ensembl chr 6:25,238,120...25,238,950
G
Ucp2
uncoupling protein 2
IEP
mRNA:increased expression:myocardium
RGD
PMID:19526854
RGD:2313528
NCBI chr 1:154,839,242...154,845,612
Ensembl chr 1:154,839,209...154,845,611
G
Ucp3
uncoupling protein 3
IEP
mRNA:increased expression:myocardium
RGD
PMID:19526854
RGD:2313528
NCBI chr 1:154,815,777...154,828,764
Ensembl chr 1:154,815,777...154,828,762
G
Uts2
urotensin 2
IDA
RGD
PMID:17900760
RGD:2306836
NCBI chr 5:161,450,846...161,456,235
Ensembl chr 5:161,450,846...161,456,237
G
Uts2r
urotensin 2 receptor
IMP
RGD
PMID:17900760
RGD:2306836
NCBI chr10:106,438,092...106,439,252
Ensembl chr10:106,438,092...106,439,252
G
Vcam1
vascular cell adhesion molecule 1
IEP
protein:increased expression:heart
RGD
PMID:23052973
RGD:7207792
NCBI chr 2:204,038,120...204,057,852
Ensembl chr 2:204,038,114...204,057,958
G
Vcan
versican
IEP
mRNA:increased expression:heart
RGD
PMID:16311904
RGD:1598497
NCBI chr 2:20,761,718...20,860,637
Ensembl chr 2:20,761,718...20,860,637
G
Vdac1
voltage-dependent anion channel 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25488258
NCBI chr10:36,532,306...36,559,642
Ensembl chr10:36,532,244...36,559,640
G
Vdr
vitamin D receptor
ISO
mRNA,protein:increased expression, activity:heart:
RGD
PMID:25365634
RGD:13432076
NCBI chr 7:128,987,981...129,037,677
Ensembl chr 7:128,987,981...129,037,677
G
Vegfa
vascular endothelial growth factor A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22050707
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
G
Xdh
xanthine dehydrogenase
IEP
RGD
PMID:3162724
RGD:13209131
NCBI chr 6:21,530,463...21,592,172
Ensembl chr 6:21,530,113...21,592,268
G
Xiap
X-linked inhibitor of apoptosis
treatment
ISO IEP
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:14998631 PMID:20501665
RGD:10003160
NCBI chr X:120,890,537...120,938,413
Ensembl chr X:120,897,907...120,934,700
G
Yes1
YES proto-oncogene 1, Src family tyrosine kinase
ISO
mRNA,protein:increased expression:myocardium (mouse)
RGD
PMID:30259997
RGD:329337366
NCBI chr 9:113,200,256...113,275,942
Ensembl chr 9:113,200,256...113,299,837
G
F3
coagulation factor III, tissue factor
treatment
IEP
RGD
PMID:26370456
RGD:11341710
NCBI chr 2:209,827,061...209,838,666
Ensembl chr 2:209,826,959...209,838,668
G
Ccn2
cellular communication network factor 2
exacerbates
IEP
protein:increased expression:urine (rat)
RGD
PMID:19921985
RGD:150517553
NCBI chr 1:20,802,199...20,805,315
Ensembl chr 1:20,802,199...20,805,734
G
Cd40lg
CD40 ligand
treatment
ISO
RGD
PMID:12244161
RGD:7248713
NCBI chr X:135,127,052...135,138,768
Ensembl chr X:135,126,969...135,138,306
G
Gata2
GATA binding protein 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28569748
NCBI chr 4:120,654,205...120,667,763
Ensembl chr 4:120,658,986...120,667,761
G
Gpx3
glutathione peroxidase 3
treatment
ISO
RGD
PMID:29290803
RGD:401827126
NCBI chr10:39,028,624...39,036,695
Ensembl chr10:39,028,570...39,037,035
G
Icam1
intercellular adhesion molecule 1
treatment
IMP
RGD
PMID:22617707 PMID:10666412
RGD:8547722 , RGD:11520779
NCBI chr 8:19,553,063...19,565,438
Ensembl chr 8:19,553,645...19,565,438
G
Il10
interleukin 10
treatment
IDA
RGD
PMID:21911153
RGD:11049478
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
G
Npy
neuropeptide Y
IEP
mRNA, protein:decreased expression:blood, mononuclear cell
RGD
PMID:18981110
RGD:10448956
NCBI chr 4:78,881,294...78,888,495
Ensembl chr 4:78,881,264...78,888,495
G
Pf4
platelet factor 4
ameliorates
IDA
RGD
PMID:24986443
RGD:329901907
NCBI chr14:17,298,304...17,299,220
Ensembl chr14:17,298,308...17,299,365
G
Selp
selectin P
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28569748
NCBI chr13:76,476,229...76,511,846
Ensembl chr13:76,476,295...76,511,845
G
Senp1
SUMO specific peptidase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28569748
NCBI chr 7:129,163,173...129,226,766
Ensembl chr 7:129,165,774...129,221,598
G
Tnf
tumor necrosis factor
treatment
IEP
liver
RGD
PMID:18972563
RGD:15023490
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Vcam1
vascular cell adhesion molecule 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28569748
NCBI chr 2:204,038,120...204,057,852
Ensembl chr 2:204,038,114...204,057,958
G
Apaf1
apoptotic peptidase activating factor 1
treatment
IDA
RGD
PMID:22143029
RGD:5686888
NCBI chr 7:25,494,143...25,579,540
Ensembl chr 7:25,494,609...25,579,540
G
Bad
BCL2-associated agonist of cell death
treatment
IDA
RGD
PMID:23056591
RGD:10053711
NCBI chr 1:204,133,502...204,142,829
Ensembl chr 1:204,131,501...204,142,823
G
Bax
BCL2 associated X, apoptosis regulator
treatment
IEP
RGD
PMID:23056591
RGD:10053711
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
G
Bcl2
BCL2, apoptosis regulator
treatment
IDA
RGD
PMID:25535961
RGD:11522737
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
Bcl2l1
Bcl2-like 1
treatment
IEP
RGD
PMID:23056591
RGD:10053711
NCBI chr 3:141,253,508...141,304,582
Ensembl chr 3:141,253,523...141,303,479
G
Bdnf
brain-derived neurotrophic factor
ISO
RGD
PMID:10549664
RGD:8655861
NCBI chr 3:96,165,042...96,215,621
Ensembl chr 3:96,165,042...96,215,615
G
Casp7
caspase 7
IEP
RGD
PMID:20702827
RGD:5684535
NCBI chr 1:255,437,438...255,476,737
Ensembl chr 1:255,437,172...255,476,729
G
Cat
catalase
treatment
IEP
protein:decreased expression,decreased activity:retina:
RGD
PMID:22509733
RGD:9068919
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
G
Ccl2
C-C motif chemokine ligand 2
treatment
IDA
RGD
PMID:24325836
RGD:11526144
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
G
Clu
clusterin
IEP
RGD
PMID:15139011
RGD:1581194
NCBI chr15:40,161,068...40,200,315
Ensembl chr15:40,174,617...40,200,315
G
Cntf
ciliary neurotrophic factor
treatment
IDA
RGD
PMID:8125754
RGD:8655591
NCBI chr 1:209,887,854...209,889,877
Ensembl chr 1:209,887,854...209,889,877
G
Dusp1
dual specificity phosphatase 1
treatment
IMP
RGD
PMID:21094639
RGD:7495849
NCBI chr10:16,680,478...16,683,275
G
Fgf2
fibroblast growth factor 2
treatment
IEP ISO
RGD
PMID:9561364 PMID:8125754 PMID:14975212
RGD:8554857 , RGD:8655591 , RGD:8655585
NCBI chr 2:120,236,328...120,290,673
Ensembl chr 2:120,236,328...120,291,221
G
Fxn
frataxin
ameliorates
ISO
RGD
PMID:27537261 PMID:27537261
RGD:401793704 , RGD:401793704
NCBI chr 1:221,874,007...221,897,543
Ensembl chr 1:221,872,420...221,897,540
G
Glul
glutamate-ammonia ligase
treatment
IEP
RGD
PMID:22008240
RGD:401794422
NCBI chr13:65,969,053...66,035,121
Ensembl chr13:66,025,630...66,035,108
G
Hdac2
histone deacetylase 2
treatment
ISO
RGD
PMID:23696608
RGD:9590210
NCBI chr20:40,548,244...40,571,609
Ensembl chr20:40,548,250...40,571,609
G
Hgf
hepatocyte growth factor
treatment
ISO IEP
mRNA,protein:increased expression:retina:
RGD
PMID:11818401 PMID:11818401
RGD:8548551 , RGD:8548551
NCBI chr 4:18,673,736...18,745,582
Ensembl chr 4:18,677,101...18,745,409
G
Hmgb1
high mobility group box 1
IDA
RGD
PMID:21999229
RGD:10402064
NCBI chr12:5,972,950...5,979,658
Ensembl chr12:5,901,586...5,978,565 Ensembl chr16:5,901,586...5,978,565
G
Hmox1
heme oxygenase 1
IEP
associated with Glaucoma
RGD
PMID:20357190
RGD:4145289
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
G
Hspb1
heat shock protein family B (small) member 1
IDA
RGD
PMID:21310899
RGD:10402767
NCBI chr12:20,794,014...20,795,675
Ensembl chr12:20,794,028...20,795,743
G
Icam1
intercellular adhesion molecule 1
treatment
IMP IEP
associated with Hypertension
RGD
PMID:10235552 PMID:15007035
RGD:8547704 , RGD:8547707
NCBI chr 8:19,553,063...19,565,438
Ensembl chr 8:19,553,645...19,565,438
G
Il1a
interleukin 1 alpha
IEP
RGD
PMID:7890488
RGD:7401191
NCBI chr 3:116,526,601...116,537,055
Ensembl chr 3:116,526,604...116,536,822
G
Il1b
interleukin 1 beta
IEP
RGD
PMID:7890488
RGD:7401191
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
G
Il6
interleukin 6
IEP
mRNA:increased expression:retina:
RGD
PMID:16530172
RGD:7829807
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
G
Kcnj10
potassium inwardly-rectifying channel, subfamily J, member 10
IEP ISO
mRNA:decreased expression:retina protein:decreased expression:retina, blood vessel
RGD
PMID:16330144 PMID:20132867
RGD:8662868 , RGD:8662890
NCBI chr13:84,802,026...84,835,383
Ensembl chr13:84,802,009...84,835,461
G
Lpar1
lysophosphatidic acid receptor 1
IEP
protein:increased expression:retina
RGD
PMID:17026968
RGD:2317696
NCBI chr 5:73,229,047...73,347,874
Ensembl chr 5:73,229,625...73,369,895
G
Map2k4
mitogen activated protein kinase kinase 4
IEP
RGD
PMID:19668425
RGD:7495824
NCBI chr10:50,343,227...50,447,956
Ensembl chr10:50,344,915...50,447,993
G
Nos3
nitric oxide synthase 3
treatment
IEP IDA
mRNA:altered expression:retina (rat) protein:increased expression:retinal vasculature, retinal ganglion cell layer (rat)
RGD
PMID:9950605 PMID:11496119 PMID:12634478
RGD:7771570 , RGD:7775036 , RGD:7775037
NCBI chr 4:10,793,834...10,814,170
Ensembl chr 4:10,793,834...10,814,166
G
Opa1
OPA1, mitochondrial dynamin like GTPase
IEP
protein:increased expression:retina, cytosol (rat)
RGD
PMID:19122832
RGD:13208943
NCBI chr11:71,108,100...71,185,170
Ensembl chr11:71,109,873...71,185,109
G
Ren
renin
treatment
IMP
RGD
PMID:24709336
RGD:11039406
NCBI chr13:44,796,260...44,807,491
Ensembl chr13:44,796,091...44,807,489
G
Rnf2
ring finger protein 2
IEP
RGD
PMID:20740046
RGD:9491844
NCBI chr13:63,553,964...63,584,047
Ensembl chr13:63,554,862...63,583,099
G
Serpinf1
serpin family F member 1
ISO
human protein in a mouse model
RGD
PMID:16822505
RGD:8554871
NCBI chr10:60,250,198...60,262,593
Ensembl chr10:60,249,708...60,262,646
G
Sod2
superoxide dismutase 2
treatment
IEP ISO
protein:decreased activity:retina:
RGD
PMID:22240151 PMID:22240151
RGD:8158043 , RGD:8158043
NCBI chr 1:47,638,318...47,645,163
Ensembl chr 1:47,636,528...47,645,189
G
Stat3
signal transducer and activator of transcription 3
treatment
IDA
RGD
PMID:21858029
RGD:8694310
NCBI chr10:85,811,206...85,863,057
Ensembl chr10:85,811,218...85,863,057
G
Tlr4
toll-like receptor 4
ISO
RGD
PMID:21031135
RGD:7794771
NCBI chr 5:80,145,867...80,159,501
Ensembl chr 5:80,145,826...80,159,628
G
Tnf
tumor necrosis factor
IEP IMP IDA
protein:increased expression:retina:
RGD
PMID:18660426 PMID:18660426 PMID:18660426
RGD:7387281 , RGD:7387281 , RGD:7387281
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Vegfa
vascular endothelial growth factor A
IDA
RGD
PMID:17591953
RGD:7421609
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
G
Xdh
xanthine dehydrogenase
treatment
IMP
RGD
PMID:9288448
RGD:13210506
NCBI chr 6:21,530,463...21,592,172
Ensembl chr 6:21,530,113...21,592,268
G
Elane
elastase, neutrophil expressed
IMP
RGD
PMID:7858993
RGD:10450555
NCBI chr 7:9,817,251...9,819,174
Ensembl chr 7:9,817,252...9,819,100
G
Itgam
integrin subunit alpha M
treatment
IEP
RGD
PMID:26315464 PMID:19105227
RGD:329901918 , RGD:329902055
NCBI chr 1:182,659,047...182,709,501
Ensembl chr 1:182,659,000...182,709,503
G
Serping1
serpin family G member 1
treatment
ISO
RGD
PMID:29395422 PMID:24585935
RGD:13525001 , RGD:13542089
NCBI chr 3:69,842,726...69,852,583
Ensembl chr 3:69,842,739...69,852,034
G
Bad
BCL2-associated agonist of cell death
treatment
IDA
RGD
PMID:23643992
RGD:10053660
NCBI chr 1:204,133,502...204,142,829
Ensembl chr 1:204,131,501...204,142,823
G
Bdnf
brain-derived neurotrophic factor
treatment
IEP
RGD
PMID:24361987
RGD:10059358
NCBI chr 3:96,165,042...96,215,621
Ensembl chr 3:96,165,042...96,215,615
G
Becn1
beclin 1
treatment
IEP
RGD
PMID:25374587
RGD:11561952
NCBI chr10:86,231,387...86,246,742
Ensembl chr10:86,231,388...86,246,742
G
Cdk5
cyclin-dependent kinase 5
treatment
IDA
RGD
PMID:25301568
RGD:13782374
NCBI chr 4:10,754,682...10,760,110
Ensembl chr 4:10,754,687...10,760,112
G
Cdk5r1
cyclin-dependent kinase 5 regulatory subunit 1
treatment
IEP
RGD
PMID:25301568
RGD:13782374
NCBI chr10:65,484,266...65,485,467
Ensembl chr10:65,483,941...65,488,456
G
Creb1
cAMP responsive element binding protein 1
treatment
IEP
RGD
PMID:17368520 PMID:29310813
RGD:155226865 , RGD:155226868
NCBI chr 9:65,903,511...65,972,562
Ensembl chr 9:65,903,547...65,970,816
G
Cxcl12
C-X-C motif chemokine ligand 12
IMP
RGD
PMID:27760212
RGD:12910551
NCBI chr 4:150,388,326...150,401,173
Ensembl chr 4:150,388,325...150,401,168
G
Cxcr4
C-X-C motif chemokine receptor 4
IMP
RGD
PMID:27760212
RGD:12910551
NCBI chr13:40,077,976...40,081,883
Ensembl chr13:40,077,976...40,081,883
G
Gapdh
glyceraldehyde-3-phosphate dehydrogenase
treatment
IEP
RGD
PMID:30195603
RGD:13792615
NCBI chr 4:157,962,312...157,967,158
Ensembl chr 4:157,962,343...157,966,235
G
Hspa5
heat shock protein family A (Hsp70) member 5
treatment
IEP
protein:increased expression:spinal cord:
RGD
PMID:24463125
RGD:11354961
NCBI chr 3:18,055,507...18,059,969
Ensembl chr 3:18,055,405...18,059,891
G
Proc
protein C, inactivator of coagulation factors Va and VIIIa
treatment
ISO
RGD
PMID:10903607
RGD:11100044
NCBI chr18:23,764,367...23,774,816
Ensembl chr18:23,764,368...23,775,133
G
Siah1
siah E3 ubiquitin protein ligase 1
treatment
IEP
RGD
PMID:30195603
RGD:13792615
NCBI chr19:20,378,908...20,402,512
Ensembl chr19:20,378,439...20,403,808
G
Tlr4
toll-like receptor 4
IMP
RGD
PMID:27760212
RGD:12910551
NCBI chr 5:80,145,867...80,159,501
Ensembl chr 5:80,145,826...80,159,628
G
Apaf1
apoptotic peptidase activating factor 1
treatment
IEP
RGD
PMID:27748062
RGD:13703108
NCBI chr 7:25,494,143...25,579,540
Ensembl chr 7:25,494,609...25,579,540
G
Bax
BCL2 associated X, apoptosis regulator
IEP
RGD
PMID:26754107
RGD:11555349
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
G
Bcl2
BCL2, apoptosis regulator
IEP
RGD
PMID:26754107
RGD:11555349
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
Casp3
caspase 3
IEP
RGD
PMID:26754107
RGD:11555349
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Casp9
caspase 9
IEP
RGD
PMID:26754107
RGD:11555349
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
G
Hif1a
hypoxia inducible factor 1 subunit alpha
IEP
protein:increased expression:testes (rat)
RGD
PMID:12193413
RGD:632997
NCBI chr 6:92,624,059...92,669,262
Ensembl chr 6:92,624,390...92,669,261
G
Hmox1
heme oxygenase 1
treatment
IMP
RGD
PMID:23142244
RGD:10755740
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
G
Mapk1
mitogen activated protein kinase 1
treatment
IMP
RGD
PMID:15944243
RGD:13800876
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
G
Mapk3
mitogen activated protein kinase 3
treatment
IMP
RGD
PMID:15944243
RGD:13800876
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
G
Nos3
nitric oxide synthase 3
IEP
protein:increased expression:testis
RGD
PMID:18205898
RGD:2292105
NCBI chr 4:10,793,834...10,814,170
Ensembl chr 4:10,793,834...10,814,166
G
Uchl5
ubiquitin C-terminal hydrolase L5
IEP
mRNA, protein:decreased expression:testis
RGD
PMID:24189580
RGD:9588240
NCBI chr13:55,520,722...55,556,503
Ensembl chr13:55,520,729...55,556,502
G
Xdh
xanthine dehydrogenase
treatment
IDA
RGD
PMID:23769121
RGD:7247698
NCBI chr 6:21,530,463...21,592,172
Ensembl chr 6:21,530,113...21,592,268
G
Acvrl1
activin A receptor like type 1
IEP
RGD
PMID:15781474
RGD:1579751
NCBI chr 7:132,239,200...132,256,592
Ensembl chr 7:132,239,729...132,256,591
G
Adamts1
ADAM metallopeptidase with thrombospondin type 1 motif, 1
IEP
mRNA, protein:increased expression:brain
RGD
PMID:16630594
RGD:9681747
NCBI chr11:24,932,227...24,941,068
Ensembl chr11:24,931,761...24,941,103
G
Adamts4
ADAM metallopeptidase with thrombospondin type 1 motif, 4
IEP
RGD
PMID:16630594
RGD:9681747
NCBI chr13:83,670,556...83,680,045
Ensembl chr13:83,670,183...83,680,065
G
Adarb1
adenosine deaminase, RNA-specific, B1
IMP
RGD
PMID:16504947
RGD:10755337
NCBI chr20:11,222,569...11,350,854
Ensembl chr20:11,222,583...11,350,852
G
Adora1
adenosine A1 receptor
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:23437309
NCBI chr13:45,658,872...45,695,821
Ensembl chr13:45,658,872...45,695,801
G
Ager
advanced glycosylation end product-specific receptor
IEP ISO
protein:altered expression:cerebral cortex, striatum (rat) protein:increased expression:brain, plasma
RGD
PMID:22528836 PMID:23288172
RGD:7245542 , RGD:8696004
NCBI chr20:4,148,150...4,151,361
Ensembl chr20:4,147,890...4,151,078
G
Agt
angiotensinogen
IEP
RGD
PMID:21934531
RGD:8549480
NCBI chr19:52,529,139...52,549,618
Ensembl chr19:52,529,185...52,540,977
G
Ahr
aryl hydrocarbon receptor
treatment
IMP
RGD
PMID:32913241
RGD:401793747
NCBI chr 6:52,234,089...52,271,568
Ensembl chr 6:52,234,089...52,271,568
G
Aifm1
apoptosis inducing factor, mitochondria associated 1
IEP ISO
mRNA:decreased expression, altered localization:CA1 pyramidal layer, nucleus: protein:increased expression:nucleus:
RGD
PMID:14526224 PMID:15087715
RGD:10047409 , RGD:10053562
NCBI chr X:127,650,223...127,689,356
Ensembl chr X:127,650,226...127,689,256
G
Ang
angiogenin
treatment
IEP
RGD
PMID:30258350
RGD:155663419
NCBI chr15:24,312,711...24,323,361
G
Ank1
ankyrin 1
IEP
RGD
PMID:9202331
RGD:1599109
NCBI chr16:68,876,294...69,054,963
Ensembl chr16:68,877,504...69,054,759
G
Ank2
ankyrin 2
IEP
RGD
PMID:9202331
RGD:1599109
NCBI chr 2:215,378,028...215,954,015
Ensembl chr 2:215,379,680...215,862,923
G
Apoe
apolipoprotein E
IEP
RGD
PMID:19623195
RGD:6903926
NCBI chr 1:79,353,924...79,357,852
Ensembl chr 1:79,353,916...79,357,932
G
Aqp4
aquaporin 4
treatment
IEP
RGD
PMID:24773551
RGD:13207320
NCBI chr18:6,507,903...6,524,558
Ensembl chr18:6,507,903...6,524,856
G
Atf2
activating transcription factor 2
IDA IEP
RGD
PMID:10077326 PMID:9813301
RGD:10047405 , RGD:10047413
NCBI chr 3:58,718,323...58,795,280
Ensembl chr 3:58,718,332...58,795,236
G
Atp5f1b
ATP synthase F1 subunit beta
IEP
protein:increased expression:cerebrum (rat)
RGD
PMID:21950801
RGD:13792582
NCBI chr 7:515,454...521,858
Ensembl chr 7:515,460...567,273
G
Axin2
axin 2
treatment
IEP
RGD
PMID:31650542
RGD:151356749
NCBI chr10:93,893,830...93,927,042
Ensembl chr10:93,899,245...93,926,231
G
Bace1
beta-secretase 1
IEP
protein:increased activity,increased expression:brain cortex
RGD
PMID:15120577
RGD:13782170
NCBI chr 8:46,142,060...46,166,268
Ensembl chr 8:46,142,116...46,165,876
G
Bad
BCL2-associated agonist of cell death
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12629175
NCBI chr 1:204,133,502...204,142,829
Ensembl chr 1:204,131,501...204,142,823
G
Bax
BCL2 associated X, apoptosis regulator
treatment
IEP
RGD
PMID:21167243
RGD:10054102
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
G
Bbc3
Bcl-2 binding component 3
IEP
protein:increased expression:hippocampus CA1, pyramidal cell
RGD
PMID:12913114
RGD:634629
NCBI chr 1:77,013,281...77,022,509
Ensembl chr 1:77,014,543...77,022,509
G
Bcl2
BCL2, apoptosis regulator
treatment
IEP IDA
protein:decreased expression:brain
RGD
PMID:18083315 PMID:22509406 PMID:16732092
RGD:2290557 , RGD:11561910 , RGD:11522725
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
Bcl2l2
Bcl2-like 2
treatment
IEP ISO
protein:increased expression:cortex and caudate putamen
RGD
PMID:10724126 PMID:12571640
RGD:14394498 , RGD:14394500
NCBI chr15:28,346,449...28,361,627
Ensembl chr15:28,356,807...28,361,624
G
Becn1
beclin 1
treatment
IEP
RGD
PMID:22509406
RGD:11561910
NCBI chr10:86,231,387...86,246,742
Ensembl chr10:86,231,388...86,246,742
G
Bex3
brain expressed X-linked 3
IEP
RGD
PMID:11124986
RGD:9743974
NCBI chr X:99,273,270...99,274,799
Ensembl chr X:99,273,161...99,274,800
G
Bnip3
BCL2 interacting protein 3
IEP
RGD
PMID:14972662
RGD:2314028
NCBI chr 1:193,708,164...193,725,348
Ensembl chr 1:193,708,167...193,725,359
G
C3
complement C3
treatment
IEP ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:23199288 PMID:22004711
RGD:7411628
NCBI chr 9:2,087,437...2,114,366
Ensembl chr 9:2,087,437...2,114,429
G
Cab39
calcium binding protein 39
IEP
protein:increased expression:brain
RGD
PMID:27798271
RGD:14398833
NCBI chr 9:86,463,095...86,524,545
Ensembl chr 9:86,463,095...86,524,544
G
Camk2a
calcium/calmodulin-dependent protein kinase II alpha
IEP ISO
protein:increased expression:hippocampus
RGD
PMID:12951199 PMID:12199152
RGD:7241547 , RGD:13681927
NCBI chr18:54,378,642...54,441,120
Ensembl chr18:54,378,784...54,438,994
G
Casp3
caspase 3
IDA
RGD
PMID:21712070
RGD:10053706
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Casp7
caspase 7
treatment
IEP
RGD
PMID:25872160
RGD:13782285
NCBI chr 1:255,437,438...255,476,737
Ensembl chr 1:255,437,172...255,476,729
G
Casp8
caspase 8
treatment
IEP
protein:increased expression:cerebral cortex:
RGD
PMID:30148677 PMID:18096138
RGD:13782286 , RGD:4142863
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
G
Casp9
caspase 9
IEP ISO
associated with Diabetes Mellitus, Experimental;protein:increased expression:neocortex CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:11333366 PMID:15246841 PMID:21712070
RGD:2311321 , RGD:10053706
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
G
Cav1
caveolin 1
treatment
IEP ISO
RGD
PMID:22007835 PMID:22007835
RGD:8661794 , RGD:8661794
NCBI chr 4:45,640,624...45,673,708
Ensembl chr 4:45,634,918...45,673,705
G
Cbl
Cbl proto-oncogene
treatment
IDA
RGD
PMID:18773943
RGD:4108486
NCBI chr 8:44,487,824...44,571,620
Ensembl chr 8:44,489,410...44,571,176
G
Cbs
cystathionine beta synthase
treatment
ISO
XCO:0000348 XCO:0000807
RGD
PMID:22212488 PMID:22212488
RGD:41410880 , RGD:41410880
NCBI chr20:9,708,089...9,732,623
Ensembl chr20:9,708,090...9,732,764
G
Ccl2
C-C motif chemokine ligand 2
treatment
IDA IEP
mRNA:increased expression:brain (rat)
RGD
PMID:21487414 PMID:7860708
RGD:8549519 , RGD:8549729
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
G
Ccl20
C-C motif chemokine ligand 20
treatment
IMP
RGD
PMID:19428685
RGD:7488896
NCBI chr 9:84,389,031...84,391,629
Ensembl chr 9:84,388,904...84,391,629
G
Ccnh
cyclin H
IEP
mRNA, protein:increased expression:hippocampus
RGD
PMID:10501206
RGD:69371
NCBI chr 2:15,835,064...15,855,648
Ensembl chr 2:15,834,833...15,855,819
G
Ccr6
C-C motif chemokine receptor 6
IEP
mRNA:increased expression:brain
RGD
PMID:19428685
RGD:7488896
NCBI chr 1:52,474,477...52,508,301
Ensembl chr 1:52,474,168...52,498,603
G
Cd40
CD40 molecule
severity
ISO
RGD
PMID:15795333
RGD:11352234
NCBI chr 3:153,790,372...153,805,279
Ensembl chr 3:153,790,449...153,805,534
G
Cd40lg
CD40 ligand
severity
ISO
RGD
PMID:15795333
RGD:11352234
NCBI chr X:135,127,052...135,138,768
Ensembl chr X:135,126,969...135,138,306
G
Cdk5
cyclin-dependent kinase 5
treatment
IEP
RGD
PMID:28254431
RGD:13506925
NCBI chr 4:10,754,682...10,760,110
Ensembl chr 4:10,754,687...10,760,112
G
Cdkn2a
cyclin-dependent kinase inhibitor 2A
ISO
protein:decreased expression:striatum, neuron
RGD
PMID:11438580
RGD:8552691
NCBI chr 5:103,984,949...103,992,143
Ensembl chr 5:103,984,949...104,003,149
G
Cebpa
CCAAT/enhancer binding protein alpha
IEP
mRNA, protein:increased expression:hippocampal pyramidal cell layer (rat)
RGD
PMID:9795105
RGD:10401192
NCBI chr 1:87,759,631...87,762,303
Ensembl chr 1:87,759,433...87,762,412
G
Chka
choline kinase alpha
IEP
mRNA:increased expression:cerebral cortex (rat)
RGD
PMID:16300643
RGD:10401831
NCBI chr 1:201,076,804...201,125,517
Ensembl chr 1:201,076,860...201,125,516
G
Coq7
coenzyme Q7, hydroxylase
severity
ISO
RGD
PMID:20170652
RGD:10402096
NCBI chr 1:172,836,359...172,851,173
Ensembl chr 1:172,835,188...172,851,158
G
Creb1
cAMP responsive element binding protein 1
IDA
RGD
PMID:10077326
RGD:10047405
NCBI chr 9:65,903,511...65,972,562
Ensembl chr 9:65,903,547...65,970,816
G
Crem
cAMP responsive element modulator
IEP
mRNA:increased expression:cerebral cortex (rat)
RGD
PMID:12437578
RGD:632385
NCBI chr17:54,238,889...54,305,989
Ensembl chr17:54,239,030...54,305,989
G
Csf3
colony stimulating factor 3
treatment
ISO
RGD
PMID:12624302
RGD:10450512
NCBI chr10:83,660,787...83,664,569
Ensembl chr10:83,661,207...83,663,603
G
Cx3cl1
C-X3-C motif chemokine ligand 1
IEP
protein:decreased expression:hippocampus
RGD
PMID:24447880
RGD:9491776
NCBI chr19:10,227,337...10,237,826
Ensembl chr19:10,227,340...10,236,833
G
Cx3cr1
C-X3-C motif chemokine receptor 1
IEP
mRNA,protein:decreased expression:hippocampus
RGD
PMID:24447880
RGD:9491776
NCBI chr 8:119,785,726...119,799,431
Ensembl chr 8:119,782,595...119,800,014
G
Cxcl12
C-X-C motif chemokine ligand 12
IEP
protein:increased expression:hippocampus:
RGD
PMID:24924806
RGD:11352662
NCBI chr 4:150,388,326...150,401,173
Ensembl chr 4:150,388,325...150,401,168
G
Cycs
cytochrome c, somatic
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11333366
NCBI chr 4:79,651,894...79,653,994
Ensembl chr 4:79,651,378...79,654,054 Ensembl chr18:79,651,378...79,654,054
G
Daxx
death-domain associated protein
treatment
IDA IEP
mRNA,protein:increased expression:cerebral cortex:
RGD
PMID:17967739 PMID:18096138
RGD:9587802 , RGD:4142863
NCBI chr20:4,970,090...4,976,145
Ensembl chr20:4,970,092...4,975,843
G
Dbn1
drebrin 1
IEP
RGD
PMID:8583659
RGD:10398814
NCBI chr17:9,150,608...9,164,982
Ensembl chr17:9,150,659...9,164,984
G
Dffb
DNA fragmentation factor subunit beta
IEP
mRNA, protein:increased expression:hippocampus CA1
RGD
PMID:11425895
RGD:628524
NCBI chr 5:164,522,446...164,534,733
Ensembl chr 5:164,522,463...164,534,628
G
Dll4
delta like canonical Notch ligand 4
ameliorates treatment disease_progression
ISO IEP
RGD
PMID:31927543 PMID:30258350 PMID:30653356
RGD:155663354 , RGD:155663419 , RGD:155663383
NCBI chr 3:106,317,114...106,327,004
Ensembl chr 3:106,316,986...106,326,931
G
Dusp1
dual specificity phosphatase 1
IEP
protein:increased expression:brain
RGD
PMID:22197701
RGD:7771582
NCBI chr10:16,680,478...16,683,275
G
Dusp16
dual specificity phosphatase 16
IEP
protein:increased expression, altered localization:hippocampus, cytosol, nucleus
RGD
PMID:23280045
RGD:7775014
NCBI chr 4:167,546,780...167,630,173
Ensembl chr 4:167,548,155...167,629,980
G
Eed
embryonic ectoderm development
IDA
RGD
PMID:24007266
RGD:9588303
NCBI chr 1:143,867,875...143,895,008
Ensembl chr 1:143,867,875...143,894,974
G
Eif2s1
eukaryotic translation initiation factor 2 subunit alpha
ISO IEP
associated with Heart Arrest
RGD
PMID:11520898 PMID:10541873
RGD:10395353 , RGD:11041881
NCBI chr 6:97,672,829...97,697,499
Ensembl chr 6:97,672,766...97,706,225
G
Elane
elastase, neutrophil expressed
treatment
IMP
RGD
PMID:19168036
RGD:10450558
NCBI chr 7:9,817,251...9,819,174
Ensembl chr 7:9,817,252...9,819,100
G
Elk1
ETS transcription factor ELK1
treatment
IEP
RGD
PMID:17091294
RGD:7488902
NCBI chr X:1,138,826...1,155,713
Ensembl chr X:1,139,756...1,155,713
G
Entpd1
ectonucleoside triphosphate diphosphohydrolase 1
IEP
mRNA:increased expression:brain:
RGD
PMID:9634555
RGD:9685492
NCBI chr 1:239,425,515...239,552,323
Ensembl chr 1:239,425,430...239,552,317
G
Ep300
E1A binding protein p300
IEP
mRNA:increased expression:cerebrum, ipsilateral side (rat)
RGD
PMID:22196858
RGD:7349341
NCBI chr 7:113,108,476...113,178,529
Ensembl chr 7:113,106,247...113,136,088 Ensembl chr 7:113,106,247...113,136,088
G
Epo
erythropoietin
treatment
IEP ISO
RGD
PMID:22282883 PMID:24702327
RGD:10401060 , RGD:11041699
NCBI chr12:19,204,258...19,207,948
Ensembl chr12:19,204,508...19,207,946
G
Ercc1
ERCC excision repair 1, endonuclease non-catalytic subunit
treatment
ISO
human gene in a rat model
RGD
PMID:19440222
RGD:2313668
NCBI chr 1:78,971,310...79,007,963
Ensembl chr 1:78,996,390...79,007,963
G
Ercc6
ERCC excision repair 6, chromatin remodeling factor
IEP
mRNA, protein:increased expression:cerebral cortex
RGD
PMID:10437118
RGD:10401104
NCBI chr16:7,764,983...7,835,587
Ensembl chr16:7,765,013...7,835,587
G
Esr1
estrogen receptor 1
treatment
IDA
RGD
PMID:24548484 PMID:25098259
RGD:10045843 , RGD:10045845
NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
G
Esr2
estrogen receptor 2
IMP
RGD
PMID:23593292
RGD:7364962
NCBI chr 6:94,858,438...94,909,630
Ensembl chr 6:94,809,547...94,908,919
G
F11r
F11 receptor
treatment
IEP
RGD
PMID:22868201
RGD:7488943
NCBI chr13:83,873,797...83,897,388
Ensembl chr13:83,873,797...83,897,402
G
F12
coagulation factor XII
treatment
ISO
RGD
PMID:16533887 PMID:16533887
RGD:11041786 , RGD:11041786
NCBI chr17:9,207,683...9,215,530
Ensembl chr17:9,207,683...9,215,530
G
Fadd
Fas associated via death domain
IEP
mRNA,protein:increased expression:cerebral cortex:
RGD
PMID:18096138
RGD:4142863
NCBI chr 1:199,743,200...199,745,746
Ensembl chr 1:199,739,994...199,745,653
G
Fas
Fas cell surface death receptor
treatment
IEP IDA ISO
protein:increased expression:brain protein:increased expression:brain (rat)
RGD
PMID:18410517 PMID:30301943 PMID:18981705 PMID:10972965
RGD:2311437 , RGD:153297779 , RGD:8686422 , RGD:8662928
NCBI chr 1:231,798,963...231,832,591
Ensembl chr 1:231,798,960...231,832,591
G
Fgfr1
Fibroblast growth factor receptor 1
IEP
mRNA:increased expression:cerebral cortex:
RGD
PMID:8858623
RGD:10402044
NCBI chr16:66,491,930...66,547,161
Ensembl chr16:66,494,042...66,547,350
G
Fgfr2
fibroblast growth factor receptor 2
treatment
IEP
associated with Experimental Diabetes Mellitus
RGD
PMID:22432030
RGD:155882598
NCBI chr 1:184,745,418...184,850,655
Ensembl chr 1:184,745,420...184,850,626
G
Flt1
Fms related receptor tyrosine kinase 1
treatment
ISO
RGD
PMID:17077813
RGD:10402150
NCBI chr12:7,296,899...7,468,626
Ensembl chr12:7,297,292...7,468,626
G
Fmr1
fragile X messenger ribonucleoprotein 1
IEP
mRNA, protein:increased expression:striatum (rat)
RGD
PMID:22817682
RGD:11566024
NCBI chr X:147,240,239...147,278,057
Ensembl chr X:147,240,301...147,278,050
G
Fto
FTO, alpha-ketoglutarate dependent dioxygenase
IEP ISO
protein:decreased expression:cerebral cortex mRNA:decreased expression:cerebral cortex mRNA:decreased expression:heart
RGD
PMID:32426101 PMID:36479246 PMID:34413770
RGD:329901764 , RGD:329951019 , RGD:329901768
NCBI chr19:15,284,898...15,692,142
Ensembl chr19:15,349,696...15,692,083
G
G6pd
glucose-6-phosphate dehydrogenase
IMP
RGD
PMID:22580330
RGD:10449127
NCBI chr X:152,201,081...152,220,863
Ensembl chr X:152,201,098...152,220,801
G
Gad1
glutamate decarboxylase 1
disease_progression
IEP
RGD
PMID:20659561
RGD:401900597
NCBI chr 3:55,369,704...55,410,335
Ensembl chr 3:55,369,704...55,410,333
G
Gad2
glutamate decarboxylase 2
disease_progression
IEP
RGD
PMID:20659561
RGD:401900597
NCBI chr17:84,763,630...84,826,155
Ensembl chr17:84,763,628...84,826,155
G
Gamt
guanidinoacetate N-methyltransferase
ameliorates
ISO
DNA:deletion
RGD
PMID:24004504
RGD:329955375
NCBI chr 7:9,448,590...9,451,413
Ensembl chr 7:9,448,628...9,451,778
G
Gatm
glycine amidinotransferase
exacerbates
ISO
DNA:deletion
RGD
PMID:24004504
RGD:329955375
NCBI chr 3:109,658,919...109,675,508
Ensembl chr 3:109,658,951...109,684,129
G
Gch1
GTP cyclohydrolase 1
treatment
IMP
RGD
PMID:9920651
RGD:329961573
NCBI chr15:20,404,267...20,437,727
Ensembl chr15:20,402,527...20,437,698
G
Ghsr
growth hormone secretagogue receptor
IEP
mRNA,protein:decreased expression:brain:
RGD
PMID:17560544
RGD:12907500
NCBI chr 2:110,268,489...110,271,865
Ensembl chr 2:110,268,489...110,271,865
G
Gja1
gap junction protein, alpha 1
treatment
ISO IEP
protein:increased expression:brain
RGD
PMID:22812228 PMID:23328809
RGD:7207263 , RGD:8662426
NCBI chr20:35,756,007...35,768,481
Ensembl chr20:35,755,991...35,768,582
G
Gjb6
gap junction protein, beta 6
IEP
protein:increased expression:hippocampus:
RGD
PMID:21718970
RGD:6480433
NCBI chr15:31,284,561...31,294,552
Ensembl chr15:31,284,419...31,294,582
G
Glrx
glutaredoxin
IEP
mRNA,protein:decreased expression:brain:
RGD
PMID:10329397
RGD:9686043
NCBI chr 2:5,341,873...5,351,686
Ensembl chr 2:5,341,885...5,351,680
G
Glul
glutamate-ammonia ligase
treatment
IEP
associated with carotid artery occlusion protein:increased expression:hippocampus
RGD
PMID:27664163 PMID:25365917 PMID:21272618 PMID:21371894
RGD:401794415 , RGD:401794591 , RGD:401794590 , RGD:401794419
NCBI chr13:65,969,053...66,035,121
Ensembl chr13:66,025,630...66,035,108
G
Got1
glutamic-oxaloacetic transaminase 1
treatment
ISO IDA
human protein in a rat model
RGD
PMID:24407245 PMID:21361730 PMID:20145654
RGD:13504852 , RGD:13504855 , RGD:13504854
NCBI chr 1:242,357,293...242,381,535
Ensembl chr 1:242,357,306...242,380,633
G
Gp6
glycoprotein VI
ameliorates
ISO
RGD
PMID:34237320
RGD:401794450
NCBI chr 1:69,429,232...69,492,709
Ensembl chr 1:69,465,789...69,491,326
G
Gpx3
glutathione peroxidase 3
treatment
ISO
RGD
PMID:30098076
RGD:401827833
NCBI chr10:39,028,624...39,036,695
Ensembl chr10:39,028,570...39,037,035
G
Grin2a
glutamate ionotropic receptor NMDA type subunit 2A
ameliorates treatment
IMP IDA ISO
associated with hyperhomocysteinemia
RGD
PMID:30885791 PMID:12932824 PMID:30885791
RGD:401940141 , RGD:401950480 , RGD:401940141
NCBI chr10:5,629,683...6,053,262
Ensembl chr10:5,631,369...6,044,637
G
Grin2b
glutamate ionotropic receptor NMDA type subunit 2B
ameliorates
IMP
RGD
PMID:30885791
RGD:401940141
NCBI chr 4:168,580,824...169,044,110
Ensembl chr 4:168,599,546...169,042,279
G
Gsr
glutathione-disulfide reductase
treatment
IDA
RGD
PMID:15525350
RGD:10401855
NCBI chr16:58,482,209...58,525,256
Ensembl chr16:58,482,505...58,525,661
G
H2ax
H2A.X variant histone
treatment
IDA
RGD
PMID:20830300
RGD:8693742
NCBI chr 8:44,671,907...44,673,262
Ensembl chr 8:44,671,786...44,673,239
G
Havcr2
hepatitis A virus cellular receptor 2
treatment
IEP
RGD
PMID:24771108
RGD:9686115
NCBI chr10:30,882,484...30,914,018
Ensembl chr10:30,882,606...30,909,137
G
Hif1a
hypoxia inducible factor 1 subunit alpha
treatment
IEP
protein:increased expression:cerebral cortex, caudoputamen (rat)
RGD
PMID:20417628 PMID:30258350
RGD:9068877 , RGD:155663419
NCBI chr 6:92,624,059...92,669,262
Ensembl chr 6:92,624,390...92,669,261
G
Hmgb1
high mobility group box 1
ISO
protein:increased expression:brain, plasma
RGD
PMID:23288172
RGD:8696004
NCBI chr12:5,972,950...5,979,658
Ensembl chr12:5,901,586...5,978,565 Ensembl chr16:5,901,586...5,978,565
G
Hnrnpa2b1
heterogeneous nuclear ribonucleoprotein A2/B1
IEP
protein:altered expression:cerebral cortex, hippocampus (rat)
RGD
PMID:20421594
RGD:10041006
NCBI chr 4:80,534,659...80,545,297
Ensembl chr 4:80,534,651...80,545,249
G
Hnrnpab
heterogeneous nuclear ribonucleoprotein A/B
treatment
IDA
RGD
PMID:22366221
RGD:9999181
NCBI chr10:35,857,040...35,862,935
Ensembl chr10:35,857,041...35,863,344
G
Hrh2
histamine receptor H 2
IEP
protein:decreased expression:caudate putamen (rat)
RGD
PMID:16181737
RGD:9685533
NCBI chr17:10,366,004...10,407,791
Ensembl chr17:10,368,298...10,407,631
G
Hsf1
heat shock transcription factor 1
treatment
IEP IDA
protein:increased expression:brain, nucleus (rat) associated with Heart Arrest
RGD
PMID:26070787 PMID:23528677
RGD:10402389 , RGD:10402772
NCBI chr 7:108,196,040...108,223,011
Ensembl chr 7:108,196,056...108,223,011
G
Hspa5
heat shock protein family A (Hsp70) member 5
treatment
IEP
RGD
PMID:25632565
RGD:11354959
NCBI chr 3:18,055,507...18,059,969
Ensembl chr 3:18,055,405...18,059,891
G
Hspa8
heat shock protein family A (Hsp70) member 8
IEP
protein:increased expression:brain, postsynaptic density (rat)
RGD
PMID:9425004
RGD:10059344
NCBI chr 8:41,183,397...41,187,260
Ensembl chr 8:41,183,264...41,187,259
G
Hspb1
heat shock protein family B (small) member 1
IEP
protein:increased expression:brain,astrocyte:
RGD
PMID:10559386
RGD:10402577
NCBI chr12:20,794,014...20,795,675
Ensembl chr12:20,794,028...20,795,743
G
Htra2
HtrA serine peptidase 2
treatment
IMP ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:15306124 PMID:19462455
RGD:10402932
NCBI chr 4:115,556,914...115,560,202
Ensembl chr 4:115,556,916...115,560,095
G
Htt
huntingtin
IEP
protein:increased degradation:brain
RGD
PMID:12957494
RGD:1304431
NCBI chr14:75,845,836...75,996,094
Ensembl chr14:75,845,836...75,995,070
G
Icam1
intercellular adhesion molecule 1
treatment
IEP
RGD
PMID:22379785
RGD:8547729
NCBI chr 8:19,553,063...19,565,438
Ensembl chr 8:19,553,645...19,565,438
G
Ifnb1
interferon beta 1
ameliorates
IDA
RGD
PMID:12973019
RGD:401851924
NCBI chr 5:103,020,758...103,021,595
Ensembl chr 5:103,020,969...103,021,523
G
Igf1
insulin-like growth factor 1
severity
IEP
protein:decreased expression:serum (rat)
RGD
PMID:25098324
RGD:12904924
NCBI chr 7:22,282,895...22,361,972
Ensembl chr 7:22,282,930...22,359,296
G
Ikbkb
inhibitor of nuclear factor kappa B kinase subunit beta
treatment
IEP
RGD
PMID:24261295
RGD:7495766
NCBI chr16:69,319,487...69,373,251
Ensembl chr16:69,319,554...69,373,250
G
Il10
interleukin 10
treatment
IDA
RGD
PMID:24053818
RGD:7364868
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
G
Il1b
interleukin 1 beta
IDA ISO
RGD
PMID:23147509 PMID:22284622
RGD:7175551 , RGD:7175554
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
G
Il1rn
interleukin 1 receptor antagonist
IDA ISO
human protein in a rat model
RGD
PMID:15837124 PMID:20412072
RGD:1626674 , RGD:8551852
NCBI chr 3:7,111,567...7,127,451
Ensembl chr 3:7,111,550...7,127,445
G
Ilk
integrin-linked kinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15472100
NCBI chr 1:160,088,839...160,095,140
Ensembl chr 1:160,088,897...160,095,140
G
Itgam
integrin subunit alpha M
treatment
ISO IEP IMP
mRNA:increased expression:cerebral cortex (mouse) mRNA:increased expression:brain (rat)
RGD
PMID:30123113 PMID:23844255 PMID:22082476 PMID:32407868 PMID:19563786 PMID:8964796 PMID:8581506 PMID:8160235 More...
RGD:329853754 , RGD:329902067 , RGD:329902058 , RGD:329901940 , RGD:329901933 , RGD:329901921 , RGD:329901917 , RGD:329901916
NCBI chr 1:182,659,047...182,709,501
Ensembl chr 1:182,659,000...182,709,503
G
Itgb3
integrin subunit beta 3
IEP
RGD
PMID:18638458
RGD:6907424
NCBI chr10:89,509,917...89,564,679
Ensembl chr10:89,509,989...89,564,679
G
Itpr1
inositol 1,4,5-trisphosphate receptor, type 1
IEP
mRNA:decreased expression:cerebral cortex (rat)
RGD
PMID:7500836
RGD:6482813
NCBI chr 4:141,187,377...141,554,240
Ensembl chr 4:141,187,418...141,510,491
G
Jak1
Janus kinase 1
IEP
RGD
PMID:10756075
RGD:19165138
NCBI chr 5:115,780,248...115,888,841
Ensembl chr 5:115,780,248...115,888,926
G
Jak2
Janus kinase 2
IDA
RGD
PMID:23764464
RGD:8694326
NCBI chr 1:226,995,334...227,054,381
Ensembl chr 1:226,995,334...227,054,189
G
Kcnj10
potassium inwardly-rectifying channel, subfamily J, member 10
IEP
protein:decreased expression:CA1 field of hippocampus, astrocyte, astrocyte projection
RGD
PMID:20833221
RGD:8662899
NCBI chr13:84,802,026...84,835,383
Ensembl chr13:84,802,009...84,835,461
G
Kcnk2
potassium two pore domain channel subfamily K member 2
severity treatment
ISO IDA IEP
protein:increased expression:cerebral cortex (rat)
RGD
PMID:15175651 PMID:24154701 PMID:25062759
RGD:9831121 , RGD:9831178 , RGD:9831122
NCBI chr13:100,766,101...100,963,435
Ensembl chr13:100,766,113...100,963,435
G
Kdm1a
lysine demethylase 1A
IEP
protein:increased expression:cerebral cortex, hippocampus, dentate gyrus (rat)
RGD
PMID:20542065
RGD:9588301
NCBI chr 5:148,782,976...148,838,319
Ensembl chr 5:148,782,976...148,838,319
G
Keap1
Kelch-like ECH-associated protein 1
ISO
protein:decreased expression:brain (mouse)
RGD
PMID:21075092
RGD:6893270
NCBI chr 8:19,768,375...19,777,862
Ensembl chr 8:19,768,375...19,777,862
G
Klf5
KLF transcription factor 5
ameliorates
IMP
RGD
PMID:32272873
RGD:45073134
NCBI chr15:76,060,320...76,079,445
Ensembl chr15:76,064,258...76,079,445
G
Kmt2a
lysine methyltransferase 2A
treatment
IMP
RGD
PMID:34694864
RGD:155888565
NCBI chr 8:45,116,763...45,193,320
Ensembl chr 8:45,118,814...45,193,181
G
Lcn2
lipocalin 2
IEP
protein:increased expression:brain
RGD
PMID:29122651 PMID:24916903
RGD:126781757 , RGD:126790489
NCBI chr 3:15,680,688...15,684,033
Ensembl chr 3:15,680,687...15,684,095
G
Lmna
lamin A/C
IDA
RGD
PMID:17683050
RGD:2293745
NCBI chr 2:173,939,751...173,960,423
Ensembl chr 2:173,939,751...173,960,423
G
Lpar1
lysophosphatidic acid receptor 1
treatment
IDA
RGD
PMID:17173873
RGD:9850154
NCBI chr 5:73,229,047...73,347,874
Ensembl chr 5:73,229,625...73,369,895
G
Ltbp1
latent transforming growth factor beta binding protein 1
treatment
IEP
RGD
PMID:11720783
RGD:10412057
NCBI chr 6:20,029,629...20,425,339
Ensembl chr 6:20,029,629...20,425,349
G
Madd
MAP-kinase activating death domain
IEP
RGD
PMID:12625816
RGD:9588641
NCBI chr 3:77,114,330...77,157,865
Ensembl chr 3:77,114,314...77,157,701
G
Map1lc3a
microtubule-associated protein 1 light chain 3 alpha
treatment
IEP
RGD
PMID:22509406
RGD:11561910
NCBI chr 3:143,783,024...143,784,670
Ensembl chr 3:143,783,024...143,784,670
G
Map2k4
mitogen activated protein kinase kinase 4
IDA
protein:increased threonine phosphorylation:heart, nucleus
RGD
PMID:9195981
RGD:7495830
NCBI chr10:50,343,227...50,447,956
Ensembl chr10:50,344,915...50,447,993
G
Map3k5
mitogen-activated protein kinase kinase kinase 5
IEP
protein:increased nitrosylation, activity:hippocampus:
RGD
PMID:23137546
RGD:10412334
NCBI chr 1:14,685,776...14,904,935
Ensembl chr 1:14,685,492...14,904,800
G
Map3k7
mitogen activated protein kinase kinase kinase 7
ameliorates
ISO
RGD
PMID:32078472 PMID:32349637 PMID:34628598 PMID:32382778
RGD:155791642 , RGD:155804284 , RGD:155804283 , RGD:155804272
NCBI chr 5:46,356,973...46,415,597
Ensembl chr 5:46,357,931...46,415,597
G
Map4k1
mitogen activated protein kinase kinase kinase kinase 1
treatment
IDA
RGD
PMID:18498770 PMID:18382279
RGD:7495845 , RGD:7495847
NCBI chr 1:84,270,951...84,292,496
Ensembl chr 1:84,271,069...84,292,493
G
Mbd1
methyl-CpG binding domain protein 1
IEP
mRNA:increased expression:hippocampus
RGD
PMID:12421618
RGD:9587846
NCBI chr18:67,869,870...67,884,501
Ensembl chr18:67,869,992...67,886,554
G
Mbd2
methyl-CpG binding domain protein 2
IEP
mRNA:increased expression:hippocampus
RGD
PMID:12421618
RGD:9587846
NCBI chr18:64,174,002...64,240,795
Ensembl chr18:64,174,002...64,240,794
G
Mbd3
methyl-CpG binding domain protein 3
IEP
mRNA:decreased expression:hippocampus
RGD
PMID:12421618
RGD:9587846
NCBI chr 7:9,312,961...9,320,166
Ensembl chr 7:9,313,098...9,320,165
G
Mbp
myelin basic protein
IEP
mRNA:increased expression:oligodendrocyte:
RGD
PMID:11460777
RGD:7349336
NCBI chr18:75,855,878...75,966,404
Ensembl chr18:75,855,878...75,966,404
G
Mcfd2
multiple coagulation factor deficiency 2, ER cargo receptor complex subunit
IEP
mRNA:increased expression:hippocampus
RGD
PMID:17610559
RGD:11062141
NCBI chr 6:7,274,469...7,285,841
Ensembl chr 6:7,274,469...7,285,841
G
Mdm2
MDM2 proto-oncogene
treatment
IDA
RGD
PMID:24334056
RGD:10412310
NCBI chr 7:53,290,660...53,315,205
Ensembl chr 7:53,290,664...53,314,915
G
Mecp2
methyl CpG binding protein 2
IEP
mRNA:increased expression:hippocampus
RGD
PMID:12421618
RGD:9587846
NCBI chr X:151,781,177...151,844,687
Ensembl chr X:151,789,930...151,844,689
G
Mff
mitochondrial fission factor
treatment
IDA
RGD
PMID:26116440
RGD:12879457
NCBI chr 9:84,007,798...84,036,039
Ensembl chr 9:84,007,798...84,036,039
G
Mfn2
mitofusin 2
IEP
protein:decreased expression:brain (rat)
RGD
PMID:25147362
RGD:13204807
NCBI chr 5:158,304,285...158,335,502
Ensembl chr 5:158,304,287...158,335,342
G
Mir126a
microRNA 126a
exacerbates
ISO
RGD
PMID:28101763
RGD:401850574
NCBI chr 3:9,415,063...9,415,180
Ensembl chr 3:9,415,063...9,415,180
G
Mir155
microRNA 155
treatment
IEP
RGD
PMID:33081480
RGD:151347423
NCBI chr11:23,774,654...23,774,718
Ensembl chr11:23,774,654...23,774,718
G
Mir195
microRNA 195
severity
IMP
RGD
PMID:32272873
RGD:45073134
NCBI chr10:54,951,838...54,951,924
Ensembl chr10:54,951,838...54,951,924
G
Mir223
microRNA 223
IMP
RGD
PMID:31237865
RGD:25824937
NCBI chr X:61,141,887...61,141,996
Ensembl chr X:61,141,887...61,141,996
G
Mmp2
matrix metallopeptidase 2
treatment
IDA IEP
protein:increased activity, increased expression:brain
RGD
PMID:11592852 PMID:24828425
RGD:8547930 , RGD:8657086
NCBI chr19:14,154,657...14,182,870
Ensembl chr19:14,154,657...14,182,870
G
Mmp9
matrix metallopeptidase 9
treatment
ISO IEP IDA
protein:increased activity, increased expression:brain
RGD
PMID:16197500 PMID:24773551 PMID:23046750 PMID:11592852
RGD:8547921 , RGD:13207320 , RGD:13207323 , RGD:8547930
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
G
Mt1
metallothionein 1
IEP
mRNA:increased expression:cerebral cortex
RGD
PMID:10884303
RGD:10412650
NCBI chr19:10,826,032...10,827,048
Ensembl chr19:10,826,032...10,827,049 Ensembl chr17:10,826,032...10,827,049
G
Mt2A
metallothionein 2A
IEP
mRNA:increased expression:cerebral cortex
RGD
PMID:10884303
RGD:10412650
NCBI chr19:10,832,009...10,832,783
Ensembl chr19:10,832,002...10,832,784
G
Mt3
metallothionein 3
IEP
mRNA, protein:increased expression:brain
RGD
PMID:10069533
RGD:9685804
NCBI chr19:10,848,754...10,850,158
Ensembl chr19:10,848,755...10,850,158
G
Mtor
mechanistic target of rapamycin kinase
treatment
IEP
RGD
PMID:30712471
RGD:155791663
NCBI chr 5:158,884,856...158,994,311
Ensembl chr 5:158,884,804...158,994,311
G
Myb
MYB proto-oncogene, transcription factor
IEP
mRNA:increased expression:brain:
RGD
PMID:24828495
RGD:11532683
NCBI chr 1:15,939,771...15,973,367
Ensembl chr 1:15,939,761...15,973,057
G
Nampt
nicotinamide phosphoribosyltransferase
treatment
IMP ISO
RGD
PMID:28528966 PMID:25603815
RGD:13781879 , RGD:13781895
NCBI chr 6:49,425,316...49,462,109
Ensembl chr 6:49,424,332...49,462,100
G
Ndrg2
NDRG family member 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23451161
NCBI chr15:24,600,981...24,609,621
Ensembl chr15:24,600,982...24,609,626
G
Ndrg4
NDRG family member 4
ISO
RGD
PMID:21636852
RGD:7247728
NCBI chr19:9,351,408...9,387,398
Ensembl chr19:9,351,404...9,386,914
G
Nefh
neurofilament heavy chain
IEP
protein:decreased expression:hippocampus
RGD
PMID:8726968
RGD:9743938
NCBI chr14:79,830,362...79,840,347
Ensembl chr14:79,830,362...79,840,351
G
Nefl
neurofilament light chain
IEP
protein:decreased expression:hippocampus
RGD
PMID:8726968
RGD:9743938
NCBI chr15:42,301,920...42,305,793
Ensembl chr15:42,301,916...42,305,793
G
Nefm
neurofilament medium chain
IEP
protein:decreased expression:hippocampus
RGD
PMID:8726968
RGD:9743938
NCBI chr15:42,360,449...42,365,753
Ensembl chr15:42,360,454...42,365,755
G
Nf1
neurofibromin 1
IEP
mRNA,protein:increased expression:astrocyte:
RGD
PMID:8820972
RGD:12789703
NCBI chr10:64,306,027...64,539,112
Ensembl chr10:64,306,301...64,536,658
G
Nfkb1
nuclear factor kappa B subunit 1
IEP
protein:increased expression:hippocampal pyramidal neuron, nucleus (rat)
RGD
PMID:9158652
RGD:10045943
NCBI chr 2:224,016,214...224,132,135
Ensembl chr 2:224,016,214...224,110,404
G
Ngb
neuroglobin
treatment
IEP ISO IMP
associated with Hypertension;mRNA, protein:decreased expression:brain
RGD
PMID:16647691 PMID:23342777 PMID:12621155 PMID:12621155
RGD:9743952 , RGD:9743965 , RGD:9743964 , RGD:9743964
NCBI chr 6:106,744,378...106,749,830
Ensembl chr 6:106,744,378...106,749,830
G
Ngfr
nerve growth factor receptor
IEP
RGD
PMID:11124986
RGD:9743974
NCBI chr10:80,515,287...80,533,518
Ensembl chr10:80,515,299...80,533,518
G
Nod2
nucleotide-binding oligomerization domain containing 2
ISO
mRNA, protein:increased expression:brain
RGD
PMID:20863826
RGD:5508733
NCBI chr19:18,382,369...18,422,817
Ensembl chr19:18,382,439...18,417,177
G
Nono
non-POU domain containing, octamer-binding
ISO
protein:altered localization:cerebral cortex (mouse)
RGD
PMID:29426953
RGD:155883175
NCBI chr X:66,554,131...66,571,992
Ensembl chr X:66,554,098...66,571,952
G
Nos1
nitric oxide synthase 1
IDA
protein:increased serine phosphorylation:dentate gyrus
RGD
PMID:23806217
RGD:7257600
NCBI chr12:38,615,111...38,795,492
Ensembl chr12:38,626,714...38,710,945
G
Nos3
nitric oxide synthase 3
treatment
IEP IDA
protein:increased expression:serum (rat)
RGD
PMID:28944915 PMID:29298658 PMID:29312485
RGD:13450951 , RGD:13503353 , RGD:13503330
NCBI chr 4:10,793,834...10,814,170
Ensembl chr 4:10,793,834...10,814,166
G
Notch1
notch receptor 1
treatment
IEP
RGD
PMID:30258350
RGD:155663419
NCBI chr 3:9,277,955...9,323,531
Ensembl chr 3:9,278,086...9,323,531
G
Nox1
NADPH oxidase 1
ameliorates
IMP
RGD
PMID:25617620
RGD:329955357
NCBI chr X:97,279,058...97,332,291
Ensembl chr X:97,279,056...97,302,236
G
Nqo1
NAD(P)H quinone dehydrogenase 1
treatment
IEP
protein:increased expression:cerebral cortex (rat) protein:increased expression:brain (rat)
RGD
PMID:29017857 PMID:28169530 PMID:28552673
RGD:13439718 , RGD:13442499 , RGD:13439727
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
G
Nrg1
neuregulin 1
treatment
ISO
RGD
PMID:31560696
RGD:405649728
NCBI chr16:59,250,658...60,304,519
Ensembl chr16:59,250,854...60,296,884
G
Nrp1
neuropilin 1
IEP
mRNA:increased expression:brain
RGD
PMID:33675584
RGD:401901171
NCBI chr19:56,359,455...56,514,628
Ensembl chr19:56,359,455...56,513,633
G
Nrxn1
neurexin 1
IEP
associated with Hypertension;mRNA:decreased expression:cerebral cortex
RGD
PMID:12437578
RGD:632385
NCBI chr 6:3,177,788...4,323,848
Ensembl chr 6:3,177,897...4,322,710
G
Ogg1
8-oxoguanine DNA glycosylase
IEP
protein:increased expression:cerebral cortex
RGD
PMID:14600440
RGD:8657406
NCBI chr 4:146,474,701...146,481,959
Ensembl chr 4:146,474,750...146,484,766
G
Opa1
OPA1, mitochondrial dynamin like GTPase
treatment
ISO IDA
protein:altered expression:brain
RGD
PMID:22345048 PMID:24633199
RGD:7800722 , RGD:13208946
NCBI chr11:71,108,100...71,185,170
Ensembl chr11:71,109,873...71,185,109
G
Optn
optineurin
IEP
protein:decreased expression:cerebral cortex (rat)
RGD
PMID:24235151
RGD:13434905
NCBI chr17:73,209,572...73,260,251
Ensembl chr17:73,209,575...73,260,251
G
Parl
presenilin associated, rhomboid-like
severity
ISO
RGD
PMID:23921894
RGD:12902620
NCBI chr11:80,594,059...80,620,506
Ensembl chr11:80,593,192...80,620,506
G
Parp1
poly (ADP-ribose) polymerase 1
treatment
IDA IEP
RGD
PMID:19840223 PMID:19840223
RGD:2325713 , RGD:2325713
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
G
Pawr
pro-apoptotic WT1 regulator
IEP ISO
mRNA:increased expression:brain: protein:increased expression:cortex,striatum:
RGD
PMID:14705148 PMID:11323519
RGD:1302269 , RGD:9835381
NCBI chr 7:43,645,028...43,725,033
Ensembl chr 7:43,645,084...43,725,028
G
Pax6
paired box 6
IEP
protein:increased expression:cerebral cortex, striatum, astroglial cell (rat)
RGD
PMID:24114637
RGD:8552354
NCBI chr 3:92,128,772...92,157,022
Ensembl chr 3:92,135,637...92,157,014
G
Pcna
proliferating cell nuclear antigen
IEP
RGD
PMID:9757027
RGD:10448974
NCBI chr 3:119,499,039...119,502,911
Ensembl chr 3:119,498,810...119,502,995
G
Pde4d
phosphodiesterase 4D
IEP
protein:increased expression:hippocampus CA1
RGD
PMID:22860212
RGD:7327148
NCBI chr 2:40,014,933...41,529,190
Ensembl chr 2:40,019,933...41,525,884
G
Pdyn
prodynorphin
IEP
mRNA:decreased expression:dentate gyrus, granule cell
RGD
PMID:8914861
RGD:401851049
NCBI chr 3:116,900,990...116,913,334
Ensembl chr 3:116,900,992...116,913,334
G
Pecam1
platelet and endothelial cell adhesion molecule 1
ISO
protein:increased expression:brain (mouse)
RGD
PMID:22382321
RGD:6766379
NCBI chr10:91,590,521...91,652,279
Ensembl chr10:91,590,521...91,652,116
G
Plat
plasminogen activator, tissue type
IEP
Protein:increased expression, increased activity:hippocampus (rat)
RGD
PMID:15882815
RGD:1580875
NCBI chr16:69,240,582...69,265,177
Ensembl chr16:69,240,585...69,268,223
G
Plau
plasminogen activator, urokinase
IEP IDA
protein:increased expression:cerebral cortex (rat)
RGD
PMID:21375013 PMID:19952306
RGD:7241584 , RGD:7241795
NCBI chr15:3,456,230...3,462,732
Ensembl chr15:3,456,232...3,462,775
G
Plxnd1
plexin D1
ameliorates
IMP
RGD
PMID:30653356
RGD:155663383
NCBI chr 4:149,002,786...149,043,097
Ensembl chr 4:149,002,784...149,043,244
G
Pparg
peroxisome proliferator-activated receptor gamma
IMP IEP
RGD
PMID:18378216 PMID:19221220 PMID:18973594
RGD:2301892 , RGD:8553032 , RGD:2301866
NCBI chr 4:148,423,102...148,548,471
Ensembl chr 4:148,423,194...148,548,468
G
Ppp1r15a
protein phosphatase 1, regulatory subunit 15A
IEP
protein:increased expression:cerebral cortex (rat)
RGD
PMID:15255948
RGD:9999154
NCBI chr 1:96,000,053...96,003,128
Ensembl chr 1:96,000,058...96,003,171
G
Ppp1r9a
protein phosphatase 1, regulatory subunit 9A
treatment
IDA
RGD
PMID:21278085
RGD:10043805
NCBI chr 4:32,970,501...33,292,360
Ensembl chr 4:33,024,450...33,286,907
G
Ppp2r5e
protein phosphatase 2 regulatory subunit B', epsilon
treatment
IEP
RGD
PMID:30712471
RGD:155791663
NCBI chr 6:94,168,846...94,317,872
Ensembl chr 6:94,168,846...94,317,872
G
Prkn
parkin RBR E3 ubiquitin protein ligase
ISO
protein:decreased expression:cerebral cortex, striatum:
RGD
PMID:12415119
RGD:10413862
NCBI chr 1:48,688,651...49,882,520
Ensembl chr 1:48,690,556...49,882,555
G
Ptafr
platelet-activating factor receptor
treatment
IEP IMP
mRNA:decreased expression:cerebral cortex (rat)
RGD
PMID:17268849 PMID:8158141
RGD:9999221 , RGD:10043297
NCBI chr 5:144,765,770...144,795,057
Ensembl chr 5:144,765,976...144,795,251
G
Pten
phosphatase and tensin homolog
IEP
RGD
PMID:12414116
RGD:1358425
NCBI chr 1:230,630,443...230,697,070
Ensembl chr 1:230,630,338...230,696,838
G
Ptger4
prostaglandin E receptor 4
IEP
protein:increased expression:hippocampus (rat)
RGD
PMID:16437207
RGD:10043375
NCBI chr 2:54,330,563...54,347,451
Ensembl chr 2:54,335,424...54,346,670
G
Ptgis
prostaglandin I2 synthase
treatment
IMP
RGD
PMID:27834752
RGD:401960086
NCBI chr 3:155,928,564...155,964,228
Ensembl chr 3:155,916,412...155,965,451
G
Ptn
pleiotrophin
IEP
mRNA:increased expression:cerebral cortex, vasculature, macrophage (rat)
RGD
PMID:9570800
RGD:9831440
NCBI chr 4:65,293,731...65,375,572
Ensembl chr 4:65,293,734...65,375,456
G
Ptpn13
protein tyrosine phosphatase, non-receptor type 13
IEP
mRNA,protein:increased expression:cerebral cortex:
RGD
PMID:18096138
RGD:4142863
NCBI chr14:6,108,202...6,282,619
Ensembl chr14:6,108,211...6,282,563
G
Ptpn5
protein tyrosine phosphatase, non-receptor type 5
severity treatment
IEP ISO IDA
protein:decreased phosphorylation, decreased expression:striatum (rat)
RGD
PMID:24198371 PMID:24198371 PMID:24198371
RGD:9835010 , RGD:9835010 , RGD:9835010
NCBI chr 1:97,620,638...97,681,186
Ensembl chr 1:97,620,642...97,679,882
G
Rack1
receptor for activated C kinase 1
IDA
RGD
PMID:24007266
RGD:9588303
NCBI chr10:33,169,415...33,174,896
Ensembl chr10:33,169,169...33,174,975
G
Robo1
roundabout guidance receptor 1
disease_progression
IEP ISO
protein:increased expression:hippocampus protein:increased expression:brain, astrocyte
RGD
PMID:26764532 PMID:23473743 PMID:27686659
RGD:11573340 , RGD:243048431 , RGD:243048429
NCBI chr11:10,580,863...11,621,675
Ensembl chr11:10,580,908...11,620,203
G
Robo2
roundabout guidance receptor 2
IEP
protein:increased expression:brain, astrocyte
RGD
PMID:27686659
RGD:243048429
NCBI chr11:12,528,949...14,096,726
Ensembl chr11:12,528,951...13,041,536
G
Robo4
roundabout guidance receptor 4
IEP
protein:increased expression:hippocampus
RGD
PMID:26764532
RGD:11573340
NCBI chr 8:37,119,953...37,133,887
Ensembl chr 8:37,119,988...37,132,519
G
Rps6
ribosomal protein S6
IDA
RGD
PMID:26556340
RGD:11041643
NCBI chr 5:101,371,716...101,374,576
Ensembl chr 5:101,371,136...101,374,602 Ensembl chr 5:101,371,136...101,374,602
G
Sema3e
semaphorin 3E
disease_progression
IEP
RGD
PMID:30653356
RGD:155663383
NCBI chr 4:20,297,534...20,555,287
Ensembl chr 4:20,299,718...20,555,229
G
Serpine1
serpin family E member 1
treatment
IDA
RGD
PMID:26851971
RGD:11073692
NCBI chr12:19,601,272...19,611,657
Ensembl chr12:19,601,272...19,611,657
G
Serpinf1
serpin family F member 1
treatment
ISO
human gene in a rat model
RGD
PMID:18624913
RGD:8613878
NCBI chr10:60,250,198...60,262,593
Ensembl chr10:60,249,708...60,262,646
G
Sgk1
serum/glucocorticoid regulated kinase 1
IEP
mRNA:increased expression:hippocampus, pyramidal cell
RGD
PMID:15046873
RGD:1580967
NCBI chr 1:22,980,257...23,098,122
Ensembl chr 1:22,980,261...23,098,283
G
Sin3a
SIN3 transcription regulator family member A
IDA
RGD
PMID:24063527
RGD:9495912
NCBI chr 8:57,481,539...57,536,195
Ensembl chr 8:57,481,573...57,536,192
G
Sirt6
sirtuin 6
IEP
mRNA, protein:decreased expression:brain
RGD
PMID:23899523
RGD:9586062
NCBI chr 7:8,082,312...8,087,776
Ensembl chr 7:8,082,364...8,098,914
G
Slc12a2
solute carrier family 12 member 2
IEP
RGD
PMID:27798271
RGD:14398833
NCBI chr18:51,348,282...51,416,448
Ensembl chr18:51,348,302...51,416,440
G
Slc17a6
solute carrier family 17 member 6
IEP
RGD
PMID:23458738
RGD:9999193
NCBI chr 1:101,212,489...101,252,543
Ensembl chr 1:101,212,489...101,252,542
G
Slc17a7
solute carrier family 17 member 7
IEP
RGD
PMID:23458738
RGD:9999193
NCBI chr 1:95,649,709...95,661,591
Ensembl chr 1:95,649,745...95,661,588
G
Slc17a8
solute carrier family 17 member 8
IEP
RGD
PMID:23458738
RGD:9999193
NCBI chr 7:23,994,212...24,049,498
Ensembl chr 7:23,994,217...24,048,079
G
Slit2
slit guidance ligand 2
IEP
protein:increased expression:hippocampus protein:increased expression:brain, astrocyte
RGD
PMID:26764532 PMID:27686659
RGD:11573340 , RGD:243048429
NCBI chr14:62,616,337...62,955,934
Ensembl chr14:62,617,067...62,955,948
G
Smpd3
sphingomyelin phosphodiesterase 3
IDA
RGD
PMID:24007266
RGD:9588303
NCBI chr19:34,162,337...34,245,786
Ensembl chr19:34,162,341...34,245,749
G
Socs1
suppressor of cytokine signaling 1
treatment
IEP
RGD
PMID:33081480
RGD:151347423
NCBI chr10:4,882,651...4,884,342
Ensembl chr10:4,882,560...4,884,383
G
Sod1
superoxide dismutase 1
treatment
ISO
human protein in a rat model CTD Direct Evidence: therapeutic human gene in a rat model
CTD RGD
PMID:12629175 PMID:15829915 PMID:16538228 PMID:16868554 PMID:21531066 PMID:17110031 More...
RGD:8655885 , RGD:8655986
NCBI chr11:29,456,673...29,462,249
Ensembl chr11:29,456,558...29,462,249
G
Sod2
superoxide dismutase 2
treatment
ISO IEP
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:11333366 PMID:30716316
RGD:27095883
NCBI chr 1:47,638,318...47,645,163
Ensembl chr 1:47,636,528...47,645,189
G
Stat3
signal transducer and activator of transcription 3
exacerbates
IDA IMP
RGD
PMID:23764464 PMID:23884942
RGD:8694326 , RGD:8694331
NCBI chr10:85,811,206...85,863,057
Ensembl chr10:85,811,218...85,863,057
G
Tert
telomerase reverse transcriptase
treatment
IDA
RGD
PMID:21914402
RGD:11038669
NCBI chr 1:29,637,213...29,659,561
Ensembl chr 1:29,637,506...29,659,561
G
Tfpi
tissue factor pathway inhibitor
treatment
ISO
RGD
PMID:18067952
RGD:11062087
NCBI chr 3:69,533,156...69,582,547
Ensembl chr 3:69,533,156...69,576,880
G
Tia1
TIA1 cytotoxic granule-associated RNA binding protein
IEP
RGD
PMID:16055272
RGD:10059581
NCBI chr 4:118,852,765...118,883,252
Ensembl chr 4:118,852,837...118,880,586
G
Tial1
Tia1 cytotoxic granule-associated RNA binding protein-like 1
IEP
RGD
PMID:10700014
RGD:1357161
NCBI chr 1:183,008,358...183,045,092
Ensembl chr 1:183,009,253...183,031,637
G
Tnf
tumor necrosis factor
treatment
IDA IEP
mRNA:increased expression:striatum,hippocampus:
RGD
PMID:24053818 PMID:11412877
RGD:7364868 , RGD:13825263
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Tnfrsf1a
TNF receptor superfamily member 1A
treatment
IEP
mRNA:increased expression:striatum,hippocampus:
RGD
PMID:21868309 PMID:11412877
RGD:8661762 , RGD:13825263
NCBI chr 4:158,150,815...158,163,592
Ensembl chr 4:158,150,820...158,163,591
G
Trpc6
transient receptor potential cation channel, subfamily C, member 6
treatment
IDA ISO
RGD
PMID:23435869 PMID:20811149 PMID:23043486
RGD:7247582 , RGD:7247585 , RGD:7247583
NCBI chr 8:5,759,387...5,864,000
Ensembl chr 8:5,758,935...5,828,092
G
Trpm2
transient receptor potential cation channel, subfamily M, member 2
IEP
mRNA:increased expression:cerebral cortex
RGD
PMID:16777714
RGD:10003026
NCBI chr20:10,703,568...10,753,189
Ensembl chr20:10,707,014...10,753,181
G
Trpv3
transient receptor potential cation channel, subfamily V, member 3
ISO
RGD
PMID:22284622
RGD:7175554
NCBI chr10:57,883,546...57,915,865
Ensembl chr10:57,883,546...57,913,296
G
Ucp2
uncoupling protein 2
treatment
IDA
RGD
PMID:19772611
RGD:7204428
NCBI chr 1:154,839,242...154,845,612
Ensembl chr 1:154,839,209...154,845,611
G
Vwf
von Willebrand factor
treatment
IDA
RGD
PMID:22771326
RGD:7207039
NCBI chr 4:158,360,152...158,491,539
Ensembl chr 4:158,360,152...158,491,539
G
Wnk1
WNK lysine deficient protein kinase 1
IEP
RGD
PMID:27798271
RGD:14398833
NCBI chr 4:153,128,334...153,253,905
Ensembl chr 4:153,128,334...153,253,905
G
Wnk2
WNK lysine deficient protein kinase 2
IEP
RGD
PMID:27798271
RGD:14398833
NCBI chr17:15,503,672...15,612,479
Ensembl chr17:15,504,261...15,612,479
G
Wnk4
WNK lysine deficient protein kinase 4
IEP
RGD
PMID:27798271
RGD:14398833
NCBI chr10:86,202,552...86,219,655
Ensembl chr10:86,188,812...86,231,829
G
Xrcc1
X-ray repair cross complementing 1
treatment
IEP
RGD
PMID:19840223
RGD:2325713
NCBI chr 1:80,140,495...80,168,705
Ensembl chr 1:80,141,207...80,168,701
G
Elane
elastase, neutrophil expressed
treatment
IMP
RGD
PMID:18165924
RGD:10450583
NCBI chr 7:9,817,251...9,819,174
Ensembl chr 7:9,817,252...9,819,100
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all